| 150340103 | CV1167982 | single nucleotide variant | NM_024996.7(GFM1):c.*9A>G | GFM1-related disorder [RCV003931165]|not provided [RCV001534982] | likely benign | 3 | 158691476 | 158691476 | Human | 1 | name , trait , alternate_id |
| 11590235 | CV290043 | single nucleotide variant | NM_024996.7(GFM1):c.*6C>T | Hepatoencephalopathy due to combined oxidative phosphorylation defect type 1 [RCV000317038]|not provided [RCV000676472]|not specified [RCV001795960] | benign | 3 | 158691473 | 158691473 | Human | 1 | name |
| 8691211 | CV141171 | single nucleotide variant | NM_024996.7(GFM1):c.-38C>T | GFM1-related disorder [RCV003925243]|Hepatoencephalopathy due to combined oxidative phosphorylation defect type 1 [RCV000389427]|not specified [RCV000125229] | benign|likely benign|uncertain significance | 3 | 158644597 | 158644597 | Human | 1 | name , trait , alternate_id |
| 8691212 | CV141172 | single nucleotide variant | NM_024996.7(GFM1):c.-31A>G | Hepatoencephalopathy due to combined oxidative phosphorylation defect type 1 [RCV000336135]|not provided [RCV004717014]|not specified [RCV000125230] | benign|likely benign | 3 | 158644604 | 158644604 | Human | 1 | name |
| 8691213 | CV141173 | single nucleotide variant | NM_024996.7(GFM1):c.-11C>T | Hepatoencephalopathy due to combined oxidative phosphorylation defect type 1 [RCV000396594]|not provided [RCV004715711]|not specified [RCV000125231] | benign|likely benign | 3 | 158644624 | 158644624 | Human | 1 | name |
| 11591681 | CV293519 | single nucleotide variant | NM_024996.7(GFM1):c.-73C>T | Hepatoencephalopathy due to combined oxidative phosphorylation defect type 1 [RCV000331237]|not provided [RCV004710937] | likely benign | 3 | 158644562 | 158644562 | Human | 1 | name |
| 11587444 | CV293528 | single nucleotide variant | NM_024996.7(GFM1):c.-33C>T | Hepatoencephalopathy due to combined oxidative phosphorylation defect type 1 [RCV000295077]|not provided [RCV001672626] | benign|likely benign | 3 | 158644602 | 158644602 | Human | 1 | name |
| 12846180 | CV367287 | single nucleotide variant | NM_024996.7(GFM1):c.-25C>T | not specified [RCV000441164] | likely benign | 3 | 158644610 | 158644610 | Human | | name |
| 28874257 | CV888242 | single nucleotide variant | NM_024996.7(GFM1):c.-85C>T | Hepatoencephalopathy due to combined oxidative phosphorylation defect type 1 [RCV001147126] | uncertain significance | 3 | 158644550 | 158644550 | Human | 1 | name |
| 28874260 | CV888243 | single nucleotide variant | NM_024996.7(GFM1):c.-66C>G | Hepatoencephalopathy due to combined oxidative phosphorylation defect type 1 [RCV001147127] | uncertain significance | 3 | 158644569 | 158644569 | Human | 1 | name |
| 127250492 | CV1055311 | single nucleotide variant | NM_024996.7(GFM1):c.81+1G>A | Hepatoencephalopathy due to combined oxidative phosphorylation defect type 1 [RCV001831352]|not provided [RCV001378369] | likely pathogenic | 3 | 158644716 | 158644716 | Human | 1 | name |
| 127247846 | CV1055312 | single nucleotide variant | NM_024996.7(GFM1):c.82-2A>C | not provided [RCV001377847] | likely pathogenic | 3 | 158645627 | 158645627 | Human | | name |
| 156446675 | CV1948026 | single nucleotide variant | NM_024996.7(GFM1):c.81+3A>G | not provided [RCV003118187] | uncertain significance | 3 | 158644718 | 158644718 | Human | | name |
| 156115444 | CV1952307 | deletion | NM_024996.7(GFM1):c.82-4del | not provided [RCV002571655] | benign | 3 | 158645619 | 158645619 | Human | | name |
| 156254398 | CV2003644 | duplication | NM_024996.7(GFM1):c.82-4dup | not provided [RCV002627557] | benign | 3 | 158645618 | 158645619 | Human | | name |
| 11654465 | CV290044 | single nucleotide variant | NM_024996.7(GFM1):c.*245A>C | Hepatoencephalopathy due to combined oxidative phosphorylation defect type 1 [RCV000317976] | uncertain significance | 3 | 158691712 | 158691712 | Human | 1 | name |
| 11592969 | CV290054 | single nucleotide variant | NM_024996.7(GFM1):c.*713C>T | Hepatoencephalopathy due to combined oxidative phosphorylation defect type 1 [RCV000343936] | benign|likely benign | 3 | 158692180 | 158692180 | Human | 1 | name |
| 11586768 | CV293141 | single nucleotide variant | NM_024996.7(GFM1):c.*766G>T | Hepatoencephalopathy due to combined oxidative phosphorylation defect type 1 [RCV000290294] | benign|uncertain significance | 3 | 158692233 | 158692233 | Human | 1 | name |
| 11593564 | CV293147 | single nucleotide variant | NM_024996.7(GFM1):c.*950C>T | Hepatoencephalopathy due to combined oxidative phosphorylation defect type 1 [RCV000349969] | uncertain significance | 3 | 158692417 | 158692417 | Human | 1 | name |
| 11651951 | CV293531 | single nucleotide variant | NM_024996.7(GFM1):c.81+5C>T | Hepatoencephalopathy due to combined oxidative phosphorylation defect type 1 [RCV000301848] | uncertain significance | 3 | 158644720 | 158644720 | Human | 1 | name |
| 11658907 | CV293574 | single nucleotide variant | NM_024996.7(GFM1):c.*119G>A | Hepatoencephalopathy due to combined oxidative phosphorylation defect type 1 [RCV000353040] | uncertain significance | 3 | 158691586 | 158691586 | Human | 1 | name |
| 11582927 | CV293575 | single nucleotide variant | NM_024996.7(GFM1):c.*226C>T | Hepatoencephalopathy due to combined oxidative phosphorylation defect type 1 [RCV000262965]|not provided [RCV001613134] | benign | 3 | 158691693 | 158691693 | Human | 1 | name |
| 11655210 | CV293589 | single nucleotide variant | NM_024996.7(GFM1):c.*559T>C | Hepatoencephalopathy due to combined oxidative phosphorylation defect type 1 [RCV000323880] | uncertain significance | 3 | 158692026 | 158692026 | Human | 1 | name |
| 11596146 | CV293590 | single nucleotide variant | NM_024996.7(GFM1):c.*578C>T | Hepatoencephalopathy due to combined oxidative phosphorylation defect type 1 [RCV000378782] | uncertain significance | 3 | 158692045 | 158692045 | Human | 1 | name |
| 11586567 | CV293593 | single nucleotide variant | NM_024996.7(GFM1):c.*691T>A | Hepatoencephalopathy due to combined oxidative phosphorylation defect type 1 [RCV000288969]|not provided [RCV004716038] | benign | 3 | 158692158 | 158692158 | Human | 1 | name |
| 11596629 | CV293594 | single nucleotide variant | NM_024996.7(GFM1):c.*731C>T | Hepatoencephalopathy due to combined oxidative phosphorylation defect type 1 [RCV000384430] | benign|uncertain significance | 3 | 158692198 | 158692198 | Human | 1 | name |
| 14713874 | CV659759 | single nucleotide variant | NM_024996.5(GFM1):c.-386G>T | not provided [RCV000828840] | benign | 3 | 158644249 | 158644249 | Human | | name |
| 15121415 | CV787365 | single nucleotide variant | NM_024996.7(GFM1):c.81+7G>C | not provided [RCV000979465] | likely benign | 3 | 158644722 | 158644722 | Human | | name |
| 28881587 | CV888249 | single nucleotide variant | NM_024996.7(GFM1):c.*116C>T | Hepatoencephalopathy due to combined oxidative phosphorylation defect type 1 [RCV001149673]|not provided [RCV001569157] | likely benign | 3 | 158691583 | 158691583 | Human | 1 | name |
| 28881591 | CV888250 | single nucleotide variant | NM_024996.7(GFM1):c.*164C>A | Hepatoencephalopathy due to combined oxidative phosphorylation defect type 1 [RCV001149674] | uncertain significance | 3 | 158691631 | 158691631 | Human | 1 | name |
| 28870417 | CV888251 | single nucleotide variant | NM_024996.7(GFM1):c.*429C>T | Hepatoencephalopathy due to combined oxidative phosphorylation defect type 1 [RCV001145360] | uncertain significance | 3 | 158691896 | 158691896 | Human | 1 | name |
| 28870420 | CV888252 | single nucleotide variant | NM_024996.7(GFM1):c.*539C>T | Hepatoencephalopathy due to combined oxidative phosphorylation defect type 1 [RCV001145361] | likely benign | 3 | 158692006 | 158692006 | Human | 1 | name |
| 28870421 | CV888253 | single nucleotide variant | NM_024996.7(GFM1):c.*572A>G | Hepatoencephalopathy due to combined oxidative phosphorylation defect type 1 [RCV001145362] | uncertain significance | 3 | 158692039 | 158692039 | Human | 1 | name |
| 28870424 | CV888254 | single nucleotide variant | NM_024996.7(GFM1):c.*635A>T | Hepatoencephalopathy due to combined oxidative phosphorylation defect type 1 [RCV001145363] | uncertain significance | 3 | 158692102 | 158692102 | Human | 1 | name |
| 28874651 | CV888255 | single nucleotide variant | NM_024996.7(GFM1):c.*803T>C | Hepatoencephalopathy due to combined oxidative phosphorylation defect type 1 [RCV001147304] | uncertain significance | 3 | 158692270 | 158692270 | Human | 1 | name |
| 127242184 | CV1055313 | single nucleotide variant | NM_024996.7(GFM1):c.234+1G>T | not provided [RCV001376884] | likely pathogenic | 3 | 158645782 | 158645782 | Human | | name |
| 127256916 | CV1055314 | single nucleotide variant | NM_024996.7(GFM1):c.573-1G>C | Hepatoencephalopathy due to combined oxidative phosphorylation defect type 1 [RCV001831371]|Leigh syndrome [RCV005361584]|not provided [RCV001379654] | likely pathogenic|conflicting interpretations of pathogenicity | 3 | 158649040 | 158649040 | Human | 2 | name |
| 127247587 | CV1055315 | single nucleotide variant | NM_024996.7(GFM1):c.999-1G>A | Hepatoencephalopathy due to combined oxidative phosphorylation defect type 1 [RCV001836383]|not provided [RCV001377804] | likely pathogenic | 3 | 158654546 | 158654546 | Human | 1 | name |
| 127237779 | CV1070492 | single nucleotide variant | NM_024996.7(GFM1):c.81+10C>T | not provided [RCV001397212] | likely benign | 3 | 158644725 | 158644725 | Human | | name |
| 127277694 | CV1092206 | single nucleotide variant | NM_024996.7(GFM1):c.690-7T>C | not provided [RCV001444576] | likely benign | 3 | 158652089 | 158652089 | Human | | name |
| 127334193 | CV1113715 | single nucleotide variant | NM_024996.7(GFM1):c.368-6A>T | not provided [RCV001473437] | likely benign | 3 | 158646737 | 158646737 | Human | | name |
| 127332702 | CV1113718 | single nucleotide variant | NM_024996.7(GFM1):c.572+9C>A | not provided [RCV001472408] | likely benign | 3 | 158646956 | 158646956 | Human | | name |
| 127325835 | CV1113719 | single nucleotide variant | NM_024996.7(GFM1):c.572+9C>T | not provided [RCV001468613] | likely benign | 3 | 158646956 | 158646956 | Human | | name |
| 127328440 | CV1113722 | single nucleotide variant | NM_024996.7(GFM1):c.998+7C>T | not provided [RCV001469541] | likely benign | 3 | 158653474 | 158653474 | Human | | name |
| 150409280 | CV1175107 | single nucleotide variant | NM_024996.7(GFM1):c.81+22A>G | Hepatoencephalopathy due to combined oxidative phosphorylation defect type 1 [RCV001543940]|not provided [RCV001655851] | benign | 3 | 158644737 | 158644737 | Human | 1 | name |
| 150409282 | CV1175108 | single nucleotide variant | NM_024996.7(GFM1):c.81+84C>G | Hepatoencephalopathy due to combined oxidative phosphorylation defect type 1 [RCV001543941]|not provided [RCV001713120] | benign | 3 | 158644799 | 158644799 | Human | 1 | name |
| 151821579 | CV1378593 | single nucleotide variant | NM_024996.7(GFM1):c.689+1G>A | Hepatoencephalopathy due to combined oxidative phosphorylation defect type 1 [RCV003464159]|not provided [RCV002029942] | likely pathogenic | 3 | 158649158 | 158649158 | Human | 1 | name |
| 151885992 | CV1418430 | single nucleotide variant | NM_024996.7(GFM1):c.367+3G>A | not provided [RCV001887469] | uncertain significance | 3 | 158646300 | 158646300 | Human | | name |
| 152051901 | CV1538862 | single nucleotide variant | NM_024996.7(GFM1):c.998+8T>G | not provided [RCV002189515] | likely benign | 3 | 158653475 | 158653475 | Human | | name |
| 152139481 | CV1555093 | single nucleotide variant | NM_024996.7(GFM1):c.367+7T>C | not provided [RCV002200391] | likely benign | 3 | 158646304 | 158646304 | Human | | name |
| 152035767 | CV1590480 | single nucleotide variant | NM_024996.7(GFM1):c.235-7T>C | not provided [RCV002205549] | likely benign | 3 | 158646158 | 158646158 | Human | | name |
| 152028812 | CV1639719 | single nucleotide variant | NM_024996.7(GFM1):c.999-8A>C | not provided [RCV002085588] | likely benign | 3 | 158654539 | 158654539 | Human | | name |
| 156363440 | CV1881513 | single nucleotide variant | NM_024996.7(GFM1):c.368-2A>G | Hepatoencephalopathy due to combined oxidative phosphorylation defect type 1 [RCV003465945]|not provided [RCV003065787] | likely pathogenic | 3 | 158646741 | 158646741 | Human | 1 | name |
| 156349393 | CV1978156 | single nucleotide variant | NM_024996.7(GFM1):c.841-4G>A | not provided [RCV002601713] | likely benign | 3 | 158653306 | 158653306 | Human | | name |
| 155932963 | CV2067442 | duplication | NM_024996.7(GFM1):c.999-4dup | not provided [RCV002838875] | benign | 3 | 158654539 | 158654540 | Human | | name |
| 155913810 | CV2077800 | single nucleotide variant | NM_024996.7(GFM1):c.998+2T>G | not provided [RCV002858685] | likely pathogenic | 3 | 158653469 | 158653469 | Human | | name |
| 155989161 | CV2101916 | single nucleotide variant | NM_024996.7(GFM1):c.689+8C>T | not provided [RCV002908073] | likely benign | 3 | 158649165 | 158649165 | Human | | name |
| 10410073 | CV210958 | single nucleotide variant | NM_024996.7(GFM1):c.690-5C>G | Hepatoencephalopathy due to combined oxidative phosphorylation defect type 1 [RCV001001208]|not provided [RCV000415998]|not specified [RCV000197431] | benign|likely benign|conflicting interpretations of pathogenicity|uncertain significance | 3 | 158652091 | 158652091 | Human | 1 | name |
| 156097392 | CV2135895 | single nucleotide variant | NM_024996.7(GFM1):c.840+4A>G | not provided [RCV002979847] | uncertain significance | 3 | 158652250 | 158652250 | Human | | name |
| 401941347 | CV2836004 | single nucleotide variant | NM_024996.7(GFM1):c.367+1G>A | Hepatoencephalopathy due to combined oxidative phosphorylation defect type 1 [RCV003461688] | likely pathogenic | 3 | 158646298 | 158646298 | Human | 1 | name |
| 401941377 | CV2836013 | single nucleotide variant | NM_024996.7(GFM1):c.573-2A>G | Hepatoencephalopathy due to combined oxidative phosphorylation defect type 1 [RCV003461694] | likely pathogenic | 3 | 158649039 | 158649039 | Human | 1 | name |
| 401943191 | CV2836017 | single nucleotide variant | NM_024996.7(GFM1):c.368-2A>C | Hepatoencephalopathy due to combined oxidative phosphorylation defect type 1 [RCV003468271] | likely pathogenic | 3 | 158646741 | 158646741 | Human | 1 | name |
| 401942862 | CV2836025 | single nucleotide variant | NM_024996.7(GFM1):c.999-1G>C | Hepatoencephalopathy due to combined oxidative phosphorylation defect type 1 [RCV003468275] | likely pathogenic | 3 | 158654546 | 158654546 | Human | 1 | name |
| 401942871 | CV2836031 | single nucleotide variant | NM_024996.7(GFM1):c.689+2T>C | Hepatoencephalopathy due to combined oxidative phosphorylation defect type 1 [RCV003468277] | likely pathogenic | 3 | 158649159 | 158649159 | Human | 1 | name |
| 402483895 | CV2857479 | single nucleotide variant | NM_024996.7(GFM1):c.81+19G>T | not provided [RCV003544289] | likely benign | 3 | 158644734 | 158644734 | Human | | name |
| 402515326 | CV2860220 | single nucleotide variant | NM_024996.7(GFM1):c.82-16C>T | not provided [RCV003575302] | likely benign | 3 | 158645613 | 158645613 | Human | | name |
| 405175739 | CV2864624 | single nucleotide variant | NM_024996.7(GFM1):c.998+1G>A | not provided [RCV003542741] | likely pathogenic | 3 | 158653468 | 158653468 | Human | | name |
| 405211924 | CV2868042 | single nucleotide variant | NM_024996.7(GFM1):c.235-1G>A | not provided [RCV003552647] | likely pathogenic | 3 | 158646164 | 158646164 | Human | | name |
| 402518413 | CV2870752 | duplication | NM_024996.7(GFM1):c.235-9dup | not provided [RCV003547513] | likely benign | 3 | 158646154 | 158646155 | Human | | name |
| 402506695 | CV2880783 | single nucleotide variant | NM_024996.7(GFM1):c.82-16C>G | not provided [RCV003546434] | likely benign | 3 | 158645613 | 158645613 | Human | | name |
| 11597475 | CV289272 | single nucleotide variant | NM_024996.7(GFM1):c.*1004T>C | Hepatoencephalopathy due to combined oxidative phosphorylation defect type 1 [RCV000394550] | uncertain significance | 3 | 158692471 | 158692471 | Human | 1 | name |
| 405158205 | CV2898144 | single nucleotide variant | NM_024996.7(GFM1):c.82-13G>A | not provided [RCV003562205] | likely benign | 3 | 158645616 | 158645616 | Human | | name |
| 402519790 | CV2902560 | single nucleotide variant | NM_024996.7(GFM1):c.368-1G>C | not provided [RCV003575767] | likely pathogenic | 3 | 158646742 | 158646742 | Human | | name |
| 402508144 | CV2924444 | single nucleotide variant | NM_024996.7(GFM1):c.82-11A>G | not provided [RCV003574668] | likely benign | 3 | 158645618 | 158645618 | Human | | name |
| 405123109 | CV2942504 | single nucleotide variant | NM_024996.7(GFM1):c.999-9T>A | not provided [RCV003671687] | likely benign | 3 | 158654538 | 158654538 | Human | | name |
| 405242083 | CV2970998 | single nucleotide variant | NM_024996.7(GFM1):c.572+1G>A | not provided [RCV003684270] | likely pathogenic | 3 | 158646948 | 158646948 | Human | | name |
| 405215842 | CV2977928 | single nucleotide variant | NM_024996.7(GFM1):c.368-4T>G | not provided [RCV003709304] | likely benign | 3 | 158646739 | 158646739 | Human | | name |
| 405208356 | CV2990782 | single nucleotide variant | NM_024996.7(GFM1):c.841-9C>A | not provided [RCV003678930] | likely benign | 3 | 158653301 | 158653301 | Human | | name |
| 405114981 | CV3019262 | single nucleotide variant | NM_024996.7(GFM1):c.840+8C>T | not provided [RCV003700127] | likely benign | 3 | 158652254 | 158652254 | Human | | name |
| 405242640 | CV3042931 | single nucleotide variant | NM_024996.7(GFM1):c.82-14C>G | not provided [RCV003719545] | likely benign | 3 | 158645615 | 158645615 | Human | | name |
| 405250354 | CV3043147 | deletion | NM_024996.7(GFM1):c.689+2del | not provided [RCV003721597] | likely pathogenic | 3 | 158649159 | 158649159 | Human | | name |
| 405084922 | CV3043772 | single nucleotide variant | NM_024996.7(GFM1):c.82-15T>G | not provided [RCV003717405] | likely benign | 3 | 158645614 | 158645614 | Human | | name |
| 405253819 | CV3045023 | single nucleotide variant | NM_024996.7(GFM1):c.81+18G>A | not provided [RCV003722709] | likely benign | 3 | 158644733 | 158644733 | Human | | name |
| 405253453 | CV3054201 | single nucleotide variant | NM_024996.7(GFM1):c.81+11A>G | not provided [RCV003722534] | likely benign | 3 | 158644726 | 158644726 | Human | | name |
| 405048441 | CV3079934 | single nucleotide variant | NM_024996.7(GFM1):c.82-13G>T | not provided [RCV003740421] | likely benign | 3 | 158645616 | 158645616 | Human | | name |
| 405212651 | CV3117875 | single nucleotide variant | NM_024996.7(GFM1):c.82-14C>T | not provided [RCV003823474] | likely benign | 3 | 158645615 | 158645615 | Human | | name |
| 405211778 | CV3146264 | single nucleotide variant | NM_024996.7(GFM1):c.368-5T>C | not provided [RCV003845795] | likely benign | 3 | 158646738 | 158646738 | Human | | name |
| 405179260 | CV3147354 | single nucleotide variant | NM_024996.7(GFM1):c.81+12T>C | not provided [RCV003842256] | likely benign | 3 | 158644727 | 158644727 | Human | | name |
| 405078594 | CV3156352 | duplication | NM_024996.7(GFM1):c.234+7dup | not provided [RCV003851410] | likely benign | 3 | 158645787 | 158645788 | Human | | name |
| 405224082 | CV3158450 | single nucleotide variant | NM_024996.7(GFM1):c.81+13A>G | not provided [RCV003863946] | likely benign | 3 | 158644728 | 158644728 | Human | | name |
| 405243883 | CV3161059 | single nucleotide variant | NM_024996.7(GFM1):c.999-7T>C | not provided [RCV003867968] | likely benign | 3 | 158654540 | 158654540 | Human | | name |
| 402466946 | CV3177708 | single nucleotide variant | NM_024996.7(GFM1):c.81+17A>G | not provided [RCV003873146] | likely benign | 3 | 158644732 | 158644732 | Human | | name |
| 402497636 | CV3179349 | single nucleotide variant | NM_024996.7(GFM1):c.572+7A>G | not provided [RCV003877616] | likely benign | 3 | 158646954 | 158646954 | Human | | name |
| 597958861 | CV3751993 | single nucleotide variant | NM_024996.7(GFM1):c.82-18C>T | not provided [RCV005081123] | likely benign | 3 | 158645611 | 158645611 | Human | | name |
| 598123915 | CV3885112 | single nucleotide variant | NM_024996.7(GFM1):c.998+5G>A | not specified [RCV005238724] | uncertain significance | 3 | 158653472 | 158653472 | Human | | name |
| 28874653 | CV888256 | single nucleotide variant | NM_024996.7(GFM1):c.*1033A>G | Hepatoencephalopathy due to combined oxidative phosphorylation defect type 1 [RCV001147305] | uncertain significance | 3 | 158692500 | 158692500 | Human | 1 | name |
| 127247338 | CV1055316 | single nucleotide variant | NM_024996.7(GFM1):c.1910-2A>T | Hepatoencephalopathy due to combined oxidative phosphorylation defect type 1 [RCV001826130]|not provided [RCV001377756] | likely pathogenic | 3 | 158690161 | 158690161 | Human | 1 | name |
| 127277305 | CV1070502 | single nucleotide variant | NM_024996.7(GFM1):c.840+10T>C | not provided [RCV001407679] | likely benign | 3 | 158652256 | 158652256 | Human | | name |
| 127273480 | CV1070510 | deletion | NM_024996.7(GFM1):c.1518+8del | not provided [RCV001406080] | likely benign | 3 | 158665481 | 158665481 | Human | | name |
| 127274615 | CV1092211 | single nucleotide variant | NM_024996.7(GFM1):c.1221+8C>T | not provided [RCV001442918] | likely benign | 3 | 158659067 | 158659067 | Human | | name |
| 127273397 | CV1092213 | single nucleotide variant | NM_024996.7(GFM1):c.1381-9C>G | not provided [RCV001431618] | likely benign | 3 | 158665328 | 158665328 | Human | | name |
| 127317745 | CV1113731 | single nucleotide variant | NM_024996.7(GFM1):c.1910-6A>C | not provided [RCV001465981] | likely benign | 3 | 158690157 | 158690157 | Human | | name |
| 127299364 | CV1113732 | single nucleotide variant | NM_024996.7(GFM1):c.2125-5C>T | not provided [RCV001453575] | likely benign | 3 | 158691331 | 158691331 | Human | | name |
| 127311012 | CV1154322 | deletion | NM_024996.7(GFM1):c.1222-3del | not provided [RCV001518467] | benign | 3 | 158660865 | 158660865 | Human | | name |
| 150409288 | CV1175110 | single nucleotide variant | NM_024996.7(GFM1):c.690-87A>G | Hepatoencephalopathy due to combined oxidative phosphorylation defect type 1 [RCV001543943]|not provided [RCV001647392] | benign | 3 | 158652009 | 158652009 | Human | 1 | name |
| 150420263 | CV1179651 | duplication | NM_024996.7(GFM1):c.81+283dup | not provided [RCV001551459] | likely benign | 3 | 158644980 | 158644981 | Human | | name |
| 150422989 | CV1179652 | single nucleotide variant | NM_024996.7(GFM1):c.368-34T>A | not provided [RCV001553401] | likely benign | 3 | 158646709 | 158646709 | Human | | name |
| 150423436 | CV1183289 | single nucleotide variant | NM_024996.7(GFM1):c.82-118A>G | not provided [RCV001555318] | likely benign | 3 | 158645511 | 158645511 | Human | | name |
| 150407027 | CV1193275 | single nucleotide variant | NM_024996.7(GFM1):c.235-85G>C | not provided [RCV001572216] | likely benign | 3 | 158646080 | 158646080 | Human | | name |
| 150421305 | CV1197032 | single nucleotide variant | NM_024996.7(GFM1):c.82-198G>A | not provided [RCV001577980] | likely benign | 3 | 158645431 | 158645431 | Human | | name |
| 150419410 | CV1197034 | deletion | NM_024996.7(GFM1):c.1910-8del | not provided [RCV001577167] | likely benign | 3 | 158690142 | 158690142 | Human | | name |
| 150442778 | CV1204762 | single nucleotide variant | NM_024996.7(GFM1):c.690-40G>A | not provided [RCV001583869] | likely benign | 3 | 158652056 | 158652056 | Human | | name |
| 150492444 | CV1253936 | single nucleotide variant | NM_024996.7(GFM1):c.690-96T>A | not provided [RCV001675032] | benign | 3 | 158652000 | 158652000 | Human | | name |
| 150501424 | CV1256296 | deletion | NM_024996.7(GFM1):c.81+283del | not provided [RCV001676920] | benign | 3 | 158644981 | 158644981 | Human | | name |
| 150542318 | CV1314734 | single nucleotide variant | NM_024996.7(GFM1):c.1764+2T>C | Hepatoencephalopathy due to combined oxidative phosphorylation defect type 1 [RCV003989093] | likely pathogenic | 3 | 158682159 | 158682159 | Human | 1 | name |
| 151830166 | CV1384389 | single nucleotide variant | NM_024996.7(GFM1):c.2125-6C>A | not provided [RCV001955602] | likely benign|uncertain significance | 3 | 158691330 | 158691330 | Human | | name |
| 8691204 | CV141164 | single nucleotide variant | NM_024996.7(GFM1):c.1083+6T>G | Hepatoencephalopathy due to combined oxidative phosphorylation defect type 1 [RCV000390538]|not provided [RCV000676469]|not specified [RCV000125222] | benign|uncertain significance | 3 | 158654637 | 158654637 | Human | 1 | name |
| 8691206 | CV141166 | single nucleotide variant | NM_024996.7(GFM1):c.1601+9G>C | Hepatoencephalopathy due to combined oxidative phosphorylation defect type 1 [RCV000400146]|not provided [RCV000676470]|not specified [RCV000125224] | benign|likely benign|uncertain significance | 3 | 158666395 | 158666395 | Human | 1 | name |
| 151735446 | CV1435622 | single nucleotide variant | NM_024996.7(GFM1):c.1765-3C>T | not provided [RCV001946515] | uncertain significance | 3 | 158684521 | 158684521 | Human | | name |
| 151790897 | CV1475482 | single nucleotide variant | NM_024996.7(GFM1):c.1765-2A>G | Hepatoencephalopathy due to combined oxidative phosphorylation defect type 1 [RCV003471216]|not provided [RCV001973042] | likely pathogenic | 3 | 158684522 | 158684522 | Human | 1 | name |
| 151892616 | CV1493761 | single nucleotide variant | NM_024996.7(GFM1):c.690-16A>G | not provided [RCV001944300] | uncertain significance | 3 | 158652080 | 158652080 | Human | | name |
| 151765889 | CV1516059 | single nucleotide variant | NM_024996.7(GFM1):c.1380+1G>T | Hepatoencephalopathy due to combined oxidative phosphorylation defect type 1 [RCV005025666]|not provided [RCV002024883] | likely pathogenic | 3 | 158662685 | 158662685 | Human | 1 | name |
| 152107606 | CV1529877 | single nucleotide variant | NM_024996.7(GFM1):c.1518+7A>G | not provided [RCV002196358] | likely benign | 3 | 158665481 | 158665481 | Human | | name |
| 152100298 | CV1539988 | single nucleotide variant | NM_024996.7(GFM1):c.368-12C>A | not provided [RCV002095430] | likely benign | 3 | 158646731 | 158646731 | Human | | name |
| 152098759 | CV1542475 | single nucleotide variant | NM_024996.7(GFM1):c.2070+7A>G | not provided [RCV002195265] | likely benign | 3 | 158690330 | 158690330 | Human | | name |
| 152035862 | CV1545850 | single nucleotide variant | NM_024996.7(GFM1):c.1083+7T>G | not provided [RCV002164925] | likely benign | 3 | 158654638 | 158654638 | Human | | name |
| 152071341 | CV1549088 | single nucleotide variant | NM_024996.7(GFM1):c.234+19T>A | not provided [RCV002091628] | likely benign | 3 | 158645800 | 158645800 | Human | | name |
| 152139311 | CV1562794 | single nucleotide variant | NM_024996.7(GFM1):c.690-17A>G | not provided [RCV002100547] | likely benign | 3 | 158652079 | 158652079 | Human | | name |
| 152155504 | CV1579645 | single nucleotide variant | NM_024996.7(GFM1):c.1083+8G>A | not provided [RCV002158784] | likely benign | 3 | 158654639 | 158654639 | Human | | name |
| 152146084 | CV1599906 | deletion | NM_024996.7(GFM1):c.1910-6del | not provided [RCV002138823] | likely benign | 3 | 158690156 | 158690156 | Human | | name |
| 152119378 | CV1600956 | duplication | NM_024996.7(GFM1):c.1222-3dup | not provided [RCV002154062] | benign | 3 | 158660864 | 158660865 | Human | | name |
| 152165980 | CV1611493 | single nucleotide variant | NM_024996.7(GFM1):c.1084-8A>G | not provided [RCV002141829] | likely benign | 3 | 158658914 | 158658914 | Human | | name |
| 152074244 | CV1638151 | single nucleotide variant | NM_024996.7(GFM1):c.1910-4C>T | not provided [RCV002192202] | likely benign | 3 | 158690159 | 158690159 | Human | | name |
| 152158096 | CV1639583 | single nucleotide variant | NM_024996.7(GFM1):c.1519-6T>C | not provided [RCV002180433] | likely benign | 3 | 158666298 | 158666298 | Human | | name |
| 152135830 | CV1642506 | duplication | NM_024996.7(GFM1):c.1910-6dup | not provided [RCV002119691] | likely benign | 3 | 158690155 | 158690156 | Human | | name |
| 152165148 | CV1648983 | single nucleotide variant | NM_024996.7(GFM1):c.1222-8T>G | not provided [RCV002204181] | likely benign | 3 | 158660866 | 158660866 | Human | | name |
| 156325485 | CV1871184 | single nucleotide variant | NM_024996.7(GFM1):c.1380+2T>G | Hepatoencephalopathy due to combined oxidative phosphorylation defect type 1 [RCV003459734]|not provided [RCV003063372] | likely pathogenic | 3 | 158662686 | 158662686 | Human | 1 | name |
| 156315136 | CV1928200 | single nucleotide variant | NM_024996.7(GFM1):c.573-18T>A | not provided [RCV002630010] | likely benign | 3 | 158649023 | 158649023 | Human | | name |
| 156050246 | CV1974339 | single nucleotide variant | NM_024996.7(GFM1):c.1909+9G>C | not provided [RCV002590637] | likely benign | 3 | 158684677 | 158684677 | Human | | name |
| 156238280 | CV1999685 | single nucleotide variant | NM_024996.7(GFM1):c.1222-7T>G | not provided [RCV002667838] | likely benign | 3 | 158660867 | 158660867 | Human | | name |
| 156117700 | CV2035677 | single nucleotide variant | NM_024996.7(GFM1):c.690-18A>G | not provided [RCV002785659] | likely benign | 3 | 158652078 | 158652078 | Human | | name |
| 10410533 | CV210952 | single nucleotide variant | NM_024996.7(GFM1):c.235-14G>A | Hepatoencephalopathy due to combined oxidative phosphorylation defect type 1 [RCV000307563]|not provided [RCV002054327]|not specified [RCV000198372] | benign|uncertain significance | 3 | 158646151 | 158646151 | Human | 1 | name |
| 10410886 | CV210955 | single nucleotide variant | NM_024996.7(GFM1):c.368-18A>G | not provided [RCV002054328]|not specified [RCV000199107] | benign | 3 | 158646725 | 158646725 | Human | | name |
| 155958766 | CV2138154 | single nucleotide variant | NM_024996.7(GFM1):c.1084-7C>T | not provided [RCV002972275] | likely benign | 3 | 158658915 | 158658915 | Human | | name |
| 155967597 | CV2142647 | single nucleotide variant | NM_024996.7(GFM1):c.1380+7G>C | not provided [RCV002995466] | likely benign | 3 | 158662691 | 158662691 | Human | | name |
| 156298761 | CV2159462 | single nucleotide variant | NM_024996.7(GFM1):c.2071-8G>C | not provided [RCV003045450] | likely benign | 3 | 158691131 | 158691131 | Human | | name |
| 156357157 | CV2166052 | single nucleotide variant | NM_024996.7(GFM1):c.367+20T>G | not provided [RCV003031311] | likely benign | 3 | 158646317 | 158646317 | Human | | name |
| 156298011 | CV2186235 | single nucleotide variant | NM_024996.7(GFM1):c.1380+1G>A | Hepatoencephalopathy due to combined oxidative phosphorylation defect type 1 [RCV005028135]|not provided [RCV003061825] | likely pathogenic | 3 | 158662685 | 158662685 | Human | 1 | name |
| 401937787 | CV2797044 | single nucleotide variant | NM_024996.7(GFM1):c.1764+1G>T | GFM1-related disorder [RCV003416882] | likely pathogenic | 3 | 158682158 | 158682158 | Human | | name , trait , alternate_id |
| 401941350 | CV2836009 | single nucleotide variant | NM_024996.7(GFM1):c.1909+2T>A | Hepatoencephalopathy due to combined oxidative phosphorylation defect type 1 [RCV003461691] | likely pathogenic | 3 | 158684670 | 158684670 | Human | 1 | name |
| 401943171 | CV2836021 | single nucleotide variant | NM_024996.7(GFM1):c.1381-1G>C | Hepatoencephalopathy due to combined oxidative phosphorylation defect type 1 [RCV003468272] | likely pathogenic | 3 | 158665336 | 158665336 | Human | 1 | name |
| 405170349 | CV2854340 | single nucleotide variant | NM_024996.7(GFM1):c.1222-6T>C | not provided [RCV003542115] | likely benign | 3 | 158660868 | 158660868 | Human | | name |
| 405203892 | CV2858461 | deletion | NM_024996.7(GFM1):c.1602-2del | not provided [RCV003551696] | likely pathogenic | 3 | 158681993 | 158681993 | Human | | name |
| 402487349 | CV2861722 | deletion | NM_024996.7(GFM1):c.690-11del | not provided [RCV003544609] | likely benign | 3 | 158652083 | 158652083 | Human | | name |
| 405026822 | CV2889959 | single nucleotide variant | NM_024996.7(GFM1):c.367+14T>C | not provided [RCV003578042] | likely benign | 3 | 158646311 | 158646311 | Human | | name |
| 405114757 | CV2896697 | single nucleotide variant | NM_024996.7(GFM1):c.2070+1G>A | Hepatoencephalopathy due to combined oxidative phosphorylation defect type 1 [RCV004574120]|not provided [RCV003558302] | likely pathogenic | 3 | 158690324 | 158690324 | Human | 1 | name |
| 405136086 | CV2896887 | single nucleotide variant | NM_024996.7(GFM1):c.689+14A>C | not provided [RCV003560381] | likely benign | 3 | 158649171 | 158649171 | Human | | name |
| 405157721 | CV2898041 | single nucleotide variant | NM_024996.7(GFM1):c.998+15T>C | not provided [RCV003562175] | likely benign | 3 | 158653482 | 158653482 | Human | | name |
| 405220721 | CV2904232 | single nucleotide variant | NM_024996.7(GFM1):c.367+15T>G | not provided [RCV003568344] | likely benign | 3 | 158646312 | 158646312 | Human | | name |
| 402471477 | CV2904479 | single nucleotide variant | NM_024996.7(GFM1):c.368-15C>A | not provided [RCV003570529] | likely benign | 3 | 158646728 | 158646728 | Human | | name |
| 405064606 | CV2927382 | single nucleotide variant | NM_024996.7(GFM1):c.1083+8G>C | not provided [RCV003580725] | likely benign | 3 | 158654639 | 158654639 | Human | | name |
| 11597816 | CV293121 | single nucleotide variant | NM_024996.7(GFM1):c.234+12C>T | Hepatoencephalopathy due to combined oxidative phosphorylation defect type 1 [RCV000398325]|not provided [RCV002057851] | likely benign|uncertain significance | 3 | 158645793 | 158645793 | Human | 1 | name |
| 11592690 | CV293122 | single nucleotide variant | NM_024996.7(GFM1):c.1083+3A>G | Hepatoencephalopathy due to combined oxidative phosphorylation defect type 1 [RCV000341073]|Inborn genetic diseases [RCV002523249]|not provided [RCV001636960] | likely benign|conflicting interpretations of pathogenicity|uncertain significance | 3 | 158654634 | 158654634 | Human | 2 | name |
| 405177063 | CV2952044 | single nucleotide variant | NM_024996.7(GFM1):c.690-14A>G | not provided [RCV003675924] | likely benign | 3 | 158652082 | 158652082 | Human | | name |
| 405132542 | CV2959239 | single nucleotide variant | NM_024996.7(GFM1):c.1909+7T>A | not provided [RCV003668508] | likely benign | 3 | 158684675 | 158684675 | Human | | name |
| 405165317 | CV2960739 | single nucleotide variant | NM_024996.7(GFM1):c.841-10T>G | not provided [RCV003674986] | likely benign | 3 | 158653300 | 158653300 | Human | | name |
| 405137820 | CV2963202 | single nucleotide variant | NM_024996.7(GFM1):c.573-13T>C | not provided [RCV003668881] | likely benign | 3 | 158649028 | 158649028 | Human | | name |
| 405210346 | CV2970507 | single nucleotide variant | NM_024996.7(GFM1):c.1222-9T>C | not provided [RCV003679267] | likely benign | 3 | 158660865 | 158660865 | Human | | name |
| 405223847 | CV2982638 | single nucleotide variant | NM_024996.7(GFM1):c.1602-7C>T | not provided [RCV003681026] | likely benign | 3 | 158681988 | 158681988 | Human | | name |
| 402516844 | CV2992269 | single nucleotide variant | NM_024996.7(GFM1):c.1909+8G>A | not provided [RCV003689998] | likely benign | 3 | 158684676 | 158684676 | Human | | name |
| 405022558 | CV2992845 | single nucleotide variant | NM_024996.7(GFM1):c.2071-1G>C | not provided [RCV003694885] | likely pathogenic | 3 | 158691138 | 158691138 | Human | | name |
| 404991109 | CV2995165 | single nucleotide variant | NM_024996.7(GFM1):c.2125-9A>C | not provided [RCV003692292] | likely benign | 3 | 158691327 | 158691327 | Human | | name |
| 405249943 | CV2997136 | single nucleotide variant | NM_024996.7(GFM1):c.2125-4C>A | not provided [RCV003721481] | likely benign | 3 | 158691332 | 158691332 | Human | | name |
| 402521737 | CV3011247 | single nucleotide variant | NM_024996.7(GFM1):c.1601+7A>G | not provided [RCV003716483] | likely benign | 3 | 158666393 | 158666393 | Human | | name |
| 405168687 | CV3029131 | single nucleotide variant | NM_024996.7(GFM1):c.1221+1G>A | not provided [RCV003704511] | likely pathogenic | 3 | 158659060 | 158659060 | Human | | name |
| 405198484 | CV3032829 | single nucleotide variant | NM_024996.7(GFM1):c.1765-7T>C | not provided [RCV003707203] | likely benign | 3 | 158684517 | 158684517 | Human | | name |
| 405156829 | CV3037456 | single nucleotide variant | NM_024996.7(GFM1):c.367+11T>G | not provided [RCV003703684] | likely benign | 3 | 158646308 | 158646308 | Human | | name |
| 405199917 | CV3041163 | single nucleotide variant | NM_024996.7(GFM1):c.367+13C>G | not provided [RCV003707343] | likely benign | 3 | 158646310 | 158646310 | Human | | name |
| 405245955 | CV3051732 | single nucleotide variant | NM_024996.7(GFM1):c.1323+9T>C | not provided [RCV003720430] | likely benign | 3 | 158660984 | 158660984 | Human | | name |
| 405178947 | CV3056466 | single nucleotide variant | NM_024996.7(GFM1):c.368-14T>C | not provided [RCV003728523] | likely benign | 3 | 158646729 | 158646729 | Human | | name |
| 405155522 | CV3064788 | single nucleotide variant | NM_024996.7(GFM1):c.572+17T>G | not provided [RCV003726718] | likely benign | 3 | 158646964 | 158646964 | Human | | name |
| 405246103 | CV3075732 | single nucleotide variant | NM_024996.7(GFM1):c.689+20T>G | not provided [RCV003738641] | likely benign | 3 | 158649177 | 158649177 | Human | | name |
| 405028733 | CV3076382 | duplication | NM_024996.7(GFM1):c.1324-9dup | not provided [RCV003738982] | benign | 3 | 158662613 | 158662614 | Human | | name |
| 404985434 | CV3128370 | single nucleotide variant | NM_024996.7(GFM1):c.572+15A>C | not provided [RCV003826643] | likely benign | 3 | 158646962 | 158646962 | Human | | name |
| 405125343 | CV3132686 | single nucleotide variant | NM_024996.7(GFM1):c.1910-9T>G | not provided [RCV003837849] | likely benign | 3 | 158690154 | 158690154 | Human | | name |
| 405078405 | CV3137020 | single nucleotide variant | NM_024996.7(GFM1):c.234+13G>A | not provided [RCV003833919] | likely benign | 3 | 158645794 | 158645794 | Human | | name |
| 405197723 | CV3146779 | single nucleotide variant | NM_024996.7(GFM1):c.1221+8C>G | not provided [RCV003844134] | likely benign | 3 | 158659067 | 158659067 | Human | | name |
| 405159177 | CV3159860 | single nucleotide variant | NM_024996.7(GFM1):c.1519-1G>C | not provided [RCV003856931] | likely pathogenic | 3 | 158666303 | 158666303 | Human | | name |
| 405095230 | CV3164215 | single nucleotide variant | NM_024996.7(GFM1):c.998+10G>A | not provided [RCV003852530] | likely benign | 3 | 158653477 | 158653477 | Human | | name |
| 405201436 | CV3164970 | single nucleotide variant | NM_024996.7(GFM1):c.998+20T>C | not provided [RCV003860831] | likely benign | 3 | 158653487 | 158653487 | Human | | name |
| 405239938 | CV3166059 | single nucleotide variant | NM_024996.7(GFM1):c.1380+9T>C | not provided [RCV003867071] | likely benign | 3 | 158662693 | 158662693 | Human | | name |
| 405226825 | CV3169487 | single nucleotide variant | NM_024996.7(GFM1):c.367+15T>C | not provided [RCV003864511] | likely benign | 3 | 158646312 | 158646312 | Human | | name |
| 402470605 | CV3171124 | single nucleotide variant | NM_024996.7(GFM1):c.573-17G>A | not provided [RCV003874087] | likely benign | 3 | 158649024 | 158649024 | Human | | name |
| 402485803 | CV3171385 | single nucleotide variant | NM_024996.7(GFM1):c.999-19A>G | not provided [RCV003876412] | likely benign | 3 | 158654528 | 158654528 | Human | | name |
| 402472747 | CV3172035 | single nucleotide variant | NM_024996.7(GFM1):c.573-18T>C | not provided [RCV003874638] | likely benign | 3 | 158649023 | 158649023 | Human | | name |
| 402467818 | CV3174184 | single nucleotide variant | NM_024996.7(GFM1):c.690-13T>C | not provided [RCV003873467] | likely benign | 3 | 158652083 | 158652083 | Human | | name |
| 405252381 | CV3177940 | single nucleotide variant | NM_024996.7(GFM1):c.840+12C>T | not provided [RCV003870720] | likely benign | 3 | 158652258 | 158652258 | Human | | name |
| 402511378 | CV3178377 | single nucleotide variant | NM_024996.7(GFM1):c.690-19A>G | not provided [RCV003878994] | likely benign | 3 | 158652077 | 158652077 | Human | | name |
| 405868980 | CV3400681 | single nucleotide variant | NM_024996.7(GFM1):c.1083+1G>C | Hepatoencephalopathy due to combined oxidative phosphorylation defect type 1 [RCV004576684] | likely pathogenic | 3 | 158654632 | 158654632 | Human | 1 | name |
| 405868982 | CV3400682 | single nucleotide variant | NM_024996.7(GFM1):c.2125-1G>A | Hepatoencephalopathy due to combined oxidative phosphorylation defect type 1 [RCV004576685] | likely pathogenic | 3 | 158691335 | 158691335 | Human | 1 | name |
| 12845051 | CV367253 | single nucleotide variant | NM_024996.7(GFM1):c.234+17G>A | not provided [RCV002525444]|not specified [RCV000439110] | likely benign | 3 | 158645798 | 158645798 | Human | | name |
| 597683353 | CV3720937 | single nucleotide variant | NM_024996.7(GFM1):c.1084-2A>G | Hepatoencephalopathy due to combined oxidative phosphorylation defect type 1 [RCV005031317] | likely pathogenic | 3 | 158658920 | 158658920 | Human | 1 | name |
| 597683363 | CV3720938 | single nucleotide variant | NM_024996.7(GFM1):c.1324-2A>G | Hepatoencephalopathy due to combined oxidative phosphorylation defect type 1 [RCV005031318] | likely pathogenic | 3 | 158662626 | 158662626 | Human | 1 | name |
| 597683374 | CV3720939 | single nucleotide variant | NM_024996.7(GFM1):c.1380+1G>C | Hepatoencephalopathy due to combined oxidative phosphorylation defect type 1 [RCV005031319] | likely pathogenic | 3 | 158662685 | 158662685 | Human | 1 | name |
| 597950952 | CV3769380 | single nucleotide variant | NM_024996.7(GFM1):c.2070+1G>T | not provided [RCV005120939] | likely pathogenic | 3 | 158690324 | 158690324 | Human | | name |
| 597946795 | CV3774964 | single nucleotide variant | NM_024996.7(GFM1):c.840+17T>G | not provided [RCV005120061] | likely benign | 3 | 158652263 | 158652263 | Human | | name |
| 597850534 | CV3803252 | single nucleotide variant | NM_024996.7(GFM1):c.2125-7T>C | not provided [RCV005145369] | likely benign | 3 | 158691329 | 158691329 | Human | | name |
| 597944991 | CV3812612 | single nucleotide variant | NM_024996.7(GFM1):c.235-16C>T | not provided [RCV005159822] | likely benign | 3 | 158646149 | 158646149 | Human | | name |
| 14693707 | CV620757 | single nucleotide variant | NM_024996.7(GFM1):c.1518+1G>A | Hepatoencephalopathy due to combined oxidative phosphorylation defect type 1 [RCV000779395] | uncertain significance | 3 | 158665475 | 158665475 | Human | | name |
| 14693708 | CV620758 | single nucleotide variant | NM_024996.7(GFM1):c.1910-1G>A | Hepatoencephalopathy due to combined oxidative phosphorylation defect type 1 [RCV000779396] | likely pathogenic|conflicting interpretations of pathogenicity|uncertain significance | 3 | 158690162 | 158690162 | Human | 1 | name |
| 15147025 | CV774813 | single nucleotide variant | NM_024996.7(GFM1):c.1083+8G>T | Hepatoencephalopathy due to combined oxidative phosphorylation defect type 1 [RCV001272461]|not provided [RCV000944842] | likely benign|uncertain significance | 3 | 158654639 | 158654639 | Human | 1 | name |
| 38489231 | CV939931 | single nucleotide variant | NM_024996.7(GFM1):c.1601+1G>A | Hepatoencephalopathy due to combined oxidative phosphorylation defect type 1 [RCV003462703]|not provided [RCV001210116] | likely pathogenic | 3 | 158666387 | 158666387 | Human | 1 | name |
| 126740219 | CV1016195 | single nucleotide variant | NM_024996.7(GFM1):c.1221+20G>A | Hepatoencephalopathy due to combined oxidative phosphorylation defect type 1 [RCV001329385]|not provided [RCV003727981] | likely benign|uncertain significance | 3 | 158659079 | 158659079 | Human | 1 | name |
| 150336891 | CV1171064 | single nucleotide variant | NM_024996.7(GFM1):c.1381-39C>T | not provided [RCV001541258] | likely benign | 3 | 158665298 | 158665298 | Human | | name |
| 150409285 | CV1175109 | single nucleotide variant | NM_024996.7(GFM1):c.689+891C>T | Hepatoencephalopathy due to combined oxidative phosphorylation defect type 1 [RCV001543942]|not provided [RCV001694070] | benign | 3 | 158650048 | 158650048 | Human | 1 | name |
| 150409289 | CV1175111 | single nucleotide variant | NM_024996.7(GFM1):c.1083+57C>T | Hepatoencephalopathy due to combined oxidative phosphorylation defect type 1 [RCV001543944]|not provided [RCV001638146] | benign | 3 | 158654688 | 158654688 | Human | 1 | name |
| 150409292 | CV1175112 | single nucleotide variant | NM_024996.7(GFM1):c.1083+82T>C | Hepatoencephalopathy due to combined oxidative phosphorylation defect type 1 [RCV001543945]|not provided [RCV001713121] | benign | 3 | 158654713 | 158654713 | Human | 1 | name |
| 150409293 | CV1175113 | single nucleotide variant | NM_024996.7(GFM1):c.1323+72A>G | Hepatoencephalopathy due to combined oxidative phosphorylation defect type 1 [RCV001543946]|not provided [RCV001619959] | benign | 3 | 158661047 | 158661047 | Human | 1 | name |
| 150409297 | CV1175114 | single nucleotide variant | NM_024996.7(GFM1):c.1519-25A>G | Hepatoencephalopathy due to combined oxidative phosphorylation defect type 1 [RCV001543948]|not provided [RCV001655852] | benign | 3 | 158666279 | 158666279 | Human | 1 | name |
| 150418912 | CV1179654 | single nucleotide variant | NM_024996.7(GFM1):c.1519-33A>T | not provided [RCV001550808] | likely benign | 3 | 158666271 | 158666271 | Human | | name |
| 150428587 | CV1186554 | single nucleotide variant | NM_024996.7(GFM1):c.368-177G>A | not provided [RCV001562453] | likely benign | 3 | 158646566 | 158646566 | Human | | name |
| 150409316 | CV1190007 | single nucleotide variant | NM_024996.7(GFM1):c.1601+90T>G | not provided [RCV001565625] | likely benign | 3 | 158666476 | 158666476 | Human | | name |
| 150416263 | CV1197033 | single nucleotide variant | NM_024996.7(GFM1):c.1765-94C>T | not provided [RCV001575761] | likely benign | 3 | 158684430 | 158684430 | Human | | name |
| 150432738 | CV1200777 | single nucleotide variant | NM_024996.7(GFM1):c.840+317T>C | not provided [RCV001581501] | likely benign | 3 | 158652563 | 158652563 | Human | | name |
| 150466422 | CV1201241 | single nucleotide variant | NM_024996.7(GFM1):c.1909+41A>G | not provided [RCV001587721] | likely benign | 3 | 158684709 | 158684709 | Human | | name |
| 150433807 | CV1217017 | single nucleotide variant | NM_024996.7(GFM1):c.689+200A>G | not provided [RCV001608919] | benign | 3 | 158649357 | 158649357 | Human | | name |
| 150460596 | CV1234662 | single nucleotide variant | NM_024996.7(GFM1):c.234+187A>G | not provided [RCV001649244] | benign | 3 | 158645968 | 158645968 | Human | | name |
| 150480978 | CV1239690 | single nucleotide variant | NM_024996.7(GFM1):c.841-224C>T | not provided [RCV001652853] | benign | 3 | 158653086 | 158653086 | Human | | name |
| 150469970 | CV1243247 | duplication | NM_024996.7(GFM1):c.1602-17dup | not provided [RCV001650768] | benign | 3 | 158681968 | 158681969 | Human | | name |
| 150472702 | CV1259341 | duplication | NM_024996.7(GFM1):c.2125-26dup | not provided [RCV001684587] | benign | 3 | 158691304 | 158691305 | Human | | name |
| 150439567 | CV1264986 | duplication | NM_024996.7(GFM1):c.998+302dup | not provided [RCV001678979] | benign | 3 | 158653757 | 158653758 | Human | | name |
| 150489418 | CV1265420 | single nucleotide variant | NM_024996.7(GFM1):c.999-221A>T | not provided [RCV001687456] | benign | 3 | 158654326 | 158654326 | Human | | name |
| 150457666 | CV1278658 | single nucleotide variant | NM_024996.7(GFM1):c.368-199G>A | not provided [RCV001709274] | benign | 3 | 158646544 | 158646544 | Human | | name |
| 150500866 | CV1283913 | deletion | NM_024996.7(GFM1):c.690-262del | not provided [RCV001718482] | benign | 3 | 158651825 | 158651825 | Human | | name |
| 151806411 | CV1401669 | deletion | NM_024996.7(GFM1):c.690_693del | GFM1-related disorder [RCV003416518]|Hepatoencephalopathy due to combined oxidative phosphorylation defect type 1 [RCV002506920]|not provided [RCV001932580] | pathogenic|likely pathogenic | 3 | 158652094 | 158652097 | Human | 1 | name , trait , alternate_id |
| 8691210 | CV141170 | single nucleotide variant | NM_024996.7(GFM1):c.2071-17A>G | Hepatoencephalopathy due to combined oxidative phosphorylation defect type 1 [RCV002483248]|not provided [RCV002055557]|not specified [RCV000125228] | benign|likely benign | 3 | 158691122 | 158691122 | Human | 1 | name |
| 152165936 | CV1611480 | single nucleotide variant | NM_024996.7(GFM1):c.1909+10G>A | not provided [RCV002141819] | likely benign | 3 | 158684678 | 158684678 | Human | | name |
| 156025558 | CV1896186 | single nucleotide variant | NM_024996.7(GFM1):c.1222-13T>C | not provided [RCV003100409] | likely benign | 3 | 158660861 | 158660861 | Human | | name |
| 156416723 | CV1969957 | single nucleotide variant | NM_024996.7(GFM1):c.1519-10C>T | not provided [RCV002589839] | likely benign | 3 | 158666294 | 158666294 | Human | | name |
| 156090801 | CV2017664 | deletion | NM_024996.7(GFM1):c.1324-15del | not provided [RCV002694934] | benign | 3 | 158662610 | 158662610 | Human | | name |
| 156184999 | CV2086508 | single nucleotide variant | NM_024996.7(GFM1):c.1601+17A>C | not provided [RCV002851955] | likely benign | 3 | 158666403 | 158666403 | Human | | name |
| 155990114 | CV2102000 | deletion | NM_024996.7(GFM1):c.1519-16del | not provided [RCV002908119] | likely benign | 3 | 158666285 | 158666285 | Human | | name |
| 156371983 | CV2174670 | single nucleotide variant | NM_024996.7(GFM1):c.1222-10G>A | not provided [RCV003049778] | likely benign | 3 | 158660864 | 158660864 | Human | | name |
| 156144157 | CV2190144 | single nucleotide variant | NM_024996.7(GFM1):c.2071-10T>C | not provided [RCV003056297] | likely benign | 3 | 158691129 | 158691129 | Human | | name |
| 402514395 | CV2860118 | single nucleotide variant | NM_024996.7(GFM1):c.1909+18A>G | not provided [RCV003575271] | likely benign | 3 | 158684686 | 158684686 | Human | | name |
| 405174598 | CV2863454 | single nucleotide variant | NM_024996.7(GFM1):c.1381-17T>C | not provided [RCV003542625] | likely benign | 3 | 158665320 | 158665320 | Human | | name |
| 402488950 | CV2866446 | single nucleotide variant | NM_024996.7(GFM1):c.1083+14T>C | not provided [RCV003572815] | likely benign | 3 | 158654645 | 158654645 | Human | | name |
| 11586308 | CV289270 | single nucleotide variant | NM_024996.7(GFM1):c.1324-15T>A | Hepatoencephalopathy due to combined oxidative phosphorylation defect type 1 [RCV000286924]|not provided [RCV002057852]|not specified [RCV000424127] | benign|likely benign|uncertain significance | 3 | 158662613 | 158662613 | Human | 1 | name |
| 405153002 | CV2893958 | single nucleotide variant | NM_024996.7(GFM1):c.1381-11T>C | not provided [RCV003561859] | likely benign | 3 | 158665326 | 158665326 | Human | | name |
| 402519109 | CV2906274 | deletion | NM_024996.7(GFM1):c.1764+17del | not provided [RCV003575714] | likely benign | 3 | 158682174 | 158682174 | Human | | name |
| 405177303 | CV2912862 | single nucleotide variant | NM_024996.7(GFM1):c.1601+13C>A | not provided [RCV003563649] | likely benign | 3 | 158666399 | 158666399 | Human | | name |
| 402483454 | CV2918115 | single nucleotide variant | NM_024996.7(GFM1):c.1601+16A>C | not provided [RCV003572306] | likely benign | 3 | 158666402 | 158666402 | Human | | name |
| 402483758 | CV2922227 | duplication | NM_024996.7(GFM1):c.1084-19dup | not provided [RCV003572335] | likely benign | 3 | 158658902 | 158658903 | Human | | name |
| 405006228 | CV2929484 | single nucleotide variant | NM_024996.7(GFM1):c.1765-20T>C | not provided [RCV003576314] | likely benign | 3 | 158684504 | 158684504 | Human | | name |
| 405211185 | CV2966936 | single nucleotide variant | NM_024996.7(GFM1):c.1519-15C>T | not provided [RCV003679419] | likely benign | 3 | 158666289 | 158666289 | Human | | name |
| 405211570 | CV2967032 | single nucleotide variant | NM_024996.7(GFM1):c.1602-18T>C | not provided [RCV003679473] | likely benign | 3 | 158681977 | 158681977 | Human | | name |
| 405242140 | CV2971013 | single nucleotide variant | NM_024996.7(GFM1):c.1764+17G>A | not provided [RCV003684282] | likely benign | 3 | 158682174 | 158682174 | Human | | name |
| 405242916 | CV2974781 | single nucleotide variant | NM_024996.7(GFM1):c.1519-19T>C | not provided [RCV003684466] | likely benign | 3 | 158666285 | 158666285 | Human | | name |
| 405216620 | CV2975335 | deletion | NM_024996.7(GFM1):c.1764+16del | not provided [RCV003679994] | benign | 3 | 158682168 | 158682168 | Human | | name |
| 405235561 | CV2976587 | single nucleotide variant | NM_024996.7(GFM1):c.1324-14A>T | not provided [RCV003683019] | likely benign | 3 | 158662614 | 158662614 | Human | | name |
| 405214578 | CV2985054 | single nucleotide variant | NM_024996.7(GFM1):c.1083+10T>A | not provided [RCV003709033] | likely benign | 3 | 158654641 | 158654641 | Human | | name |
| 405240606 | CV2990138 | microsatellite | NM_024996.7(GFM1):c.234+2TA[5] | not provided [RCV003683928] | likely benign | 3 | 158645782 | 158645783 | Human | | name |
| 402479163 | CV2990403 | single nucleotide variant | NM_024996.7(GFM1):c.1910-13T>A | not provided [RCV003686415] | likely benign | 3 | 158690150 | 158690150 | Human | | name |
| 405235020 | CV3040612 | single nucleotide variant | NM_024996.7(GFM1):c.1324-18T>C | not provided [RCV003712090] | likely benign | 3 | 158662610 | 158662610 | Human | | name |
| 405084196 | CV3043649 | single nucleotide variant | NM_024996.7(GFM1):c.2070+10C>G | not provided [RCV003717357] | likely benign | 3 | 158690333 | 158690333 | Human | | name |
| 405123061 | CV3046522 | single nucleotide variant | NM_024996.7(GFM1):c.1765-12A>C | not provided [RCV003724103] | likely benign | 3 | 158684512 | 158684512 | Human | | name |
| 405081995 | CV3046672 | single nucleotide variant | NM_024996.7(GFM1):c.1602-14T>A | not provided [RCV003717145] | likely benign | 3 | 158681981 | 158681981 | Human | | name |
| 405136657 | CV3048365 | deletion | NM_024996.7(GFM1):c.1909+16del | not provided [RCV003725269] | likely benign | 3 | 158684682 | 158684682 | Human | | name |
| 405243876 | CV3053959 | single nucleotide variant | NM_024996.7(GFM1):c.1909+14G>A | not provided [RCV003719840] | likely benign | 3 | 158684682 | 158684682 | Human | | name |
| 405092287 | CV3054676 | single nucleotide variant | NM_024996.7(GFM1):c.1380+11G>A | not provided [RCV003717903] | likely benign | 3 | 158662695 | 158662695 | Human | | name |
| 405254428 | CV3055357 | single nucleotide variant | NM_024996.7(GFM1):c.2125-17T>C | not provided [RCV003723007] | likely benign | 3 | 158691319 | 158691319 | Human | | name |
| 405228830 | CV3065976 | single nucleotide variant | NM_024996.7(GFM1):c.1221+16T>C | not provided [RCV003734538] | likely benign | 3 | 158659075 | 158659075 | Human | | name |
| 405225648 | CV3068402 | single nucleotide variant | NM_024996.7(GFM1):c.1381-15C>A | not provided [RCV003733995] | likely benign | 3 | 158665322 | 158665322 | Human | | name |
| 405042943 | CV3074145 | single nucleotide variant | NM_024996.7(GFM1):c.1084-15A>C | not provided [RCV003740060] | likely benign | 3 | 158658907 | 158658907 | Human | | name |
| 405028272 | CV3076271 | single nucleotide variant | NM_024996.7(GFM1):c.1601+13C>T | not provided [RCV003738948] | likely benign | 3 | 158666399 | 158666399 | Human | | name |
| 405236528 | CV3076621 | single nucleotide variant | NM_024996.7(GFM1):c.1765-11T>C | not provided [RCV003735999] | likely benign | 3 | 158684513 | 158684513 | Human | | name |
| 405048424 | CV3079933 | single nucleotide variant | NM_024996.7(GFM1):c.1084-18C>A | not provided [RCV003740420] | likely benign | 3 | 158658904 | 158658904 | Human | | name |
| 405048770 | CV3080029 | single nucleotide variant | NM_024996.7(GFM1):c.2124+20C>G | not provided [RCV003740443] | likely benign | 3 | 158691212 | 158691212 | Human | | name |
| 405138309 | CV3125379 | single nucleotide variant | NM_024996.7(GFM1):c.2124+20C>A | not provided [RCV003816486] | likely benign | 3 | 158691212 | 158691212 | Human | | name |
| 405143035 | CV3141314 | single nucleotide variant | NM_024996.7(GFM1):c.1381-13T>C | not provided [RCV003839430] | likely benign | 3 | 158665324 | 158665324 | Human | | name |
| 405233017 | CV3144909 | single nucleotide variant | NM_024996.7(GFM1):c.1084-13T>C | not provided [RCV003853166] | likely benign | 3 | 158658909 | 158658909 | Human | | name |
| 405050868 | CV3150947 | single nucleotide variant | NM_024996.7(GFM1):c.2071-12G>A | not provided [RCV003849551] | likely benign | 3 | 158691127 | 158691127 | Human | | name |
| 405165545 | CV3160450 | single nucleotide variant | NM_024996.7(GFM1):c.1909+20C>T | not provided [RCV003857330] | likely benign | 3 | 158684688 | 158684688 | Human | | name |
| 402465025 | CV3177060 | single nucleotide variant | NM_024996.7(GFM1):c.1764+18T>C | not provided [RCV003872691] | likely benign | 3 | 158682175 | 158682175 | Human | | name |
| 405283131 | CV3218500 | single nucleotide variant | NM_024996.7(GFM1):c.689+884T>C | GFM1-related disorder [RCV003957290] | likely benign | 3 | 158650041 | 158650041 | Human | | name , trait , alternate_id |
| 12842496 | CV367009 | single nucleotide variant | NM_024996.7(GFM1):c.1764+11A>T | GFM1-related disorder [RCV003922707]|not provided [RCV002061398]|not specified [RCV000434519] | benign|likely benign | 3 | 158682168 | 158682168 | Human | 1 | name , trait , alternate_id |
| 12848392 | CV367011 | single nucleotide variant | NM_024996.7(GFM1):c.1909+13C>T | not provided [RCV002061399]|not specified [RCV000445199] | benign|likely benign | 3 | 158684681 | 158684681 | Human | | name |
| 12833320 | CV368293 | single nucleotide variant | NM_024996.7(GFM1):c.1909+13C>G | not provided [RCV002064932]|not specified [RCV000418274] | benign|likely benign | 3 | 158684681 | 158684681 | Human | | name |
| 597943216 | CV3765746 | single nucleotide variant | NM_024996.7(GFM1):c.2070+17A>G | not provided [RCV005119124] | likely benign | 3 | 158690340 | 158690340 | Human | | name |
| 597876745 | CV3825679 | single nucleotide variant | NM_024996.7(GFM1):c.1324-20T>C | not provided [RCV005177553] | likely benign | 3 | 158662608 | 158662608 | Human | | name |
| 597948412 | CV3852490 | single nucleotide variant | NM_024996.7(GFM1):c.1221+15A>C | not provided [RCV005189568] | likely benign | 3 | 158659074 | 158659074 | Human | | name |
| 598123386 | CV3884906 | single nucleotide variant | NM_024996.7(GFM1):c.689+887G>A | not specified [RCV005238515] | uncertain significance | 3 | 158650044 | 158650044 | Human | | name |
| 616934945 | CV4009182 | single nucleotide variant | NM_024996.7(GFM1):c.1519-10C>G | not provided [RCV005402354] | likely pathogenic | 3 | 158666294 | 158666294 | Human | | name |
| 12902465 | CV406138 | duplication | NM_024996.7(GFM1):c.2125-11dup | not provided [RCV003736791]|not specified [RCV000487169] | benign|likely benign | 3 | 158691317 | 158691318 | Human | | name |
| 13541192 | CV500638 | single nucleotide variant | NM_024996.7(GFM1):c.689+908G>A | Combined oxidative phosphorylation deficiency [RCV000851196]|Hepatoencephalopathy due to combined oxidative phosphorylation defect type 1 [RCV003465353]|not provided [RCV001377165] | pathogenic|likely pathogenic|likely benign | 3 | 158650065 | 158650065 | Human | 2 | name |
| 13536850 | CV500641 | single nucleotide variant | NM_024996.7(GFM1):c.2071-20T>C | not provided [RCV002065262]|not specified [RCV000609575] | benign|likely benign | 3 | 158691119 | 158691119 | Human | | name |
| 13529930 | CV500648 | deletion | NM_024996.7(GFM1):c.2125-11del | not specified [RCV000600494] | likely benign | 3 | 158691318 | 158691318 | Human | | name |
| 14712892 | CV659644 | single nucleotide variant | NM_024996.7(GFM1):c.689+611A>G | not provided [RCV000828564] | benign | 3 | 158649768 | 158649768 | Human | | name |
| 14725357 | CV659645 | single nucleotide variant | NM_024996.7(GFM1):c.840+108C>G | not provided [RCV000833404] | likely benign | 3 | 158652354 | 158652354 | Human | | name |
| 14713901 | CV659647 | single nucleotide variant | NM_024996.7(GFM1):c.998+150G>A | not provided [RCV000828848] | benign | 3 | 158653617 | 158653617 | Human | | name |
| 14719374 | CV659651 | single nucleotide variant | NM_024996.7(GFM1):c.1323+83A>G | Hepatoencephalopathy due to combined oxidative phosphorylation defect type 1 [RCV001543947]|not provided [RCV000830746] | benign | 3 | 158661058 | 158661058 | Human | 1 | name |
| 14736514 | CV659655 | single nucleotide variant | NM_024996.7(GFM1):c.1601+38A>G | not provided [RCV000838508] | benign | 3 | 158666424 | 158666424 | Human | | name |
| 14746204 | CV659760 | single nucleotide variant | NM_024996.7(GFM1):c.367+223C>T | not provided [RCV000844192] | benign | 3 | 158646520 | 158646520 | Human | | name |
| 28876717 | CV891597 | single nucleotide variant | NM_024996.7(GFM1):c.2070+11T>G | Hepatoencephalopathy due to combined oxidative phosphorylation defect type 1 [RCV001148123]|not provided [RCV001673019] | benign|likely benign | 3 | 158690334 | 158690334 | Human | 1 | name |
| 150418127 | CV1179653 | single nucleotide variant | NM_024996.7(GFM1):c.1519-211T>G | not provided [RCV001550465] | likely benign | 3 | 158666093 | 158666093 | Human | | name |
| 150423455 | CV1183290 | single nucleotide variant | NM_024996.7(GFM1):c.1221+203G>A | not provided [RCV001555345] | likely benign | 3 | 158659262 | 158659262 | Human | | name |
| 150424480 | CV1183291 | single nucleotide variant | NM_024996.7(GFM1):c.1222-321A>G | not provided [RCV001556710] | likely benign | 3 | 158660553 | 158660553 | Human | | name |
| 150410134 | CV1190008 | single nucleotide variant | NM_024996.7(GFM1):c.1909+232A>C | not provided [RCV001565897] | likely benign | 3 | 158684900 | 158684900 | Human | | name |
| 150432902 | CV1200883 | single nucleotide variant | NM_024996.7(GFM1):c.689+1184A>G | not provided [RCV001581607] | likely benign | 3 | 158650341 | 158650341 | Human | | name |
| 150487105 | CV1203407 | single nucleotide variant | NM_024996.7(GFM1):c.1084-299A>T | not provided [RCV001591585] | likely benign | 3 | 158658623 | 158658623 | Human | | name |
| 150430942 | CV1204058 | single nucleotide variant | NM_024996.7(GFM1):c.1909+131C>T | not provided [RCV001580833] | likely benign | 3 | 158684799 | 158684799 | Human | | name |
| 150467910 | CV1207173 | single nucleotide variant | NM_024996.7(GFM1):c.1221+222T>C | not provided [RCV001587965] | likely benign | 3 | 158659281 | 158659281 | Human | | name |
| 150499502 | CV1209092 | single nucleotide variant | NM_024996.7(GFM1):c.1221+323T>C | not provided [RCV001594310] | likely benign | 3 | 158659382 | 158659382 | Human | | name |
| 150451315 | CV1232784 | single nucleotide variant | NM_024996.7(GFM1):c.1380+221T>A | not provided [RCV001647859] | benign | 3 | 158662905 | 158662905 | Human | | name |
| 150474816 | CV1252918 | single nucleotide variant | NM_024996.7(GFM1):c.1765-298A>G | not provided [RCV001671826] | benign | 3 | 158684226 | 158684226 | Human | | name |
| 150494703 | CV1267398 | single nucleotide variant | NM_024996.7(GFM1):c.1324-267G>A | not provided [RCV001688426] | benign | 3 | 158662361 | 158662361 | Human | | name |
| 150478851 | CV1273367 | single nucleotide variant | NM_024996.7(GFM1):c.689+1211A>C | not provided [RCV001696570] | benign | 3 | 158650368 | 158650368 | Human | | name |
| 14713908 | CV659894 | single nucleotide variant | NM_024996.7(GFM1):c.1519-211T>C | not provided [RCV000828850] | benign | 3 | 158666093 | 158666093 | Human | | name |
| 11596009 | CV290052 | deletion | NM_024996.7(GFM1):c.*454_*456del | Combined oxidative phosphorylation deficiency [RCV000377206] | likely benign | 3 | 158691919 | 158691921 | Human | 1 | name |
| 38487059 | CV939930 | deletion | NM_024996.7(GFM1):c.997_998+2del | Hepatoencephalopathy due to combined oxidative phosphorylation defect type 1 [RCV001833837]|not provided [RCV001209160] | likely pathogenic | 3 | 158653466 | 158653469 | Human | 1 | name |
| 405242852 | CV3043828 | microsatellite | NM_024996.7(GFM1):c.1381-17TTC[2] | not provided [RCV003719599] | likely benign | 3 | 158665320 | 158665322 | Human | | name |
| 151794486 | CV1395016 | deletion | NM_024996.7(GFM1):c.841-520_878del | not provided [RCV001973353] | likely pathogenic | 3 | 158652787 | 158653344 | Human | | name |
| 11583036 | CV293586 | insertion | NM_024996.7(GFM1):c.*483_*484insTA | Combined oxidative phosphorylation deficiency [RCV000264012] | likely benign | 3 | 158691950 | 158691951 | Human | 1 | name |
| 127280528 | CV1070491 | single nucleotide variant | NM_024996.7(GFM1):c.21A>G (p.Ala7=) | not provided [RCV001409823] | likely benign | 3 | 158644655 | 158644655 | Human | | name |
| 152147162 | CV1615578 | single nucleotide variant | NM_024996.7(GFM1):c.12G>C (p.Leu4=) | not provided [RCV002101653] | likely benign | 3 | 158644646 | 158644646 | Human | | name |
| 405014106 | CV2930196 | single nucleotide variant | NM_024996.7(GFM1):c.27C>T (p.Val9=) | not provided [RCV003576919] | likely benign | 3 | 158644661 | 158644661 | Human | | name |
| 11585639 | CV293119 | single nucleotide variant | NM_024996.7(GFM1):c.18T>C (p.Ala6=) | Hepatoencephalopathy due to combined oxidative phosphorylation defect type 1 [RCV000282348]|not provided [RCV000676466]|not specified [RCV001795958] | benign | 3 | 158644652 | 158644652 | Human | 1 | name |
| 405010665 | CV2933620 | deletion | NM_024996.7(GFM1):c.368-11_368-9del | not provided [RCV003576705] | likely benign | 3 | 158646730 | 158646732 | Human | | name |
| 405013707 | CV2997576 | single nucleotide variant | NM_024996.7(GFM1):c.18T>G (p.Ala6=) | not provided [RCV003694129] | likely benign | 3 | 158644652 | 158644652 | Human | | name |
| 127270508 | CV1092202 | single nucleotide variant | NM_024996.7(GFM1):c.54C>T (p.Pro18=) | not provided [RCV001430658] | likely benign | 3 | 158644688 | 158644688 | Human | | name |
| 127312215 | CV1113714 | single nucleotide variant | NM_024996.7(GFM1):c.39G>A (p.Gly13=) | not provided [RCV001464314] | likely benign | 3 | 158644673 | 158644673 | Human | | name |
| 127288250 | CV1134608 | single nucleotide variant | NM_024996.7(GFM1):c.54C>A (p.Pro18=) | not provided [RCV001495151] | likely benign | 3 | 158644688 | 158644688 | Human | | name |
| 127325326 | CV1134609 | single nucleotide variant | NM_024996.7(GFM1):c.66C>G (p.Gly22=) | not provided [RCV001505984] | likely benign | 3 | 158644700 | 158644700 | Human | | name |
| 150463686 | CV1276261 | deletion | NM_024996.7(GFM1):c.81+281_81+283del | not provided [RCV001710206] | benign | 3 | 158644981 | 158644983 | Human | | name |
| 150509976 | CV1286319 | deletion | NM_024996.7(GFM1):c.81+282_81+283del | not provided [RCV001720847] | benign | 3 | 158644981 | 158644982 | Human | | name |
| 152083308 | CV1525306 | single nucleotide variant | NM_024996.7(GFM1):c.36G>C (p.Leu12=) | not provided [RCV002131106] | likely benign | 3 | 158644670 | 158644670 | Human | | name |
| 152055624 | CV1610162 | single nucleotide variant | NM_024996.7(GFM1):c.87T>C (p.Asn29=) | not provided [RCV002167393] | likely benign | 3 | 158645634 | 158645634 | Human | | name |
| 10409699 | CV210949 | single nucleotide variant | NM_024996.7(GFM1):c.3G>A (p.Met1Ile) | Hepatoencephalopathy due to combined oxidative phosphorylation defect type 1 [RCV001273487]|not provided [RCV000196656] | pathogenic | 3 | 158644637 | 158644637 | Human | 1 | name |
| 156209039 | CV2165185 | deletion | NM_024996.7(GFM1):c.1221+8_1221+9del | not provided [RCV003024735] | likely benign | 3 | 158659066 | 158659067 | Human | | name |
| 405001661 | CV3015295 | deletion | NM_024996.7(GFM1):c.1602-8_1602-7del | not provided [RCV003693237] | likely benign | 3 | 158681986 | 158681987 | Human | | name |
| 405187610 | CV3124411 | deletion | NM_024996.7(GFM1):c.368-14_368-12del | not provided [RCV003820610] | likely benign | 3 | 158646728 | 158646730 | Human | | name |
| 405112660 | CV3133553 | single nucleotide variant | NM_024996.7(GFM1):c.30G>A (p.Ala10=) | not provided [RCV003836346] | likely benign | 3 | 158644664 | 158644664 | Human | | name |
| 405294173 | CV3203541 | deletion | NM_024996.7(GFM1):c.1910-9_1910-8del | GFM1-related disorder [RCV003934065] | likely benign | 3 | 158690142 | 158690143 | Human | | name , trait , alternate_id |
| 597915158 | CV3740693 | single nucleotide variant | NM_024996.7(GFM1):c.61C>T (p.Leu21=) | not provided [RCV005074030] | likely benign | 3 | 158644695 | 158644695 | Human | | name |
| 597869470 | CV3764624 | single nucleotide variant | NM_024996.7(GFM1):c.60C>T (p.Ser20=) | not provided [RCV005107423] | likely benign | 3 | 158644694 | 158644694 | Human | | name |
| 15190225 | CV763713 | single nucleotide variant | NM_024996.7(GFM1):c.51C>T (p.Ala17=) | Hepatoencephalopathy due to combined oxidative phosphorylation defect type 1 [RCV001272457]|not provided [RCV000932460] | likely benign|uncertain significance | 3 | 158644685 | 158644685 | Human | 1 | name |
| 38492502 | CV940740 | deletion | NM_024996.7(GFM1):c.1765-2_1765-1del | Hepatoencephalopathy due to combined oxidative phosphorylation defect type 1 [RCV001833935]|not provided [RCV001223407] | pathogenic | 3 | 158684522 | 158684523 | Human | 1 | name |
| 127280879 | CV1070493 | single nucleotide variant | NM_024996.7(GFM1):c.102A>C (p.Arg34=) | not provided [RCV001410097] | likely benign | 3 | 158645649 | 158645649 | Human | | name |
| 127251355 | CV1070494 | single nucleotide variant | NM_024996.7(GFM1):c.141A>C (p.Arg47=) | not provided [RCV001417766] | likely benign | 3 | 158645688 | 158645688 | Human | | name |
| 127249511 | CV1070495 | single nucleotide variant | NM_024996.7(GFM1):c.168T>C (p.Asp56=) | not provided [RCV001417337] | likely benign | 3 | 158645715 | 158645715 | Human | | name |
| 127310427 | CV1134610 | single nucleotide variant | NM_024996.7(GFM1):c.279A>G (p.Glu93=) | not provided [RCV001481138] | likely benign | 3 | 158646209 | 158646209 | Human | | name |
| 152095183 | CV1603883 | single nucleotide variant | NM_024996.7(GFM1):c.171T>C (p.Ser57=) | GFM1-related disorder [RCV003893206]|not provided [RCV002213263] | likely benign | 3 | 158645718 | 158645718 | Human | 1 | name , trait , alternate_id |
| 152053745 | CV1665300 | single nucleotide variant | NM_024996.7(GFM1):c.186A>G (p.Leu62=) | not provided [RCV002089464] | likely benign | 3 | 158645733 | 158645733 | Human | | name |
| 156352891 | CV1994623 | single nucleotide variant | NM_024996.7(GFM1):c.153C>T (p.Ile51=) | not provided [RCV002675718] | likely benign | 3 | 158645700 | 158645700 | Human | | name |
| 155977104 | CV2085326 | single nucleotide variant | NM_024996.7(GFM1):c.291A>G (p.Gln97=) | not provided [RCV002863585] | likely benign | 3 | 158646221 | 158646221 | Human | | name |
| 10409468 | CV210950 | single nucleotide variant | NM_024996.7(GFM1):c.16G>C (p.Ala6Pro) | not provided [RCV000196171] | uncertain significance | 3 | 158644650 | 158644650 | Human | | name |
| 402487005 | CV2865460 | single nucleotide variant | NM_024996.7(GFM1):c.249T>C (p.Asp83=) | not provided [RCV003544573] | likely benign | 3 | 158646179 | 158646179 | Human | | name |
| 405139153 | CV2970325 | single nucleotide variant | NM_024996.7(GFM1):c.171T>A (p.Ser57=) | not provided [RCV003669047] | likely benign | 3 | 158645718 | 158645718 | Human | | name |
| 405244963 | CV2972727 | deletion | NM_024996.7(GFM1):c.1222-10_1222-7del | not provided [RCV003685007] | likely benign | 3 | 158660861 | 158660864 | Human | | name |
| 405090573 | CV3044781 | single nucleotide variant | NM_024996.7(GFM1):c.207C>T (p.Tyr69=) | not provided [RCV003717788] | likely benign | 3 | 158645754 | 158645754 | Human | | name |
| 402521482 | CV3126930 | single nucleotide variant | NM_024996.7(GFM1):c.213C>T (p.Gly71=) | not provided [RCV003824848] | likely benign | 3 | 158645760 | 158645760 | Human | | name |
| 405062190 | CV3148342 | single nucleotide variant | NM_024996.7(GFM1):c.183A>G (p.Thr61=) | not provided [RCV003850298] | likely benign | 3 | 158645730 | 158645730 | Human | | name |
| 402487382 | CV3181910 | single nucleotide variant | NM_024996.7(GFM1):c.204C>T (p.Tyr68=) | not provided [RCV003876579] | likely benign | 3 | 158645751 | 158645751 | Human | | name |
| 405261980 | CV3220014 | single nucleotide variant | NM_024996.7(GFM1):c.102A>G (p.Arg34=) | GFM1-related disorder [RCV003967162]|not provided [RCV005064893] | likely benign | 3 | 158645649 | 158645649 | Human | 1 | name , trait , alternate_id |
| 597683340 | CV3720935 | deletion | NM_024996.7(GFM1):c.49del (p.Ala17fs) | Hepatoencephalopathy due to combined oxidative phosphorylation defect type 1 [RCV005031316] | likely pathogenic | 3 | 158644681 | 158644681 | Human | 1 | name |
| 597874459 | CV3775496 | single nucleotide variant | NM_024996.7(GFM1):c.139C>A (p.Arg47=) | not provided [RCV005123226] | likely benign | 3 | 158645686 | 158645686 | Human | | name |
| 13788801 | CV549907 | single nucleotide variant | NM_024996.7(GFM1):c.193C>A (p.Arg65=) | Hepatoencephalopathy due to combined oxidative phosphorylation defect type 1 [RCV001148014]|not provided [RCV000676467] | likely benign|uncertain significance | 3 | 158645740 | 158645740 | Human | 1 | name |
| 14705334 | CV654317 | deletion | NM_024996.7(GFM1):c.54del (p.Ala19fs) | Hepatoencephalopathy due to combined oxidative phosphorylation defect type 1 [RCV000826110]|not provided [RCV002538243] | pathogenic|likely pathogenic | 3 | 158644684 | 158644684 | Human | 1 | name |
| 15110136 | CV708673 | single nucleotide variant | NM_024996.7(GFM1):c.192A>G (p.Glu64=) | Hepatoencephalopathy due to combined oxidative phosphorylation defect type 1 [RCV001832207]|not provided [RCV000960840] | likely benign | 3 | 158645739 | 158645739 | Human | 1 | name |
| 15130602 | CV781599 | single nucleotide variant | NM_024996.7(GFM1):c.294A>G (p.Arg98=) | not provided [RCV000981069] | likely benign | 3 | 158646224 | 158646224 | Human | | name |
| 127283800 | CV1070496 | single nucleotide variant | NM_024996.7(GFM1):c.324C>T (p.Tyr108=) | not provided [RCV001412023] | likely benign | 3 | 158646254 | 158646254 | Human | | name |
| 127275338 | CV1070497 | single nucleotide variant | NM_024996.7(GFM1):c.612C>T (p.Pro204=) | not provided [RCV001406692] | likely benign | 3 | 158649080 | 158649080 | Human | | name |
| 127231067 | CV1070498 | single nucleotide variant | NM_024996.7(GFM1):c.705T>C (p.Tyr235=) | not provided [RCV001395108] | likely benign | 3 | 158652111 | 158652111 | Human | | name |
| 127260018 | CV1070499 | single nucleotide variant | NM_024996.7(GFM1):c.735G>A (p.Ala245=) | not provided [RCV001419959] | likely benign | 3 | 158652141 | 158652141 | Human | | name |
| 127233998 | CV1070500 | single nucleotide variant | NM_024996.7(GFM1):c.738C>A (p.Ala246=) | not provided [RCV001414114] | likely benign | 3 | 158652144 | 158652144 | Human | | name |
| 127229960 | CV1070501 | single nucleotide variant | NM_024996.7(GFM1):c.744C>T (p.Asp248=) | not provided [RCV001412253] | likely benign | 3 | 158652150 | 158652150 | Human | | name |
| 127254275 | CV1070503 | single nucleotide variant | NM_024996.7(GFM1):c.960A>G (p.Pro320=) | not provided [RCV001418529] | likely benign | 3 | 158653429 | 158653429 | Human | | name |
| 127280226 | CV1092203 | single nucleotide variant | NM_024996.7(GFM1):c.363T>C (p.Thr121=) | not provided [RCV001446328] | likely benign | 3 | 158646293 | 158646293 | Human | | name |
| 127275822 | CV1092204 | single nucleotide variant | NM_024996.7(GFM1):c.465C>T (p.Thr155=) | not provided [RCV001443507] | likely benign | 3 | 158646840 | 158646840 | Human | | name |
| 127270930 | CV1092205 | single nucleotide variant | NM_024996.7(GFM1):c.540C>T (p.Gly180=) | not provided [RCV001441608] | likely benign | 3 | 158646915 | 158646915 | Human | | name |
| 127239238 | CV1092207 | single nucleotide variant | NM_024996.7(GFM1):c.996G>A (p.Glu332=) | not provided [RCV001433935] | likely benign | 3 | 158653465 | 158653465 | Human | | name |
| 127332937 | CV1113716 | single nucleotide variant | NM_024996.7(GFM1):c.504G>A (p.Pro168=) | not provided [RCV001472584] | likely benign | 3 | 158646879 | 158646879 | Human | | name |
| 127305840 | CV1113717 | single nucleotide variant | NM_024996.7(GFM1):c.552C>T (p.Ala184=) | not provided [RCV001455339] | likely benign | 3 | 158646927 | 158646927 | Human | | name |
| 127310438 | CV1113720 | single nucleotide variant | NM_024996.7(GFM1):c.580C>T (p.Leu194=) | not provided [RCV001456613] | likely benign | 3 | 158649048 | 158649048 | Human | | name |
| 127292271 | CV1113721 | single nucleotide variant | NM_024996.7(GFM1):c.687T>C (p.Phe229=) | not provided [RCV001451732] | likely benign | 3 | 158649155 | 158649155 | Human | | name |
| 127338215 | CV1134611 | single nucleotide variant | NM_024996.7(GFM1):c.426C>T (p.Val142=) | not provided [RCV001493692] | likely benign | 3 | 158646801 | 158646801 | Human | | name |
| 127328611 | CV1134612 | single nucleotide variant | NM_024996.7(GFM1):c.792T>C (p.Leu264=) | not provided [RCV001486867] | likely benign | 3 | 158652198 | 158652198 | Human | | name |
| 127313833 | CV1134613 | single nucleotide variant | NM_024996.7(GFM1):c.861T>C (p.Thr287=) | not provided [RCV001482082] | likely benign | 3 | 158653330 | 158653330 | Human | | name |
| 127309038 | CV1134614 | single nucleotide variant | NM_024996.7(GFM1):c.873A>G (p.Ser291=) | not provided [RCV001480744] | likely benign | 3 | 158653342 | 158653342 | Human | | name |
| 127314949 | CV1134615 | single nucleotide variant | NM_024996.7(GFM1):c.928T>C (p.Leu310=) | not provided [RCV001502597] | likely benign | 3 | 158653397 | 158653397 | Human | | name |
| 150470014 | CV1209245 | deletion | NM_024996.7(GFM1):c.2125-32_2125-30del | not provided [RCV001588356] | likely benign | 3 | 158691302 | 158691304 | Human | | name |
| 151757307 | CV1340376 | single nucleotide variant | NM_024996.7(GFM1):c.67T>A (p.Trp23Arg) | not provided [RCV001913584] | uncertain significance | 3 | 158644701 | 158644701 | Human | | name |
| 151716491 | CV1345995 | single nucleotide variant | NM_024996.7(GFM1):c.97T>C (p.Cys33Arg) | not provided [RCV001965306] | uncertain significance | 3 | 158645644 | 158645644 | Human | | name |
| 151884110 | CV1366616 | single nucleotide variant | NM_024996.7(GFM1):c.69G>A (p.Trp23Ter) | Hepatoencephalopathy due to combined oxidative phosphorylation defect type 1 [RCV003464295]|not provided [RCV001941657] | pathogenic|likely pathogenic | 3 | 158644703 | 158644703 | Human | 1 | name |
| 151824690 | CV1373321 | duplication | NM_024996.7(GFM1):c.136dup (p.Ile46fs) | not provided [RCV001934484] | pathogenic | 3 | 158645677 | 158645678 | Human | | name |
| 151788222 | CV1419759 | single nucleotide variant | NM_024996.7(GFM1):c.62T>C (p.Leu21Pro) | not provided [RCV001951780] | uncertain significance | 3 | 158644696 | 158644696 | Human | | name |
| 152082627 | CV1525189 | single nucleotide variant | NM_024996.7(GFM1):c.720T>A (p.Ala240=) | not provided [RCV002131016] | likely benign | 3 | 158652126 | 158652126 | Human | | name |
| 152064229 | CV1535763 | single nucleotide variant | NM_024996.7(GFM1):c.420T>C (p.Gly140=) | not provided [RCV002168403] | likely benign | 3 | 158646795 | 158646795 | Human | | name |
| 152161471 | CV1555403 | single nucleotide variant | NM_024996.7(GFM1):c.757C>T (p.Leu253=) | not provided [RCV002103878] | likely benign | 3 | 158652163 | 158652163 | Human | | name |
| 152061574 | CV1559360 | single nucleotide variant | NM_024996.7(GFM1):c.930A>G (p.Leu310=) | not provided [RCV002168064] | likely benign | 3 | 158653399 | 158653399 | Human | | name |
| 152106797 | CV1560147 | single nucleotide variant | NM_024996.7(GFM1):c.762T>A (p.Ile254=) | not provided [RCV002133956] | likely benign | 3 | 158652168 | 158652168 | Human | | name |
| 152094327 | CV1565744 | single nucleotide variant | NM_024996.7(GFM1):c.406A>C (p.Arg136=) | not provided [RCV002150999] | likely benign | 3 | 158646781 | 158646781 | Human | | name |
| 152154411 | CV1579477 | single nucleotide variant | NM_024996.7(GFM1):c.699T>C (p.Val233=) | not provided [RCV002158659] | likely benign | 3 | 158652105 | 158652105 | Human | | name |
| 152127789 | CV1583671 | single nucleotide variant | NM_024996.7(GFM1):c.981T>A (p.Ala327=) | not provided [RCV002198916] | likely benign | 3 | 158653450 | 158653450 | Human | | name |
| 152142141 | CV1586492 | single nucleotide variant | NM_024996.7(GFM1):c.732G>A (p.Ala244=) | not provided [RCV002178196] | likely benign | 3 | 158652138 | 158652138 | Human | | name |
| 152105600 | CV1602709 | single nucleotide variant | NM_024996.7(GFM1):c.471T>G (p.Thr157=) | not provided [RCV002196107] | likely benign | 3 | 158646846 | 158646846 | Human | | name |
| 152151914 | CV1626668 | single nucleotide variant | NM_024996.7(GFM1):c.933T>C (p.Asp311=) | not provided [RCV002202101] | likely benign | 3 | 158653402 | 158653402 | Human | | name |
| 152113400 | CV1639308 | single nucleotide variant | NM_024996.7(GFM1):c.724T>C (p.Leu242=) | not provided [RCV002197082] | likely benign | 3 | 158652130 | 158652130 | Human | | name |
| 156353841 | CV1880016 | single nucleotide variant | NM_024996.7(GFM1):c.90G>T (p.Trp30Cys) | Inborn genetic diseases [RCV004632166]|not provided [RCV003065079] | likely benign|uncertain significance | 3 | 158645637 | 158645637 | Human | 1 | name |
| 156405826 | CV1884645 | single nucleotide variant | NM_024996.7(GFM1):c.552C>G (p.Ala184=) | not provided [RCV003070146] | likely benign | 3 | 158646927 | 158646927 | Human | | name |
| 156192070 | CV1893021 | single nucleotide variant | NM_024996.7(GFM1):c.441T>A (p.Ala147=) | not provided [RCV003083905] | likely benign | 3 | 158646816 | 158646816 | Human | | name |
| 156127630 | CV1927313 | deletion | NM_024996.7(GFM1):c.2125-22_2125-20del | not provided [RCV002640582] | benign | 3 | 158691314 | 158691316 | Human | | name |
| 156350835 | CV1978356 | single nucleotide variant | NM_024996.7(GFM1):c.360T>C (p.Asp120=) | not provided [RCV002601813] | likely benign | 3 | 158646290 | 158646290 | Human | | name |
| 156388108 | CV1989854 | single nucleotide variant | NM_024996.7(GFM1):c.666C>T (p.Ala222=) | not provided [RCV002604437] | likely benign | 3 | 158649134 | 158649134 | Human | | name |
| 155904484 | CV2031337 | single nucleotide variant | NM_024996.7(GFM1):c.318C>T (p.Ala106=) | not provided [RCV002726384] | likely benign | 3 | 158646248 | 158646248 | Human | | name |
| 156129913 | CV2036510 | single nucleotide variant | NM_024996.7(GFM1):c.894A>G (p.Gly298=) | not provided [RCV002786128] | likely benign | 3 | 158653363 | 158653363 | Human | | name |
| 156043021 | CV2044185 | single nucleotide variant | NM_024996.7(GFM1):c.435C>T (p.Leu145=) | not provided [RCV002781563] | likely benign | 3 | 158646810 | 158646810 | Human | | name |
| 155908446 | CV2077589 | single nucleotide variant | NM_024996.7(GFM1):c.642T>C (p.Ile214=) | not provided [RCV002858305] | likely benign | 3 | 158649110 | 158649110 | Human | | name |
| 10409151 | CV210951 | single nucleotide variant | NM_024996.7(GFM1):c.77A>G (p.Lys26Arg) | Hepatoencephalopathy due to combined oxidative phosphorylation defect type 1 [RCV000398210]|not provided [RCV000915754]|not specified [RCV000195533] | benign|likely benign | 3 | 158644711 | 158644711 | Human | 1 | name |
| 10411528 | CV210954 | deletion | NM_024996.7(GFM1):c.273del (p.Met92fs) | Hepatoencephalopathy due to combined oxidative phosphorylation defect type 1 [RCV002500612]|not provided [RCV000200452] | pathogenic|likely pathogenic | 3 | 158646202 | 158646202 | Human | 1 | name |
| 10409258 | CV210961 | single nucleotide variant | NM_024996.7(GFM1):c.960A>C (p.Pro320=) | GFM1-related disorder [RCV004748652]|Hepatoencephalopathy due to combined oxidative phosphorylation defect type 1 [RCV000316489]|not provided [RCV000910628]|not specified [RCV000195750] | benign|likely benign|uncertain significance | 3 | 158653429 | 158653429 | Human | 1 | name , trait , alternate_id |
| 156248170 | CV2119752 | single nucleotide variant | NM_024996.7(GFM1):c.990T>C (p.Asn330=) | not provided [RCV002959109] | likely benign | 3 | 158653459 | 158653459 | Human | | name |
| 156314565 | CV2120256 | single nucleotide variant | NM_024996.7(GFM1):c.657G>A (p.Glu219=) | not provided [RCV002962820] | likely benign | 3 | 158649125 | 158649125 | Human | | name |
| 156286743 | CV2134196 | single nucleotide variant | NM_024996.7(GFM1):c.684C>T (p.Asp228=) | not provided [RCV003009801] | likely benign | 3 | 158649152 | 158649152 | Human | | name |
| 155995074 | CV2156289 | single nucleotide variant | NM_024996.7(GFM1):c.459C>T (p.Cys153=) | not provided [RCV002996750] | likely benign | 3 | 158646834 | 158646834 | Human | | name |
| 156005544 | CV2165098 | single nucleotide variant | NM_024996.7(GFM1):c.975C>T (p.Asn325=) | not provided [RCV003034976] | likely benign | 3 | 158653444 | 158653444 | Human | | name |
| 156270086 | CV2167996 | single nucleotide variant | NM_024996.7(GFM1):c.807G>C (p.Leu269=) | not provided [RCV003026956] | likely benign | 3 | 158652213 | 158652213 | Human | | name |
| 156169995 | CV2169851 | single nucleotide variant | NM_024996.7(GFM1):c.750G>T (p.Arg250=) | not provided [RCV003023483] | likely benign | 3 | 158652156 | 158652156 | Human | | name |
| 243050218 | CV2419587 | single nucleotide variant | NM_024996.7(GFM1):c.72G>C (p.Gln24His) | not provided [RCV003156519] | uncertain significance | 3 | 158644706 | 158644706 | Human | | name |
| 401799022 | CV2741598 | single nucleotide variant | NM_024996.7(GFM1):c.28G>T (p.Ala10Ser) | not provided [RCV003323006] | uncertain significance | 3 | 158644662 | 158644662 | Human | | name |
| 401922999 | CV2825040 | single nucleotide variant | NM_024996.7(GFM1):c.88T>G (p.Trp30Gly) | not provided [RCV003434784] | likely benign | 3 | 158645635 | 158645635 | Human | | name |
| 401941378 | CV2836014 | deletion | NM_024996.7(GFM1):c.136del (p.Ile46fs) | Hepatoencephalopathy due to combined oxidative phosphorylation defect type 1 [RCV003461695] | likely pathogenic | 3 | 158645678 | 158645678 | Human | 1 | name |
| 401961533 | CV2843877 | single nucleotide variant | NM_024996.7(GFM1):c.53C>T (p.Pro18Leu) | not provided [RCV003481716] | uncertain significance | 3 | 158644687 | 158644687 | Human | | name |
| 402485868 | CV2855265 | single nucleotide variant | NM_024996.7(GFM1):c.612C>G (p.Pro204=) | not provided [RCV003544403] | likely benign | 3 | 158649080 | 158649080 | Human | | name |
| 402474094 | CV2858049 | deletion | NM_024996.7(GFM1):c.2071-14_2071-13del | not provided [RCV003543076] | likely benign | 3 | 158691124 | 158691125 | Human | | name |
| 402490645 | CV2866717 | single nucleotide variant | NM_024996.7(GFM1):c.402C>G (p.Ala134=) | not provided [RCV003572978] | likely benign | 3 | 158646777 | 158646777 | Human | | name |
| 11597009 | CV290039 | single nucleotide variant | NM_024996.7(GFM1):c.702A>G (p.Arg234=) | Hepatoencephalopathy due to combined oxidative phosphorylation defect type 1 [RCV000388686] | uncertain significance | 3 | 158652108 | 158652108 | Human | 1 | name |
| 11585320 | CV290042 | single nucleotide variant | NM_024996.7(GFM1):c.897C>T (p.Ser299=) | Hepatoencephalopathy due to combined oxidative phosphorylation defect type 1 [RCV000280136]|not provided [RCV001453939] | likely benign|uncertain significance | 3 | 158653366 | 158653366 | Human | 1 | name |
| 405176577 | CV2915609 | single nucleotide variant | NM_024996.7(GFM1):c.774C>T (p.Ala258=) | not provided [RCV003563516] | likely benign | 3 | 158652180 | 158652180 | Human | | name |
| 405064180 | CV2927283 | single nucleotide variant | NM_024996.7(GFM1):c.516T>C (p.Phe172=) | not provided [RCV003580672] | likely benign | 3 | 158646891 | 158646891 | Human | | name |
| 405014232 | CV2930354 | single nucleotide variant | NM_024996.7(GFM1):c.303T>C (p.Thr101=) | not provided [RCV003576999] | likely benign | 3 | 158646233 | 158646233 | Human | | name |
| 402469139 | CV2930913 | single nucleotide variant | NM_024996.7(GFM1):c.702A>C (p.Arg234=) | not provided [RCV003570064] | likely benign | 3 | 158652108 | 158652108 | Human | | name |
| 11592303 | CV293120 | single nucleotide variant | NM_024996.7(GFM1):c.56C>T (p.Ala19Val) | GFM1-related disorder [RCV003950210]|Hepatoencephalopathy due to combined oxidative phosphorylation defect type 1 [RCV000337390]|not provided [RCV000943185] | benign|likely benign|conflicting interpretations of pathogenicity|uncertain significance | 3 | 158644690 | 158644690 | Human | 1 | name , trait , alternate_id |
| 11595909 | CV293532 | single nucleotide variant | NM_024996.7(GFM1):c.987C>A (p.Leu329=) | Hepatoencephalopathy due to combined oxidative phosphorylation defect type 1 [RCV000376033]|not provided [RCV000933080] | likely benign|uncertain significance | 3 | 158653456 | 158653456 | Human | 1 | name |
| 405161405 | CV2951337 | single nucleotide variant | NM_024996.7(GFM1):c.558C>T (p.Ala186=) | not provided [RCV003670755] | likely benign | 3 | 158646933 | 158646933 | Human | | name |
| 404984023 | CV2989525 | single nucleotide variant | NM_024996.7(GFM1):c.850C>A (p.Arg284=) | not provided [RCV003691509] | likely benign | 3 | 158653319 | 158653319 | Human | | name |
| 402480667 | CV2991065 | single nucleotide variant | NM_024996.7(GFM1):c.582A>C (p.Leu194=) | not provided [RCV003686516] | likely benign | 3 | 158649050 | 158649050 | Human | | name |
| 405118381 | CV2997440 | single nucleotide variant | NM_024996.7(GFM1):c.402C>T (p.Ala134=) | not provided [RCV003723608] | likely benign | 3 | 158646777 | 158646777 | Human | | name |
| 402519205 | CV3002368 | single nucleotide variant | NM_024996.7(GFM1):c.576T>G (p.Ser192=) | not provided [RCV003690161] | likely benign | 3 | 158649044 | 158649044 | Human | | name |
| 405129969 | CV3010861 | single nucleotide variant | NM_024996.7(GFM1):c.831T>C (p.Ser277=) | not provided [RCV003701586] | likely benign | 3 | 158652237 | 158652237 | Human | | name |
| 402499718 | CV3012966 | single nucleotide variant | NM_024996.7(GFM1):c.885A>G (p.Val295=) | not provided [RCV003688366] | likely benign | 3 | 158653354 | 158653354 | Human | | name |
| 405039725 | CV3013525 | single nucleotide variant | NM_024996.7(GFM1):c.747C>T (p.His249=) | not provided [RCV003696162] | likely benign | 3 | 158652153 | 158652153 | Human | | name |
| 405003705 | CV3016382 | single nucleotide variant | NM_024996.7(GFM1):c.753G>A (p.Gln251=) | not provided [RCV003693413] | likely benign | 3 | 158652159 | 158652159 | Human | | name |
| 405090869 | CV3021780 | single nucleotide variant | NM_024996.7(GFM1):c.789G>A (p.Gln263=) | not provided [RCV003699725] | likely benign | 3 | 158652195 | 158652195 | Human | | name |
| 405052874 | CV3022252 | single nucleotide variant | NM_024996.7(GFM1):c.336A>G (p.Lys112=) | not provided [RCV003697130] | likely benign | 3 | 158646266 | 158646266 | Human | | name |
| 405141748 | CV3026293 | single nucleotide variant | NM_024996.7(GFM1):c.384A>G (p.Thr128=) | not provided [RCV003702518] | likely benign | 3 | 158646759 | 158646759 | Human | | name |
| 402510499 | CV3042498 | deletion | NM_024996.7(GFM1):c.1910-22_1910-20del | not provided [RCV003715625] | likely benign | 3 | 158690141 | 158690143 | Human | | name |
| 405237000 | CV3080671 | deletion | NM_024996.7(GFM1):c.1222-14_1222-11del | not provided [RCV003736073] | likely benign | 3 | 158660858 | 158660861 | Human | | name |
| 405237031 | CV3080691 | microsatellite | NM_024996.7(GFM1):c.2071-16_2071-14del | not provided [RCV003736079] | likely benign | 3 | 158691120 | 158691122 | Human | | name |
| 405084546 | CV3121960 | deletion | NM_024996.7(GFM1):c.1518+16_1518+19del | not provided [RCV003810715] | likely benign | 3 | 158665487 | 158665490 | Human | | name |
| 405195176 | CV3128657 | deletion | NM_024996.7(GFM1):c.2125-28_2125-17del | not provided [RCV003821395] | likely benign | 3 | 158691308 | 158691319 | Human | | name |
| 405107406 | CV3136205 | single nucleotide variant | NM_024996.7(GFM1):c.363T>A (p.Thr121=) | not provided [RCV003835551] | likely benign | 3 | 158646293 | 158646293 | Human | | name |
| 405083341 | CV3137577 | single nucleotide variant | NM_024996.7(GFM1):c.945A>G (p.Glu315=) | not provided [RCV003834286] | likely benign | 3 | 158653414 | 158653414 | Human | | name |
| 405212650 | CV3169789 | single nucleotide variant | NM_024996.7(GFM1):c.948C>T (p.Tyr316=) | not provided [RCV003862388] | likely benign | 3 | 158653417 | 158653417 | Human | | name |
| 402477788 | CV3170173 | single nucleotide variant | NM_024996.7(GFM1):c.900C>T (p.Ala300=) | not provided [RCV003875561] | likely benign | 3 | 158653369 | 158653369 | Human | | name |
| 405255287 | CV3176122 | single nucleotide variant | NM_024996.7(GFM1):c.906G>A (p.Lys302=) | not provided [RCV003872206] | likely benign | 3 | 158653375 | 158653375 | Human | | name |
| 407512862 | CV3433020 | single nucleotide variant | NM_024996.7(GFM1):c.73A>G (p.Arg25Gly) | Inborn genetic diseases [RCV004626937] | likely benign | 3 | 158644707 | 158644707 | Human | 1 | name |
| 12842583 | CV367289 | single nucleotide variant | NM_024996.7(GFM1):c.597G>A (p.Ala199=) | not provided [RCV001439230]|not specified [RCV000434679] | likely benign | 3 | 158649065 | 158649065 | Human | | name |
| 597892175 | CV3763104 | single nucleotide variant | NM_024996.7(GFM1):c.696T>C (p.Ile232=) | not provided [RCV005110876] | likely benign | 3 | 158652102 | 158652102 | Human | | name |
| 15125839 | CV763714 | single nucleotide variant | NM_024996.7(GFM1):c.807G>A (p.Leu269=) | not provided [RCV000941271] | likely benign | 3 | 158652213 | 158652213 | Human | | name |
| 15183202 | CV763715 | single nucleotide variant | NM_024996.7(GFM1):c.837A>G (p.Leu279=) | not provided [RCV000930538] | likely benign | 3 | 158652243 | 158652243 | Human | | name |
| 15144051 | CV781600 | single nucleotide variant | NM_024996.7(GFM1):c.498C>T (p.Asn166=) | Hepatoencephalopathy due to combined oxidative phosphorylation defect type 1 [RCV001836054]|not provided [RCV000983429] | likely benign | 3 | 158646873 | 158646873 | Human | 1 | name |
| 15145800 | CV781601 | single nucleotide variant | NM_024996.7(GFM1):c.843A>G (p.Leu281=) | not provided [RCV000983730] | likely benign | 3 | 158653312 | 158653312 | Human | | name |
| 40906634 | CV977819 | single nucleotide variant | NM_024996.7(GFM1):c.825G>A (p.Ser275=) | Hepatoencephalopathy due to combined oxidative phosphorylation defect type 1 [RCV001280046] | uncertain significance | 3 | 158652231 | 158652231 | Human | 1 | name |
| 127254429 | CV1070504 | single nucleotide variant | NM_024996.7(GFM1):c.1143T>C (p.Gly381=) | not provided [RCV001400802] | likely benign | 3 | 158658981 | 158658981 | Human | | name |
| 127264911 | CV1070505 | single nucleotide variant | NM_024996.7(GFM1):c.1152C>A (p.Ile384=) | not provided [RCV001403439] | likely benign | 3 | 158658990 | 158658990 | Human | | name |
| 127242492 | CV1070506 | single nucleotide variant | NM_024996.7(GFM1):c.1263T>C (p.Phe421=) | not provided [RCV001393349] | likely benign | 3 | 158660915 | 158660915 | Human | | name |
| 127262679 | CV1070507 | single nucleotide variant | NM_024996.7(GFM1):c.1299C>T (p.Asp433=) | not provided [RCV001402707] | likely benign | 3 | 158660951 | 158660951 | Human | | name |
| 127250661 | CV1070508 | single nucleotide variant | NM_024996.7(GFM1):c.1422A>G (p.Thr474=) | not provided [RCV001417630] | likely benign | 3 | 158665378 | 158665378 | Human | | name |
| 127248350 | CV1070509 | single nucleotide variant | NM_024996.7(GFM1):c.1473A>G (p.Thr491=) | not provided [RCV001399353] | likely benign | 3 | 158665429 | 158665429 | Human | | name |
| 127255344 | CV1070511 | single nucleotide variant | NM_024996.7(GFM1):c.1629A>T (p.Ser543=) | not provided [RCV001418724] | likely benign | 3 | 158682022 | 158682022 | Human | | name |
| 127250642 | CV1070512 | single nucleotide variant | NM_024996.7(GFM1):c.1665C>A (p.Val555=) | not provided [RCV001417627] | likely benign | 3 | 158682058 | 158682058 | Human | | name |
| 127233179 | CV1070513 | single nucleotide variant | NM_024996.7(GFM1):c.2055T>C (p.Phe685=) | not provided [RCV001413778] | likely benign | 3 | 158690308 | 158690308 | Human | | name |
| 127268035 | CV1070514 | single nucleotide variant | NM_024996.7(GFM1):c.2139C>T (p.Tyr713=) | not provided [RCV001404300] | likely benign | 3 | 158691350 | 158691350 | Human | | name |
| 127256669 | CV1092208 | single nucleotide variant | NM_024996.7(GFM1):c.1005A>G (p.Ser335=) | not provided [RCV001426857] | likely benign | 3 | 158654553 | 158654553 | Human | | name |
| 127275784 | CV1092209 | single nucleotide variant | NM_024996.7(GFM1):c.1074T>C (p.Phe358=) | not provided [RCV001432518] | likely benign | 3 | 158654622 | 158654622 | Human | | name |
| 127268272 | CV1092210 | single nucleotide variant | NM_024996.7(GFM1):c.1161A>G (p.Thr387=) | not provided [RCV001429908] | likely benign | 3 | 158658999 | 158658999 | Human | | name |
| 127273167 | CV1092212 | single nucleotide variant | NM_024996.7(GFM1):c.1329A>G (p.Ser443=) | not provided [RCV001431564] | likely benign | 3 | 158662633 | 158662633 | Human | | name |
| 127261068 | CV1092214 | single nucleotide variant | NM_024996.7(GFM1):c.1434C>T (p.Pro478=) | not provided [RCV001428010] | likely benign | 3 | 158665390 | 158665390 | Human | | name |
| 127276110 | CV1092215 | single nucleotide variant | NM_024996.7(GFM1):c.1857T>A (p.Val619=) | not provided [RCV001432628] | likely benign | 3 | 158684616 | 158684616 | Human | | name |
| 127278591 | CV1092216 | single nucleotide variant | NM_024996.7(GFM1):c.2166A>G (p.Pro722=) | not provided [RCV001445163] | likely benign | 3 | 158691377 | 158691377 | Human | | name |
| 127323488 | CV1113723 | single nucleotide variant | NM_024996.7(GFM1):c.1179A>T (p.Val393=) | not provided [RCV001467891] | likely benign | 3 | 158659017 | 158659017 | Human | | name |
| 127299397 | CV1113724 | single nucleotide variant | NM_024996.7(GFM1):c.1188A>G (p.Gln396=) | not provided [RCV001453582] | likely benign | 3 | 158659026 | 158659026 | Human | | name |
| 127309375 | CV1113725 | single nucleotide variant | NM_024996.7(GFM1):c.1311C>T (p.Ser437=) | not provided [RCV001463594] | likely benign | 3 | 158660963 | 158660963 | Human | | name |
| 127329786 | CV1113726 | single nucleotide variant | NM_024996.7(GFM1):c.1536T>C (p.Tyr512=) | not provided [RCV001470423] | likely benign | 3 | 158666321 | 158666321 | Human | | name |
| 127336667 | CV1113727 | single nucleotide variant | NM_024996.7(GFM1):c.1782C>T (p.Cys594=) | GFM1-related disorder [RCV003965956]|not provided [RCV001475138] | likely benign | 3 | 158684541 | 158684541 | Human | 1 | name , trait , alternate_id |
| 127316851 | CV1113728 | single nucleotide variant | NM_024996.7(GFM1):c.1818G>A (p.Gly606=) | not provided [RCV001465651] | likely benign | 3 | 158684577 | 158684577 | Human | | name |
| 127288244 | CV1113729 | single nucleotide variant | NM_024996.7(GFM1):c.1851C>T (p.His617=) | GFM1-related disorder [RCV003973309]|not provided [RCV001450412] | likely benign | 3 | 158684610 | 158684610 | Human | 1 | name , trait , alternate_id |
| 127324381 | CV1113730 | single nucleotide variant | NM_024996.7(GFM1):c.1881C>T (p.Ile627=) | not provided [RCV001468192] | likely benign | 3 | 158684640 | 158684640 | Human | | name |
| 127327341 | CV1113733 | single nucleotide variant | NM_024996.7(GFM1):c.2170T>C (p.Leu724=) | not provided [RCV001469047] | likely benign | 3 | 158691381 | 158691381 | Human | | name |
| 127331649 | CV1113734 | single nucleotide variant | NM_024996.7(GFM1):c.2178C>T (p.Ser726=) | not provided [RCV001471711] | likely benign | 3 | 158691389 | 158691389 | Human | | name |
| 127331778 | CV1134616 | single nucleotide variant | NM_024996.7(GFM1):c.1035C>T (p.Ser345=) | not provided [RCV001489057] | likely benign | 3 | 158654583 | 158654583 | Human | | name |
| 127317373 | CV1134617 | single nucleotide variant | NM_024996.7(GFM1):c.1101A>G (p.Gln367=) | not provided [RCV001483140] | likely benign | 3 | 158658939 | 158658939 | Human | | name |
| 127296402 | CV1134618 | single nucleotide variant | NM_024996.7(GFM1):c.1290A>G (p.Thr430=) | not provided [RCV001497458] | likely benign | 3 | 158660942 | 158660942 | Human | | name |
| 127332383 | CV1134619 | single nucleotide variant | NM_024996.7(GFM1):c.1326G>A (p.Glu442=) | not provided [RCV001489456] | likely benign | 3 | 158662630 | 158662630 | Human | | name |
| 127326172 | CV1134620 | single nucleotide variant | NM_024996.7(GFM1):c.1350C>T (p.Val450=) | not provided [RCV001485969] | likely benign | 3 | 158662654 | 158662654 | Human | | name |
| 127327129 | CV1134621 | single nucleotide variant | NM_024996.7(GFM1):c.1371T>C (p.Pro457=) | not provided [RCV001486231] | likely benign | 3 | 158662675 | 158662675 | Human | | name |
| 127306383 | CV1134622 | single nucleotide variant | NM_024996.7(GFM1):c.1383C>T (p.Asn461=) | Hepatoencephalopathy due to combined oxidative phosphorylation defect type 1 [RCV001563842]|not provided [RCV001480040] | likely benign|uncertain significance | 3 | 158665339 | 158665339 | Human | 1 | name |
| 127291895 | CV1134623 | single nucleotide variant | NM_024996.7(GFM1):c.1686G>A (p.Glu562=) | not provided [RCV001496388] | likely benign | 3 | 158682079 | 158682079 | Human | | name |
| 127328984 | CV1134624 | single nucleotide variant | NM_024996.7(GFM1):c.1893A>G (p.Glu631=) | not provided [RCV001487128] | likely benign | 3 | 158684652 | 158684652 | Human | | name |
| 127306797 | CV1134625 | single nucleotide variant | NM_024996.7(GFM1):c.2061G>C (p.Leu687=) | not provided [RCV001480179] | likely benign | 3 | 158690314 | 158690314 | Human | | name |
| 150421419 | CV1193276 | single nucleotide variant | NM_024996.7(GFM1):c.1065C>T (p.Gly355=) | not provided [RCV001570541] | likely benign | 3 | 158654613 | 158654613 | Human | | name |
| 150451070 | CV1200416 | deletion | NM_024996.7(GFM1):c.748del (p.Arg250fs) | Hepatoencephalopathy due to combined oxidative phosphorylation defect type 1 [RCV001580712] | likely pathogenic | 3 | 158652153 | 158652153 | Human | 1 | name |
| 150548796 | CV1294519 | single nucleotide variant | NM_024996.7(GFM1):c.265A>G (p.Met89Val) | not provided [RCV001752011] | uncertain significance | 3 | 158646195 | 158646195 | Human | | name |
| 151881980 | CV1364015 | deletion | NM_024996.7(GFM1):c.612del (p.Met205fs) | not provided [RCV001999737] | pathogenic | 3 | 158649078 | 158649078 | Human | | name |
| 151768446 | CV1367438 | deletion | NM_024996.7(GFM1):c.890del (p.Leu297fs) | Hepatoencephalopathy due to combined oxidative phosphorylation defect type 1 [RCV005038385]|not provided [RCV001863844] | pathogenic|likely pathogenic | 3 | 158653355 | 158653355 | Human | 1 | name |
| 151782720 | CV1383481 | deletion | NM_024996.7(GFM1):c.649del (p.Ile218fs) | not provided [RCV001865113] | pathogenic | 3 | 158649117 | 158649117 | Human | | name |
| 8691205 | CV141165 | single nucleotide variant | NM_024996.7(GFM1):c.127A>G (p.Asn43Asp) | Hepatoencephalopathy due to combined oxidative phosphorylation defect type 1 [RCV000361226]|not provided [RCV000964843]|not specified [RCV000125223] | benign|likely benign|conflicting interpretations of pathogenicity|uncertain significance | 3 | 158645674 | 158645674 | Human | 1 | name |
| 151884148 | CV1428547 | deletion | NM_024996.7(GFM1):c.769del (p.Val257fs) | not provided [RCV002000207] | pathogenic | 3 | 158652175 | 158652175 | Human | | name |
| 152141653 | CV1532966 | single nucleotide variant | NM_024996.7(GFM1):c.2073C>T (p.Val691=) | not provided [RCV002156850] | likely benign | 3 | 158691141 | 158691141 | Human | | name |
| 152174935 | CV1536198 | single nucleotide variant | NM_024996.7(GFM1):c.1140G>A (p.Lys380=) | not provided [RCV002163318] | likely benign | 3 | 158658978 | 158658978 | Human | | name |
| 152129379 | CV1549263 | single nucleotide variant | NM_024996.7(GFM1):c.2079A>G (p.Leu693=) | not provided [RCV002099277] | likely benign | 3 | 158691147 | 158691147 | Human | | name |
| 152084297 | CV1554876 | single nucleotide variant | NM_024996.7(GFM1):c.1168A>C (p.Arg390=) | not provided [RCV002211835] | likely benign | 3 | 158659006 | 158659006 | Human | | name |
| 152106758 | CV1560142 | single nucleotide variant | NM_024996.7(GFM1):c.1584C>G (p.Thr528=) | not provided [RCV002133951] | likely benign | 3 | 158666369 | 158666369 | Human | | name |
| 152089283 | CV1563074 | single nucleotide variant | NM_024996.7(GFM1):c.1078C>T (p.Leu360=) | not provided [RCV002113849] | likely benign | 3 | 158654626 | 158654626 | Human | | name |
| 152151020 | CV1567585 | single nucleotide variant | NM_024996.7(GFM1):c.1707T>C (p.Phe569=) | not provided [RCV002158193] | likely benign | 3 | 158682100 | 158682100 | Human | | name |
| 152157224 | CV1586133 | single nucleotide variant | NM_024996.7(GFM1):c.1935T>A (p.Ile645=) | not provided [RCV002140307] | likely benign | 3 | 158690188 | 158690188 | Human | | name |
| 152156416 | CV1589577 | single nucleotide variant | NM_024996.7(GFM1):c.1917A>C (p.Ala639=) | not provided [RCV002122497] | likely benign | 3 | 158690170 | 158690170 | Human | | name |
| 152163035 | CV1600698 | single nucleotide variant | NM_024996.7(GFM1):c.2160T>C (p.Tyr720=) | not provided [RCV002141255] | likely benign | 3 | 158691371 | 158691371 | Human | | name |
| 152076745 | CV1604582 | single nucleotide variant | NM_024996.7(GFM1):c.2121A>C (p.Thr707=) | not provided [RCV002092324] | likely benign | 3 | 158691189 | 158691189 | Human | | name |
| 152076664 | CV1606964 | single nucleotide variant | NM_024996.7(GFM1):c.2151T>C (p.Tyr717=) | not provided [RCV002130312] | likely benign | 3 | 158691362 | 158691362 | Human | | name |
| 152165814 | CV1611451 | single nucleotide variant | NM_024996.7(GFM1):c.2040A>G (p.Gly680=) | not provided [RCV002141793] | likely benign | 3 | 158690293 | 158690293 | Human | | name |
| 152122698 | CV1613590 | single nucleotide variant | NM_024996.7(GFM1):c.1524G>A (p.Leu508=) | not provided [RCV002081778] | likely benign | 3 | 158666309 | 158666309 | Human | | name |
| 152148078 | CV1623819 | single nucleotide variant | NM_024996.7(GFM1):c.2058A>G (p.Thr686=) | not provided [RCV002157741] | likely benign | 3 | 158690311 | 158690311 | Human | | name |
| 152136054 | CV1634554 | single nucleotide variant | NM_024996.7(GFM1):c.1998A>T (p.Ala666=) | not provided [RCV002218731] | likely benign | 3 | 158690251 | 158690251 | Human | | name |
| 152074650 | CV1638263 | single nucleotide variant | NM_024996.7(GFM1):c.1617T>C (p.His539=) | not provided [RCV002192250] | likely benign | 3 | 158682010 | 158682010 | Human | | name |
| 152157689 | CV1650903 | single nucleotide variant | NM_024996.7(GFM1):c.2226T>C (p.Leu742=) | not provided [RCV002140380] | likely benign | 3 | 158691437 | 158691437 | Human | | name |
| 152107534 | CV1657330 | single nucleotide variant | NM_024996.7(GFM1):c.1872C>A (p.Ile624=) | not provided [RCV002215019] | likely benign|conflicting interpretations of pathogenicity | 3 | 158684631 | 158684631 | Human | | name |
| 153302302 | CV1688161 | single nucleotide variant | NM_024996.7(GFM1):c.153C>G (p.Ile51Met) | not provided [RCV002265387] | uncertain significance | 3 | 158645700 | 158645700 | Human | | name |
| 155641867 | CV1707163 | single nucleotide variant | NM_024996.7(GFM1):c.228G>T (p.Met76Ile) | not provided [RCV002288093] | uncertain significance | 3 | 158645775 | 158645775 | Human | | name |
| 156384858 | CV1874772 | single nucleotide variant | NM_024996.7(GFM1):c.1821C>A (p.Leu607=) | not provided [RCV003050777] | likely benign | 3 | 158684580 | 158684580 | Human | | name |
| 156060711 | CV1876323 | single nucleotide variant | NM_024996.7(GFM1):c.1236A>G (p.Val412=) | not provided [RCV003053332] | likely benign | 3 | 158660888 | 158660888 | Human | | name |
| 156223623 | CV1899978 | single nucleotide variant | NM_024996.7(GFM1):c.2184A>G (p.Gln728=) | not provided [RCV003085092] | likely benign | 3 | 158691395 | 158691395 | Human | | name |
| 156211740 | CV1902475 | single nucleotide variant | NM_024996.7(GFM1):c.185T>G (p.Leu62Ter) | not provided [RCV003084624] | pathogenic | 3 | 158645732 | 158645732 | Human | | name |
| 156414484 | CV1912367 | single nucleotide variant | NM_024996.7(GFM1):c.1056A>G (p.Pro352=) | not provided [RCV002588636] | likely benign | 3 | 158654604 | 158654604 | Human | | name |
| 8596315 | CV19200 | single nucleotide variant | NM_024996.7(GFM1):c.139C>T (p.Arg47Ter) | Hepatoencephalopathy due to combined oxidative phosphorylation defect type 1 [RCV000004378]|not provided [RCV001207728] | pathogenic | 3 | 158645686 | 158645686 | Human | 1 | name |
| 156449670 | CV1941934 | single nucleotide variant | NM_024996.7(GFM1):c.2034A>G (p.Gln678=) | not provided [RCV003121796] | likely benign | 3 | 158690287 | 158690287 | Human | | name |
| 156264744 | CV1993853 | single nucleotide variant | NM_024996.7(GFM1):c.2100C>T (p.Ser700=) | not provided [RCV002646335] | likely benign | 3 | 158691168 | 158691168 | Human | | name |
| 156390293 | CV1998694 | duplication | NM_024996.7(GFM1):c.817dup (p.Ile273fs) | Hepatoencephalopathy due to combined oxidative phosphorylation defect type 1 [RCV003464582]|not provided [RCV002680697] | pathogenic | 3 | 158652217 | 158652218 | Human | 1 | name |
| 156229802 | CV2043420 | single nucleotide variant | NM_024996.7(GFM1):c.1335T>C (p.His445=) | not provided [RCV002805270] | likely benign | 3 | 158662639 | 158662639 | Human | | name |
| 156037502 | CV2052596 | single nucleotide variant | NM_024996.7(GFM1):c.1080G>A (p.Leu360=) | not provided [RCV002796305] | likely benign | 3 | 158654628 | 158654628 | Human | | name |
| 156052916 | CV2064652 | single nucleotide variant | NM_024996.7(GFM1):c.2082T>C (p.Asn694=) | not provided [RCV002846498] | likely benign | 3 | 158691150 | 158691150 | Human | | name |
| 155981882 | CV2070159 | single nucleotide variant | NM_024996.7(GFM1):c.1305C>A (p.Ala435=) | not provided [RCV002842561] | likely benign | 3 | 158660957 | 158660957 | Human | | name |
| 155972086 | CV2078036 | single nucleotide variant | NM_024996.7(GFM1):c.2022A>T (p.Val674=) | not provided [RCV002863365] | likely benign | 3 | 158690275 | 158690275 | Human | | name |
| 156022974 | CV2079173 | single nucleotide variant | NM_024996.7(GFM1):c.2142A>C (p.Thr714=) | not provided [RCV002885045] | likely benign | 3 | 158691353 | 158691353 | Human | | name |
| 155906590 | CV2080384 | single nucleotide variant | NM_024996.7(GFM1):c.1740G>A (p.Lys580=) | not provided [RCV002858191] | likely benign | 3 | 158682133 | 158682133 | Human | | name |
| 156321696 | CV2101066 | single nucleotide variant | NM_024996.7(GFM1):c.1350C>G (p.Val450=) | not provided [RCV002899339] | likely benign | 3 | 158662654 | 158662654 | Human | | name |
| 10410175 | CV210953 | single nucleotide variant | NM_024996.7(GFM1):c.238A>G (p.Lys80Glu) | not provided [RCV000197651] | uncertain significance | 3 | 158646168 | 158646168 | Human | | name |
| 10409956 | CV210964 | single nucleotide variant | NM_024996.7(GFM1):c.1209C>T (p.Ala403=) | Hepatoencephalopathy due to combined oxidative phosphorylation defect type 1 [RCV001147220]|not provided [RCV000946773]|not specified [RCV000197193] | benign | 3 | 158659047 | 158659047 | Human | 1 | name |
| 10409961 | CV210968 | single nucleotide variant | NM_024996.7(GFM1):c.1593C>T (p.Ala531=) | GFM1-related disorder [RCV003927840]|Hepatoencephalopathy due to combined oxidative phosphorylation defect type 1 [RCV001148120]|not provided [RCV000883125]|not specified [RCV000197206] | benign|likely benign | 3 | 158666378 | 158666378 | Human | 1 | name , trait , alternate_id |
| 155940136 | CV2119771 | single nucleotide variant | NM_024996.7(GFM1):c.1374T>A (p.Ser458=) | not provided [RCV002971224] | likely benign | 3 | 158662678 | 158662678 | Human | | name |
| 156306291 | CV2129792 | single nucleotide variant | NM_024996.7(GFM1):c.2103T>C (p.Thr701=) | not provided [RCV002962381] | likely benign | 3 | 158691171 | 158691171 | Human | | name |
| 156208740 | CV2131463 | duplication | NM_024996.7(GFM1):c.303dup (p.Ile102fs) | Hepatoencephalopathy due to combined oxidative phosphorylation defect type 1 [RCV004572498]|not provided [RCV002985505] | pathogenic|likely pathogenic | 3 | 158646232 | 158646233 | Human | 1 | name |
| 156245011 | CV2147751 | single nucleotide variant | NM_024996.7(GFM1):c.1539C>T (p.Gly513=) | not provided [RCV003026143] | likely benign | 3 | 158666324 | 158666324 | Human | | name |
| 156248786 | CV2156167 | single nucleotide variant | NM_024996.7(GFM1):c.2238A>G (p.Lys746=) | not provided [RCV003008370] | likely benign | 3 | 158691449 | 158691449 | Human | | name |
| 156365851 | CV2177003 | single nucleotide variant | NM_024996.7(GFM1):c.2130G>A (p.Lys710=) | not provided [RCV003049342] | likely benign | 3 | 158691341 | 158691341 | Human | | name |
| 156258092 | CV2185402 | single nucleotide variant | NM_024996.7(GFM1):c.1677G>A (p.Leu559=) | not provided [RCV003044023] | likely benign | 3 | 158682070 | 158682070 | Human | | name |
| 156261511 | CV2191048 | single nucleotide variant | NM_024996.7(GFM1):c.2112G>A (p.Arg704=) | not provided [RCV003044134] | likely benign | 3 | 158691180 | 158691180 | Human | | name |
| 156200229 | CV2256060 | single nucleotide variant | NM_024996.7(GFM1):c.268G>C (p.Asp90His) | Inborn genetic diseases [RCV002803410] | uncertain significance | 3 | 158646198 | 158646198 | Human | 1 | name |
| 243059819 | CV2412626 | single nucleotide variant | NM_024996.7(GFM1):c.1209C>A (p.Ala403=) | Hepatoencephalopathy due to combined oxidative phosphorylation defect type 1 [RCV003135362] | uncertain significance | 3 | 158659047 | 158659047 | Human | 1 | name |
| 329350064 | CV2477262 | single nucleotide variant | NM_024996.7(GFM1):c.130G>A (p.Glu44Lys) | not provided [RCV003221587] | uncertain significance | 3 | 158645677 | 158645677 | Human | | name |
| 329350068 | CV2477263 | single nucleotide variant | NM_024996.7(GFM1):c.137T>A (p.Ile46Lys) | not provided [RCV003221588] | uncertain significance | 3 | 158645684 | 158645684 | Human | | name |
| 401856598 | CV2752587 | single nucleotide variant | NM_024996.7(GFM1):c.152T>G (p.Ile51Ser) | Hepatoencephalopathy due to combined oxidative phosphorylation defect type 1 [RCV003340925] | uncertain significance | 3 | 158645699 | 158645699 | Human | 1 | name |
| 401941349 | CV2836006 | deletion | NM_024996.7(GFM1):c.914del (p.Gly305fs) | Hepatoencephalopathy due to combined oxidative phosphorylation defect type 1 [RCV003461690] | pathogenic | 3 | 158653382 | 158653382 | Human | 1 | name |
| 401943305 | CV2836008 | deletion | NM_024996.7(GFM1):c.626del (p.Gly209fs) | Hepatoencephalopathy due to combined oxidative phosphorylation defect type 1 [RCV003468268] | likely pathogenic | 3 | 158649092 | 158649092 | Human | 1 | name |
| 401941376 | CV2836011 | duplication | NM_024996.7(GFM1):c.579dup (p.Leu194fs) | Hepatoencephalopathy due to combined oxidative phosphorylation defect type 1 [RCV003461693] | likely pathogenic | 3 | 158649044 | 158649045 | Human | 1 | name |
| 401941381 | CV2836019 | deletion | NM_024996.7(GFM1):c.909del (p.Asn303fs) | Hepatoencephalopathy due to combined oxidative phosphorylation defect type 1 [RCV003461698] | likely pathogenic | 3 | 158653378 | 158653378 | Human | 1 | name |
| 401943044 | CV2836022 | deletion | NM_024996.7(GFM1):c.381del (p.Phe127fs) | Hepatoencephalopathy due to combined oxidative phosphorylation defect type 1 [RCV003468273] | likely pathogenic | 3 | 158646756 | 158646756 | Human | 1 | name |
| 401942875 | CV2836033 | duplication | NM_024996.7(GFM1):c.361dup (p.Thr121fs) | Hepatoencephalopathy due to combined oxidative phosphorylation defect type 1 [RCV003468278] | likely pathogenic | 3 | 158646290 | 158646291 | Human | 1 | name |
| 401942879 | CV2836035 | deletion | NM_024996.7(GFM1):c.636del (p.Gly213fs) | Hepatoencephalopathy due to combined oxidative phosphorylation defect type 1 [RCV003468279] | likely pathogenic | 3 | 158649102 | 158649102 | Human | 1 | name |
| 401941390 | CV2836037 | deletion | NM_024996.7(GFM1):c.974del (p.Asn325fs) | Hepatoencephalopathy due to combined oxidative phosphorylation defect type 1 [RCV003461707]|not provided [RCV003708805] | pathogenic|likely pathogenic | 3 | 158653442 | 158653442 | Human | 1 | name |
| 405016362 | CV2855753 | single nucleotide variant | NM_024996.7(GFM1):c.1242C>G (p.Ala414=) | not provided [RCV003577166] | likely benign | 3 | 158660894 | 158660894 | Human | | name |
| 402483176 | CV2860754 | single nucleotide variant | NM_024996.7(GFM1):c.2019G>T (p.Gly673=) | not provided [RCV003544224] | likely benign | 3 | 158690272 | 158690272 | Human | | name |
| 405175696 | CV2864618 | insertion | NM_024996.7(GFM1):c.1602-19_1602-18insC | not provided [RCV003542738] | likely benign | 3 | 158681976 | 158681977 | Human | | name |
| 402490305 | CV2867000 | single nucleotide variant | NM_024996.7(GFM1):c.1791C>T (p.Gly597=) | not provided [RCV003544815] | likely benign | 3 | 158684550 | 158684550 | Human | | name |
| 402495190 | CV2875085 | single nucleotide variant | NM_024996.7(GFM1):c.2031G>A (p.Gly677=) | not provided [RCV003545325] | likely benign | 3 | 158690284 | 158690284 | Human | | name |
| 405224819 | CV2885656 | single nucleotide variant | NM_024996.7(GFM1):c.1719A>G (p.Thr573=) | not provided [RCV003554477] | likely benign | 3 | 158682112 | 158682112 | Human | | name |
| 405048181 | CV2886695 | single nucleotide variant | NM_024996.7(GFM1):c.1182G>A (p.Arg394=) | not provided [RCV003579600] | likely benign | 3 | 158659020 | 158659020 | Human | | name |
| 405228333 | CV2894537 | single nucleotide variant | NM_024996.7(GFM1):c.1554A>G (p.Thr518=) | not provided [RCV003555066] | likely benign | 3 | 158666339 | 158666339 | Human | | name |
| 11646658 | CV290038 | deletion | NM_024996.7(GFM1):c.424del (p.Val142fs) | Hepatoencephalopathy due to combined oxidative phosphorylation defect type 1 [RCV000272222]|not provided [RCV000814936] | pathogenic|likely pathogenic|conflicting interpretations of pathogenicity|uncertain significance | 3 | 158646799 | 158646799 | Human | 1 | name |
| 402475880 | CV2916085 | single nucleotide variant | NM_024996.7(GFM1):c.2077C>T (p.Leu693=) | not provided [RCV003571314] | likely benign | 3 | 158691145 | 158691145 | Human | | name |
| 405212668 | CV2917597 | single nucleotide variant | NM_024996.7(GFM1):c.1911C>T (p.Ala637=) | not provided [RCV003567362] | likely benign | 3 | 158690164 | 158690164 | Human | | name |
| 405202658 | CV2918714 | single nucleotide variant | NM_024996.7(GFM1):c.1183T>C (p.Leu395=) | not provided [RCV003565999] | likely benign | 3 | 158659021 | 158659021 | Human | | name |
| 402482736 | CV2921825 | single nucleotide variant | NM_024996.7(GFM1):c.1416G>A (p.Arg472=) | not provided [RCV003572242] | likely benign | 3 | 158665372 | 158665372 | Human | | name |
| 405064800 | CV2927307 | single nucleotide variant | NM_024996.7(GFM1):c.1929A>G (p.Leu643=) | not provided [RCV003580682] | likely benign | 3 | 158690182 | 158690182 | Human | | name |
| 405039898 | CV2929961 | single nucleotide variant | NM_024996.7(GFM1):c.1287C>T (p.Asp429=) | not provided [RCV003579027] | likely benign | 3 | 158660939 | 158660939 | Human | | name |
| 11589760 | CV293129 | single nucleotide variant | NM_024996.7(GFM1):c.1831C>T (p.Leu611=) | Hepatoencephalopathy due to combined oxidative phosphorylation defect type 1 [RCV000312996]|not provided [RCV001521349] | benign|conflicting interpretations of pathogenicity|uncertain significance | 3 | 158684590 | 158684590 | Human | 1 | name |
| 11585522 | CV293543 | single nucleotide variant | NM_024996.7(GFM1):c.1032C>T (p.Asn344=) | Hepatoencephalopathy due to combined oxidative phosphorylation defect type 1 [RCV000281525]|not provided [RCV000952513]|not specified [RCV000429176] | benign|likely benign|conflicting interpretations of pathogenicity|uncertain significance | 3 | 158654580 | 158654580 | Human | 1 | name |
| 11584766 | CV293571 | single nucleotide variant | NM_024996.7(GFM1):c.2190C>T (p.Asp730=) | Hepatoencephalopathy due to combined oxidative phosphorylation defect type 1 [RCV000275898]|not provided [RCV000913641] | benign|likely benign|uncertain significance | 3 | 158691401 | 158691401 | Human | 1 | name |
| 405067585 | CV2944603 | single nucleotide variant | NM_024996.7(GFM1):c.2013C>T (p.Arg671=) | not provided [RCV003663783] | likely benign | 3 | 158690266 | 158690266 | Human | | name |
| 405176493 | CV2951954 | single nucleotide variant | NM_024996.7(GFM1):c.1812C>G (p.Leu604=) | not provided [RCV003675875] | likely benign | 3 | 158684571 | 158684571 | Human | | name |
| 405128723 | CV2957168 | single nucleotide variant | NM_024996.7(GFM1):c.2247C>T (p.Ala749=) | not provided [RCV003672122] | likely benign | 3 | 158691458 | 158691458 | Human | | name |
| 405241176 | CV2970687 | single nucleotide variant | NM_024996.7(GFM1):c.1338T>G (p.Val446=) | not provided [RCV003684076] | likely benign | 3 | 158662642 | 158662642 | Human | | name |
| 405214321 | CV2981370 | single nucleotide variant | NM_024996.7(GFM1):c.1863T>C (p.Ser621=) | not provided [RCV003709113] | likely benign | 3 | 158684622 | 158684622 | Human | | name |
| 405248496 | CV2982357 | single nucleotide variant | NM_024996.7(GFM1):c.2205T>C (p.Tyr735=) | not provided [RCV003685912] | likely benign | 3 | 158691416 | 158691416 | Human | | name |
| 402515160 | CV2993196 | single nucleotide variant | NM_024996.7(GFM1):c.1470G>A (p.Glu490=) | not provided [RCV003716009] | likely benign | 3 | 158665426 | 158665426 | Human | | name |
| 405205734 | CV2997820 | single nucleotide variant | NM_024996.7(GFM1):c.2025C>T (p.Ile675=) | not provided [RCV003678709] | likely benign | 3 | 158690278 | 158690278 | Human | | name |
| 404988710 | CV2998476 | single nucleotide variant | NM_024996.7(GFM1):c.295G>T (p.Gly99Ter) | not provided [RCV003692030] | pathogenic | 3 | 158646225 | 158646225 | Human | | name |
| 402481092 | CV3001088 | single nucleotide variant | NM_024996.7(GFM1):c.1815T>C (p.Ser605=) | not provided [RCV003686614] | likely benign | 3 | 158684574 | 158684574 | Human | | name |
| 405248407 | CV3003655 | single nucleotide variant | NM_024996.7(GFM1):c.2241A>G (p.Gly747=) | not provided [RCV003721111] | likely benign | 3 | 158691452 | 158691452 | Human | | name |
| 405121883 | CV3004173 | single nucleotide variant | NM_024996.7(GFM1):c.1017C>T (p.Thr339=) | not provided [RCV003723977] | likely benign | 3 | 158654565 | 158654565 | Human | | name |
| 402505389 | CV3007277 | single nucleotide variant | NM_024996.7(GFM1):c.1512T>C (p.Tyr504=) | not provided [RCV003688793] | likely benign | 3 | 158665468 | 158665468 | Human | | name |
| 402524127 | CV3015055 | single nucleotide variant | NM_024996.7(GFM1):c.1731T>C (p.Asn577=) | not provided [RCV003690516] | likely benign | 3 | 158682124 | 158682124 | Human | | name |
| 405121565 | CV3024624 | single nucleotide variant | NM_024996.7(GFM1):c.1134A>G (p.Leu378=) | not provided [RCV003700814] | likely benign | 3 | 158658972 | 158658972 | Human | | name |
| 402478136 | CV3032925 | single nucleotide variant | NM_024996.7(GFM1):c.1758A>G (p.Val586=) | not provided [RCV003712524] | likely benign | 3 | 158682151 | 158682151 | Human | | name |
| 405186896 | CV3040506 | single nucleotide variant | NM_024996.7(GFM1):c.1014A>G (p.Lys338=) | not provided [RCV003706042] | likely benign | 3 | 158654562 | 158654562 | Human | | name |
| 405079232 | CV3050308 | single nucleotide variant | NM_024996.7(GFM1):c.2172A>G (p.Leu724=) | not provided [RCV003717006] | likely benign | 3 | 158691383 | 158691383 | Human | | name |
| 405040159 | CV3067952 | single nucleotide variant | NM_024996.7(GFM1):c.1479A>T (p.Ile493=) | not provided [RCV003739854] | likely benign | 3 | 158665435 | 158665435 | Human | | name |
| 405040172 | CV3067953 | single nucleotide variant | NM_024996.7(GFM1):c.1890A>G (p.Gly630=) | not provided [RCV003739855] | likely benign | 3 | 158684649 | 158684649 | Human | | name |
| 405236975 | CV3076420 | single nucleotide variant | NM_024996.7(GFM1):c.1401A>G (p.Ser467=) | not provided [RCV003735954] | likely benign | 3 | 158665357 | 158665357 | Human | | name |
| 405114135 | CV3133839 | single nucleotide variant | NM_024996.7(GFM1):c.2028T>A (p.Thr676=) | not provided [RCV003836634] | likely benign | 3 | 158690281 | 158690281 | Human | | name |
| 405175928 | CV3148158 | deletion | NM_024996.7(GFM1):c.857del (p.Ala286fs) | not provided [RCV003858130] | pathogenic | 3 | 158653326 | 158653326 | Human | | name |
| 405224982 | CV3158881 | single nucleotide variant | NM_024996.7(GFM1):c.1212C>T (p.Asp404=) | not provided [RCV003864183] | likely benign | 3 | 158659050 | 158659050 | Human | | name |
| 405251448 | CV3181327 | single nucleotide variant | NM_024996.7(GFM1):c.1800T>C (p.Ser600=) | not provided [RCV003870329] | likely benign | 3 | 158684559 | 158684559 | Human | | name |
| 405292618 | CV3192779 | single nucleotide variant | NM_024996.7(GFM1):c.1503G>T (p.Leu501=) | GFM1-related disorder [RCV003964600] | likely benign | 3 | 158665459 | 158665459 | Human | | name , trait , alternate_id |
| 405868969 | CV3400676 | deletion | NM_024996.7(GFM1):c.548del (p.Pro183fs) | Hepatoencephalopathy due to combined oxidative phosphorylation defect type 1 [RCV004576679] | likely pathogenic | 3 | 158646921 | 158646921 | Human | 1 | name |
| 596930095 | CV3538687 | single nucleotide variant | NM_024996.7(GFM1):c.221C>T (p.Ala74Val) | not provided [RCV004792156] | uncertain significance | 3 | 158645768 | 158645768 | Human | | name |
| 12743223 | CV361581 | duplication | NM_024996.7(GFM1):c.829dup (p.Ser277fs) | Hepatoencephalopathy due to combined oxidative phosphorylation defect type 1 [RCV000779394]|not provided [RCV000416186] | likely pathogenic|conflicting interpretations of pathogenicity|uncertain significance | 3 | 158652232 | 158652233 | Human | 1 | name |
| 12836918 | CV367003 | single nucleotide variant | NM_024996.7(GFM1):c.1494A>G (p.Glu498=) | Hepatoencephalopathy due to combined oxidative phosphorylation defect type 1 [RCV001148119]|not provided [RCV000897890] | likely benign|uncertain significance | 3 | 158665450 | 158665450 | Human | 1 | name |
| 12837315 | CV367254 | single nucleotide variant | NM_024996.7(GFM1):c.2059C>T (p.Leu687=) | GFM1-related disorder [RCV003970232]|not provided [RCV000881004] | benign|likely benign | 3 | 158690312 | 158690312 | Human | 1 | name , trait , alternate_id |
| 12847695 | CV368282 | single nucleotide variant | NM_024996.7(GFM1):c.1626A>G (p.Gln542=) | not provided [RCV002522390]|not specified [RCV000443950] | likely benign|uncertain significance | 3 | 158682019 | 158682019 | Human | | name |
| 597904680 | CV3784676 | single nucleotide variant | NM_024996.7(GFM1):c.155C>T (p.Ser52Leu) | not provided [RCV005127727] | uncertain significance | 3 | 158645702 | 158645702 | Human | | name |
| 597873568 | CV3836324 | single nucleotide variant | NM_024996.7(GFM1):c.1989A>G (p.Gln663=) | not provided [RCV005177121] | likely benign | 3 | 158690242 | 158690242 | Human | | name |
| 13527487 | CV500085 | single nucleotide variant | NM_024996.7(GFM1):c.1377C>T (p.Asn459=) | not provided [RCV000943989]|not specified [RCV000605197] | likely benign | 3 | 158662681 | 158662681 | Human | | name |
| 14704643 | CV631016 | single nucleotide variant | NM_024996.7(GFM1):c.193C>T (p.Arg65Ter) | Hepatoencephalopathy due to combined oxidative phosphorylation defect type 1 [RCV003467367]|not provided [RCV000798054] | pathogenic | 3 | 158645740 | 158645740 | Human | 1 | name |
| 14712185 | CV631019 | duplication | NM_024996.7(GFM1):c.521dup (p.Asn174fs) | not provided [RCV000819934] | pathogenic | 3 | 158646894 | 158646895 | Human | | name |
| 14704846 | CV631020 | deletion | NM_024996.7(GFM1):c.539del (p.Gly180fs) | Hepatoencephalopathy due to combined oxidative phosphorylation defect type 1 [RCV003232990]|not provided [RCV000798894] | pathogenic | 3 | 158646912 | 158646912 | Human | 1 | name |
| 14708463 | CV631021 | deletion | NM_024996.7(GFM1):c.720del (p.Glu241fs) | Hepatoencephalopathy due to combined oxidative phosphorylation defect type 1 [RCV001273488]|not provided [RCV000809691] | pathogenic | 3 | 158652126 | 158652126 | Human | 1 | name |
| 15202095 | CV720277 | single nucleotide variant | NM_024996.7(GFM1):c.1102T>C (p.Leu368=) | GFM1-related disorder [RCV003950391]|Hepatoencephalopathy due to combined oxidative phosphorylation defect type 1 [RCV001272462]|not provided [RCV000891379] | likely benign | 3 | 158658940 | 158658940 | Human | 1 | name , trait , alternate_id |
| 15168199 | CV733888 | single nucleotide variant | NM_024996.7(GFM1):c.1368G>A (p.Lys456=) | Hepatoencephalopathy due to combined oxidative phosphorylation defect type 1 [RCV001272464]|not provided [RCV000904804] | likely benign | 3 | 158662672 | 158662672 | Human | 1 | name |
| 15152469 | CV733889 | single nucleotide variant | NM_024996.7(GFM1):c.1683A>G (p.Pro561=) | not provided [RCV000901572] | likely benign | 3 | 158682076 | 158682076 | Human | | name |
| 15150014 | CV748088 | single nucleotide variant | NM_024996.7(GFM1):c.220G>T (p.Ala74Ser) | GFM1-related disorder [RCV003923302]|Hepatoencephalopathy due to combined oxidative phosphorylation defect type 1 [RCV001272458]|not provided [RCV000923394] | likely benign|uncertain significance | 3 | 158645767 | 158645767 | Human | 1 | name , trait , alternate_id |
| 15113655 | CV748090 | single nucleotide variant | NM_024996.7(GFM1):c.1308C>T (p.Asn436=) | Hepatoencephalopathy due to combined oxidative phosphorylation defect type 1 [RCV001272463]|not provided [RCV000917135] | likely benign | 3 | 158660960 | 158660960 | Human | 1 | name |
| 15138203 | CV748091 | single nucleotide variant | NM_024996.7(GFM1):c.2016T>C (p.His672=) | Hepatoencephalopathy due to combined oxidative phosphorylation defect type 1 [RCV001825858]|not provided [RCV000921294] | benign|likely benign | 3 | 158690269 | 158690269 | Human | 1 | name |
| 15173822 | CV763716 | single nucleotide variant | NM_024996.7(GFM1):c.1110T>C (p.Tyr370=) | not provided [RCV000928367] | likely benign | 3 | 158658948 | 158658948 | Human | | name |
| 15172320 | CV763717 | single nucleotide variant | NM_024996.7(GFM1):c.1242C>T (p.Ala414=) | not provided [RCV000928089] | likely benign | 3 | 158660894 | 158660894 | Human | | name |
| 15125847 | CV763718 | single nucleotide variant | NM_024996.7(GFM1):c.1305C>G (p.Ala435=) | Hepatoencephalopathy due to combined oxidative phosphorylation defect type 1 [RCV001147221]|not provided [RCV000941272] | likely benign|uncertain significance | 3 | 158660957 | 158660957 | Human | 1 | name |
| 15181531 | CV763719 | single nucleotide variant | NM_024996.7(GFM1):c.1704A>G (p.Glu568=) | not provided [RCV000930149] | likely benign | 3 | 158682097 | 158682097 | Human | | name |
| 15196228 | CV763720 | single nucleotide variant | NM_024996.7(GFM1):c.1926A>G (p.Thr642=) | not provided [RCV000934162] | likely benign | 3 | 158690179 | 158690179 | Human | | name |
| 15175415 | CV763721 | single nucleotide variant | NM_024996.7(GFM1):c.2163G>A (p.Gln721=) | not provided [RCV000928670] | likely benign | 3 | 158691374 | 158691374 | Human | | name |
| 15191510 | CV763722 | single nucleotide variant | NM_024996.7(GFM1):c.2232T>C (p.Val744=) | not provided [RCV000932821] | likely benign | 3 | 158691443 | 158691443 | Human | | name |
| 15142716 | CV781602 | single nucleotide variant | NM_024996.7(GFM1):c.1116C>T (p.Arg372=) | not provided [RCV000983205] | likely benign | 3 | 158658954 | 158658954 | Human | | name |
| 15117346 | CV781603 | single nucleotide variant | NM_024996.7(GFM1):c.1362A>G (p.Ala454=) | not provided [RCV000978748] | likely benign | 3 | 158662666 | 158662666 | Human | | name |
| 15129504 | CV781604 | single nucleotide variant | NM_024996.7(GFM1):c.1656A>G (p.Val552=) | not provided [RCV000980888] | likely benign | 3 | 158682049 | 158682049 | Human | | name |
| 15107305 | CV781605 | single nucleotide variant | NM_024996.7(GFM1):c.1722C>T (p.Phe574=) | not provided [RCV000976800] | likely benign | 3 | 158682115 | 158682115 | Human | | name |
| 15124977 | CV781606 | single nucleotide variant | NM_024996.7(GFM1):c.1830C>T (p.Val610=) | Hepatoencephalopathy due to combined oxidative phosphorylation defect type 1 [RCV001832275]|not provided [RCV000980112] | likely benign | 3 | 158684589 | 158684589 | Human | 1 | name |
| 21404288 | CV800333 | single nucleotide variant | NM_024996.7(GFM1):c.100C>T (p.Arg34Ter) | Hepatoencephalopathy due to combined oxidative phosphorylation defect type 1 [RCV001002683]|not provided [RCV002549188] | pathogenic|likely pathogenic | 3 | 158645647 | 158645647 | Human | 1 | name |
| 21404280 | CV800334 | single nucleotide variant | NM_024996.7(GFM1):c.248A>T (p.Asp83Val) | Hepatoencephalopathy due to combined oxidative phosphorylation defect type 1 [RCV001002680]|not provided [RCV003769390]|not specified [RCV004702570] | pathogenic|likely pathogenic|uncertain significance | 3 | 158646178 | 158646178 | Human | 1 | name |
| 38460563 | CV931813 | duplication | NM_024996.7(GFM1):c.486dup (p.Lys163fs) | not provided [RCV001211855] | pathogenic | 3 | 158646860 | 158646861 | Human | | name |
| 40906631 | CV977816 | single nucleotide variant | NM_024996.7(GFM1):c.221C>G (p.Ala74Gly) | Hepatoencephalopathy due to combined oxidative phosphorylation defect type 1 [RCV001280043] | uncertain significance | 3 | 158645768 | 158645768 | Human | 1 | name |
| 126740227 | CV1016194 | single nucleotide variant | NM_024996.7(GFM1):c.408A>T (p.Arg136Ser) | Hepatoencephalopathy due to combined oxidative phosphorylation defect type 1 [RCV001329387] | uncertain significance | 3 | 158646783 | 158646783 | Human | 1 | name |
| 127262956 | CV1059669 | deletion | NM_024996.7(GFM1):c.1346del (p.Pro449fs) | not provided [RCV001380852] | pathogenic | 3 | 158662649 | 158662649 | Human | | name |
| 127234267 | CV1108807 | single nucleotide variant | NM_024996.7(GFM1):c.409G>A (p.Val137Met) | Hepatoencephalopathy due to combined oxidative phosphorylation defect type 1 [RCV001449659] | pathogenic|likely pathogenic | 3 | 158646784 | 158646784 | Human | 1 | name |
| 150429566 | CV1189280 | single nucleotide variant | NM_024996.7(GFM1):c.344A>G (p.Asn115Ser) | Hepatoencephalopathy due to combined oxidative phosphorylation defect type 1 [RCV001563841]|Inborn genetic diseases [RCV002568428]|not provided [RCV002072149] | likely benign|uncertain significance | 3 | 158646274 | 158646274 | Human | 2 | name |
| 150544345 | CV1313288 | deletion | NM_024996.7(GFM1):c.1510del (p.Tyr504fs) | Hepatoencephalopathy due to combined oxidative phosphorylation defect type 1 [RCV001783359] | pathogenic | 3 | 158665466 | 158665466 | Human | 1 | name |
| 151811749 | CV1376751 | deletion | NM_024996.7(GFM1):c.1217del (p.Met406fs) | not provided [RCV001900022] | pathogenic | 3 | 158659055 | 158659055 | Human | | name |
| 151834519 | CV1384956 | single nucleotide variant | NM_024996.7(GFM1):c.928T>G (p.Leu310Val) | Inborn genetic diseases [RCV005343188]|not provided [RCV001956014] | uncertain significance | 3 | 158653397 | 158653397 | Human | 1 | name |
| 151865072 | CV1405948 | single nucleotide variant | NM_024996.7(GFM1):c.898G>A (p.Ala300Thr) | not provided [RCV001959726] | uncertain significance | 3 | 158653367 | 158653367 | Human | | name |
| 8691207 | CV141167 | single nucleotide variant | NM_024996.7(GFM1):c.476A>G (p.Asn159Ser) | Hepatoencephalopathy due to combined oxidative phosphorylation defect type 1 [RCV000999807]|not provided [RCV000224568]|not specified [RCV000125225] | benign|likely benign | 3 | 158646851 | 158646851 | Human | 1 | name |
| 8691208 | CV141168 | single nucleotide variant | NM_024996.7(GFM1):c.568A>C (p.Met190Leu) | Hepatoencephalopathy due to combined oxidative phosphorylation defect type 1 [RCV000368039]|not provided [RCV000224632]|not specified [RCV000125226] | benign|likely benign|uncertain significance | 3 | 158646943 | 158646943 | Human | 1 | name |
| 151810708 | CV1417379 | single nucleotide variant | NM_024996.7(GFM1):c.626G>A (p.Gly209Asp) | not provided [RCV002028944] | uncertain significance | 3 | 158649094 | 158649094 | Human | | name |
| 151745926 | CV1428227 | deletion | NM_024996.7(GFM1):c.1172del (p.Lys391fs) | Hepatoencephalopathy due to combined oxidative phosphorylation defect type 1 [RCV003471067]|not provided [RCV001926961] | pathogenic|likely pathogenic | 3 | 158659008 | 158659008 | Human | 1 | name |
| 151884131 | CV1428542 | single nucleotide variant | NM_024996.7(GFM1):c.850C>T (p.Arg284Ter) | Hepatoencephalopathy due to combined oxidative phosphorylation defect type 1 [RCV003471142]|not provided [RCV002000204] | pathogenic|likely pathogenic | 3 | 158653319 | 158653319 | Human | 1 | name |
| 151790768 | CV1436152 | deletion | NM_024996.7(GFM1):c.1878del (p.Phe626fs) | not provided [RCV001990059] | pathogenic | 3 | 158684637 | 158684637 | Human | | name |
| 151756271 | CV1449341 | single nucleotide variant | NM_024996.7(GFM1):c.491G>A (p.Arg164His) | not provided [RCV001986779] | uncertain significance | 3 | 158646866 | 158646866 | Human | | name |
| 151844551 | CV1457853 | single nucleotide variant | NM_024996.7(GFM1):c.335A>G (p.Lys112Arg) | not provided [RCV001936531] | uncertain significance | 3 | 158646265 | 158646265 | Human | | name |
| 151760159 | CV1459382 | single nucleotide variant | NM_024996.7(GFM1):c.910A>G (p.Lys304Glu) | Hepatoencephalopathy due to combined oxidative phosphorylation defect type 1 [RCV005023284]|not provided [RCV002044178] | likely pathogenic | 3 | 158653379 | 158653379 | Human | 1 | name |
| 151887216 | CV1464495 | single nucleotide variant | NM_024996.7(GFM1):c.532C>T (p.Arg178Ter) | Hepatoencephalopathy due to combined oxidative phosphorylation defect type 1 [RCV003464305]|not provided [RCV001942340] | pathogenic|likely pathogenic | 3 | 158646907 | 158646907 | Human | 1 | name |
| 151787838 | CV1471467 | duplication | NM_024996.7(GFM1):c.1015dup (p.Thr339fs) | not provided [RCV001972741] | pathogenic | 3 | 158654559 | 158654560 | Human | | name |
| 151807907 | CV1477712 | deletion | NM_024996.7(GFM1):c.89_99del (p.Trp30fs) | Hepatoencephalopathy due to combined oxidative phosphorylation defect type 1 [RCV003146413]|not provided [RCV001953530] | pathogenic|likely pathogenic | 3 | 158645636 | 158645646 | Human | 1 | name |
| 152029582 | CV1568345 | single nucleotide variant | NM_024996.7(GFM1):c.988A>G (p.Asn330Asp) | not provided [RCV002105636] | likely benign | 3 | 158653457 | 158653457 | Human | | name |
| 156347866 | CV1868525 | single nucleotide variant | NM_024996.7(GFM1):c.490C>T (p.Arg164Cys) | not provided [RCV003064618] | uncertain significance | 3 | 158646865 | 158646865 | Human | | name |
| 155987891 | CV1884163 | single nucleotide variant | NM_024996.7(GFM1):c.662G>A (p.Arg221Gln) | Inborn genetic diseases [RCV004985175]|not provided [RCV003075974] | uncertain significance | 3 | 158649130 | 158649130 | Human | 1 | name |
| 156406180 | CV1894783 | duplication | NM_024996.7(GFM1):c.1632dup (p.Gly545fs) | Hepatoencephalopathy due to combined oxidative phosphorylation defect type 1 [RCV003465956]|not provided [RCV003070265] | pathogenic|likely pathogenic | 3 | 158682024 | 158682025 | Human | 1 | name |
| 155941923 | CV1902227 | single nucleotide variant | NM_024996.7(GFM1):c.707G>A (p.Gly236Asp) | not provided [RCV003073598] | uncertain significance | 3 | 158652113 | 158652113 | Human | | name |
| 156294667 | CV1904492 | single nucleotide variant | NM_024996.7(GFM1):c.703T>A (p.Tyr235Asn) | Inborn genetic diseases [RCV004985208]|not provided [RCV002598896] | uncertain significance | 3 | 158652109 | 158652109 | Human | 1 | name |
| 8596314 | CV19199 | single nucleotide variant | NM_024996.7(GFM1):c.521A>G (p.Asn174Ser) | Hepatoencephalopathy due to combined oxidative phosphorylation defect type 1 [RCV000004377]|not provided [RCV000657878] | pathogenic|likely pathogenic | 3 | 158646896 | 158646896 | Human | 1 | name |
| 156389900 | CV1980110 | single nucleotide variant | NM_024996.7(GFM1):c.824C>T (p.Ser275Leu) | not provided [RCV002634889] | uncertain significance | 3 | 158652230 | 158652230 | Human | | name |
| 156255083 | CV2041229 | single nucleotide variant | NM_024996.7(GFM1):c.502C>T (p.Pro168Ser) | not provided [RCV002806140] | uncertain significance | 3 | 158646877 | 158646877 | Human | | name |
| 156006275 | CV2041964 | single nucleotide variant | NM_024996.7(GFM1):c.307C>T (p.Gln103Ter) | Hepatoencephalopathy due to combined oxidative phosphorylation defect type 1 [RCV005027946]|not provided [RCV002756445] | pathogenic|likely pathogenic | 3 | 158646237 | 158646237 | Human | 1 | name |
| 156096955 | CV2050910 | single nucleotide variant | NM_024996.7(GFM1):c.931G>A (p.Asp311Asn) | not provided [RCV002824408] | uncertain significance | 3 | 158653400 | 158653400 | Human | | name |
| 156024482 | CV2077945 | deletion | NM_024996.7(GFM1):c.1406del (p.Gly469fs) | not provided [RCV002866766] | pathogenic | 3 | 158665361 | 158665361 | Human | | name |
| 156080937 | CV2083679 | single nucleotide variant | NM_024996.7(GFM1):c.604C>T (p.Gln202Ter) | not provided [RCV002847382] | pathogenic | 3 | 158649072 | 158649072 | Human | | name |
| 156105243 | CV2084365 | deletion | NM_024996.7(GFM1):c.1589del (p.Thr530fs) | not provided [RCV002848233] | pathogenic | 3 | 158666374 | 158666374 | Human | | name |
| 156335312 | CV2099370 | single nucleotide variant | NM_024996.7(GFM1):c.715C>T (p.Pro239Ser) | not provided [RCV002900169] | uncertain significance | 3 | 158652121 | 158652121 | Human | | name |
| 156245775 | CV2105624 | duplication | NM_024996.7(GFM1):c.1831dup (p.Leu611fs) | Hepatoencephalopathy due to combined oxidative phosphorylation defect type 1 [RCV005028031]|not provided [RCV002933367] | pathogenic|likely pathogenic | 3 | 158684588 | 158684589 | Human | 1 | name |
| 10410599 | CV210956 | single nucleotide variant | NM_024996.7(GFM1):c.622G>A (p.Glu208Lys) | Hepatoencephalopathy due to combined oxidative phosphorylation defect type 1 [RCV000764473]|not provided [RCV000198516] | likely pathogenic|conflicting interpretations of pathogenicity|uncertain significance | 3 | 158649090 | 158649090 | Human | 1 | name |
| 10411189 | CV210957 | single nucleotide variant | NM_024996.7(GFM1):c.688G>A (p.Gly230Ser) | GFM1-related disorder [RCV003417713]|Hepatoencephalopathy due to combined oxidative phosphorylation defect type 1 [RCV003330568]|not provided [RCV000199744] | pathogenic|likely pathogenic | 3 | 158649156 | 158649156 | Human | 1 | name , trait , alternate_id |
| 10410633 | CV210959 | single nucleotide variant | NM_024996.7(GFM1):c.700C>T (p.Arg234Ter) | Hepatoencephalopathy due to combined oxidative phosphorylation defect type 1 [RCV000995549]|not provided [RCV000198570] | pathogenic|likely pathogenic | 3 | 158652106 | 158652106 | Human | 1 | name |
| 10410980 | CV210960 | single nucleotide variant | NM_024996.7(GFM1):c.731C>T (p.Ala244Val) | not provided [RCV002122403] | likely benign | 3 | 158652137 | 158652137 | Human | | name |
| 10409807 | CV210969 | deletion | NM_024996.7(GFM1):c.1596del (p.Val533fs) | Hepatoencephalopathy due to combined oxidative phosphorylation defect type 1 [RCV003468887]|not provided [RCV000196892] | pathogenic|likely pathogenic | 3 | 158666381 | 158666381 | Human | 1 | name |
| 10410726 | CV210972 | deletion | NM_024996.7(GFM1):c.2232del (p.Gly747fs) | Hepatoencephalopathy due to combined oxidative phosphorylation defect type 1 [RCV001833146]|not provided [RCV000198766] | pathogenic|likely pathogenic|uncertain significance | 3 | 158691442 | 158691442 | Human | 1 | name |
| 156318316 | CV2137878 | single nucleotide variant | NM_024996.7(GFM1):c.595G>T (p.Ala199Ser) | Inborn genetic diseases [RCV003170768]|not provided [RCV002963035] | uncertain significance | 3 | 158649063 | 158649063 | Human | 1 | name |
| 156081545 | CV2138224 | single nucleotide variant | NM_024996.7(GFM1):c.796G>T (p.Glu266Ter) | not provided [RCV002979277] | pathogenic | 3 | 158652202 | 158652202 | Human | | name |
| 155980875 | CV2140415 | single nucleotide variant | NM_024996.7(GFM1):c.406A>G (p.Arg136Gly) | not provided [RCV002996092] | uncertain significance | 3 | 158646781 | 158646781 | Human | | name |
| 155929475 | CV2155726 | single nucleotide variant | NM_024996.7(GFM1):c.817A>G (p.Ile273Val) | not provided [RCV003013561] | uncertain significance | 3 | 158652223 | 158652223 | Human | | name |
| 156323406 | CV2163031 | single nucleotide variant | NM_024996.7(GFM1):c.332G>A (p.Trp111Ter) | not provided [RCV003029326] | pathogenic | 3 | 158646262 | 158646262 | Human | | name |
| 156339055 | CV2179621 | deletion | NM_024996.7(GFM1):c.1634del (p.Gly545fs) | not provided [RCV003030184] | pathogenic | 3 | 158682026 | 158682026 | Human | | name |
| 156312776 | CV2196415 | single nucleotide variant | NM_024996.7(GFM1):c.551C>T (p.Ala184Val) | Inborn genetic diseases [RCV002648298] | uncertain significance | 3 | 158646926 | 158646926 | Human | 1 | name |
| 156276409 | CV2255784 | single nucleotide variant | NM_024996.7(GFM1):c.319A>G (p.Thr107Ala) | Inborn genetic diseases [RCV002792804] | uncertain significance | 3 | 158646249 | 158646249 | Human | 1 | name |
| 156026967 | CV2271124 | single nucleotide variant | NM_024996.7(GFM1):c.980C>G (p.Ala327Gly) | Inborn genetic diseases [RCV002845093] | uncertain significance | 3 | 158653449 | 158653449 | Human | 1 | name |
| 156266786 | CV2305592 | single nucleotide variant | NM_024996.7(GFM1):c.631T>C (p.Phe211Leu) | Inborn genetic diseases [RCV002920851] | uncertain significance | 3 | 158649099 | 158649099 | Human | 1 | name |
| 243052275 | CV2412625 | single nucleotide variant | NM_024996.7(GFM1):c.830C>T (p.Ser277Phe) | Hepatoencephalopathy due to combined oxidative phosphorylation defect type 1 [RCV003131016] | uncertain significance | 3 | 158652236 | 158652236 | Human | 1 | name |
| 243050987 | CV2415598 | single nucleotide variant | NM_024996.7(GFM1):c.754G>A (p.Glu252Lys) | Hepatoencephalopathy due to combined oxidative phosphorylation defect type 1 [RCV003148198] | uncertain significance | 3 | 158652160 | 158652160 | Human | 1 | name |
| 243051496 | CV2415933 | single nucleotide variant | NM_024996.7(GFM1):c.575C>A (p.Ser192Tyr) | Hepatoencephalopathy due to combined oxidative phosphorylation defect type 1 [RCV003148553] | uncertain significance | 3 | 158649043 | 158649043 | Human | 1 | name |
| 243053314 | CV2418137 | single nucleotide variant | NM_024996.7(GFM1):c.679G>A (p.Gly227Arg) | Hepatoencephalopathy due to combined oxidative phosphorylation defect type 1 [RCV003153203] | uncertain significance | 3 | 158649147 | 158649147 | Human | 1 | name |
| 329358873 | CV2454335 | single nucleotide variant | NM_024996.7(GFM1):c.982A>G (p.Ile328Val) | Inborn genetic diseases [RCV003204080] | uncertain significance | 3 | 158653451 | 158653451 | Human | 1 | name |
| 401897548 | CV2787010 | single nucleotide variant | NM_024996.7(GFM1):c.379T>C (p.Phe127Leu) | Inborn genetic diseases [RCV003375051] | uncertain significance | 3 | 158646754 | 158646754 | Human | 1 | name |
| 401934668 | CV2800499 | single nucleotide variant | NM_024996.7(GFM1):c.851G>A (p.Arg284Gln) | GFM1-related disorder [RCV003412009] | uncertain significance | 3 | 158653320 | 158653320 | Human | | name , trait , alternate_id |
| 401943309 | CV2836007 | single nucleotide variant | NM_024996.7(GFM1):c.787C>T (p.Gln263Ter) | Hepatoencephalopathy due to combined oxidative phosphorylation defect type 1 [RCV003468267]|not provided [RCV003699108] | pathogenic|likely pathogenic | 3 | 158652193 | 158652193 | Human | 1 | name |
| 401941375 | CV2836010 | single nucleotide variant | NM_024996.7(GFM1):c.705T>G (p.Tyr235Ter) | Hepatoencephalopathy due to combined oxidative phosphorylation defect type 1 [RCV003461692] | likely pathogenic | 3 | 158652111 | 158652111 | Human | 1 | name |
| 401941382 | CV2836020 | single nucleotide variant | NM_024996.7(GFM1):c.929T>G (p.Leu310Ter) | Hepatoencephalopathy due to combined oxidative phosphorylation defect type 1 [RCV003461699] | likely pathogenic | 3 | 158653398 | 158653398 | Human | 1 | name |
| 401942942 | CV2836023 | duplication | NM_024996.7(GFM1):c.1157dup (p.Asn386fs) | Hepatoencephalopathy due to combined oxidative phosphorylation defect type 1 [RCV003468274] | likely pathogenic | 3 | 158658993 | 158658994 | Human | 1 | name |
| 401942866 | CV2836027 | deletion | NM_024996.7(GFM1):c.1951del (p.Ala651fs) | Hepatoencephalopathy due to combined oxidative phosphorylation defect type 1 [RCV003468276] | likely pathogenic | 3 | 158690203 | 158690203 | Human | 1 | name |
| 401941385 | CV2836028 | single nucleotide variant | NM_024996.7(GFM1):c.725T>G (p.Leu242Ter) | Hepatoencephalopathy due to combined oxidative phosphorylation defect type 1 [RCV003461702]|not provided [RCV003661061] | pathogenic|likely pathogenic | 3 | 158652131 | 158652131 | Human | 1 | name |
| 401941386 | CV2836029 | duplication | NM_024996.7(GFM1):c.1303dup (p.Ala435fs) | Hepatoencephalopathy due to combined oxidative phosphorylation defect type 1 [RCV003461703] | likely pathogenic | 3 | 158660954 | 158660955 | Human | 1 | name |
| 401941387 | CV2836030 | single nucleotide variant | NM_024996.7(GFM1):c.527T>A (p.Leu176Ter) | Hepatoencephalopathy due to combined oxidative phosphorylation defect type 1 [RCV003461704] | likely pathogenic | 3 | 158646902 | 158646902 | Human | 1 | name |
| 401941388 | CV2836032 | deletion | NM_024996.7(GFM1):c.1799del (p.Ser600fs) | Hepatoencephalopathy due to combined oxidative phosphorylation defect type 1 [RCV003461705] | likely pathogenic | 3 | 158684558 | 158684558 | Human | 1 | name |
| 401941389 | CV2836034 | single nucleotide variant | NM_024996.7(GFM1):c.324C>G (p.Tyr108Ter) | Hepatoencephalopathy due to combined oxidative phosphorylation defect type 1 [RCV003461706] | likely pathogenic | 3 | 158646254 | 158646254 | Human | 1 | name |
| 402477430 | CV2853759 | duplication | NM_024996.7(GFM1):c.1399dup (p.Ser467fs) | not provided [RCV003543609] | pathogenic | 3 | 158665351 | 158665352 | Human | | name |
| 11594727 | CV289258 | single nucleotide variant | NM_024996.7(GFM1):c.373G>A (p.Val125Met) | GFM1-related disorder [RCV004748738]|Hepatoencephalopathy due to combined oxidative phosphorylation defect type 1 [RCV000362292]|not provided [RCV000942298] | likely benign|conflicting interpretations of pathogenicity|uncertain significance | 3 | 158646748 | 158646748 | Human | 1 | name , trait , alternate_id |
| 11591986 | CV289259 | single nucleotide variant | NM_024996.7(GFM1):c.643G>A (p.Val215Ile) | Hepatoencephalopathy due to combined oxidative phosphorylation defect type 1 [RCV000987347]|not provided [RCV000676468]|not specified [RCV001795959] | benign | 3 | 158649111 | 158649111 | Human | 4 | name |
| 11591986 | CV289259 | single nucleotide variant | NM_024996.7(GFM1):c.643G>A (p.Val215Ile) | Hepatoencephalopathy due to combined oxidative phosphorylation defect type 1 [RCV000987347]|not provided [RCV000676468]|not specified [RCV001795959] | benign | 3 | 158649111 | 158649112 | Human | 4 | name |
| 405165454 | CV2905886 | single nucleotide variant | NM_024996.7(GFM1):c.628A>G (p.Asn210Asp) | not provided [RCV003562704] | uncertain significance | 3 | 158649096 | 158649096 | Human | | name |
| 405212904 | CV2984050 | single nucleotide variant | NM_024996.7(GFM1):c.494A>G (p.Tyr165Cys) | not provided [RCV003708864] | uncertain significance | 3 | 158646869 | 158646869 | Human | | name |
| 405170533 | CV3122490 | single nucleotide variant | NM_024996.7(GFM1):c.691C>T (p.Gln231Ter) | not provided [RCV003819079] | pathogenic | 3 | 158652097 | 158652097 | Human | | name |
| 405281559 | CV3224212 | single nucleotide variant | NM_024996.7(GFM1):c.961T>C (p.Ser321Pro) | not specified [RCV003988594] | uncertain significance | 3 | 158653430 | 158653430 | Human | | name |
| 405786573 | CV3258292 | single nucleotide variant | NM_024996.7(GFM1):c.614T>C (p.Met205Thr) | Inborn genetic diseases [RCV004387796] | uncertain significance | 3 | 158649082 | 158649082 | Human | 1 | name |
| 405868976 | CV3400679 | duplication | NM_024996.7(GFM1):c.323dup (p.Tyr108Ter) | Hepatoencephalopathy due to combined oxidative phosphorylation defect type 1 [RCV004576682] | likely pathogenic | 3 | 158646252 | 158646253 | Human | 1 | name |
| 407512860 | CV3433019 | single nucleotide variant | NM_024996.7(GFM1):c.479G>A (p.Arg160His) | Inborn genetic diseases [RCV004626936] | uncertain significance | 3 | 158646854 | 158646854 | Human | 1 | name |
| 597871103 | CV3805951 | deletion | NM_024996.7(GFM1):c.2068del (p.Asp690fs) | not provided [RCV005148361] | pathogenic | 3 | 158690321 | 158690321 | Human | | name |
| 597876586 | CV3859941 | single nucleotide variant | NM_024996.7(GFM1):c.964G>A (p.Glu322Lys) | not provided [RCV005198349] | uncertain significance | 3 | 158653433 | 158653433 | Human | | name |
| 8602269 | CV39555 | single nucleotide variant | NM_024996.7(GFM1):c.748C>T (p.Arg250Trp) | Combined oxidative phosphorylation deficiency [RCV000851197]|Hepatoencephalopathy due to combined oxidative phosphorylation defect type 1 [RCV000023564]|See cases [RCV003156063]|not provided [RCV000800330] | pathogenic|likely pathogenic | 3 | 158652154 | 158652154 | Human | 2 | name |
| 617152750 | CV4018380 | single nucleotide variant | NM_024996.7(GFM1):c.640A>T (p.Ile214Phe) | not specified [RCV005418640] | uncertain significance | 3 | 158649108 | 158649108 | Human | | name |
| 12906536 | CV414920 | single nucleotide variant | NM_024996.7(GFM1):c.776A>G (p.Asn259Ser) | not provided [RCV000489339] | likely pathogenic|conflicting interpretations of pathogenicity | 3 | 158652182 | 158652182 | Human | | name |
| 13528243 | CV513259 | single nucleotide variant | NM_024996.7(GFM1):c.395A>C (p.Glu132Ala) | Hepatoencephalopathy due to combined oxidative phosphorylation defect type 1 [RCV000625929] | likely pathogenic | 3 | 158646770 | 158646770 | Human | 1 | name |
| 13705927 | CV536641 | single nucleotide variant | NM_024996.7(GFM1):c.455A>C (p.Gln152Pro) | not provided [RCV000658473] | likely pathogenic|conflicting interpretations of pathogenicity | 3 | 158646830 | 158646830 | Human | | name |
| 15184721 | CV720276 | single nucleotide variant | NM_024996.7(GFM1):c.788A>G (p.Gln263Arg) | GFM1-related disorder [RCV003968054]|Hepatoencephalopathy due to combined oxidative phosphorylation defect type 1 [RCV001272460]|not provided [RCV000886511] | benign|likely benign | 3 | 158652194 | 158652194 | Human | 1 | name , trait , alternate_id |
| 15120722 | CV748089 | single nucleotide variant | NM_024996.7(GFM1):c.667A>G (p.Ile223Val) | GFM1-related disorder [RCV003960371]|Hepatoencephalopathy due to combined oxidative phosphorylation defect type 1 [RCV001272459]|not provided [RCV000918367] | likely benign|conflicting interpretations of pathogenicity|uncertain significance | 3 | 158649135 | 158649135 | Human | 1 | name , trait , alternate_id |
| 28912120 | CV800335 | single nucleotide variant | NM_024996.7(GFM1):c.958C>G (p.Pro320Ala) | Hepatoencephalopathy due to combined oxidative phosphorylation defect type 1 [RCV001002678] | pathogenic | 3 | 158653427 | 158653427 | Human | 1 | name |
| 21404278 | CV800338 | deletion | NM_024996.7(GFM1):c.1404del (p.Gly469fs) | Hepatoencephalopathy due to combined oxidative phosphorylation defect type 1 [RCV001002677]|not provided [RCV001869432] | pathogenic | 3 | 158665357 | 158665357 | Human | 1 | name |
| 26899224 | CV827644 | single nucleotide variant | NM_024996.7(GFM1):c.661C>T (p.Arg221Ter) | Hepatoencephalopathy due to combined oxidative phosphorylation defect type 1 [RCV003462600]|not provided [RCV001067025] | pathogenic | 3 | 158649129 | 158649129 | Human | 1 | name |
| 26902536 | CV857615 | single nucleotide variant | NM_024996.7(GFM1):c.952C>T (p.Pro318Ser) | Hepatoencephalopathy due to combined oxidative phosphorylation defect type 1 [RCV001089485]|not specified [RCV004702633] | likely pathogenic|uncertain significance | 3 | 158653421 | 158653421 | Human | 1 | name |
| 28876049 | CV858765 | single nucleotide variant | NM_024996.7(GFM1):c.749G>A (p.Arg250Gln) | Developmental regression [RCV001090179]|not provided [RCV002555936]|not specified [RCV004526801] | likely pathogenic|uncertain significance | 3 | 158652155 | 158652155 | Human | 1 | name |
| 28881227 | CV888244 | single nucleotide variant | NM_024996.7(GFM1):c.596C>T (p.Ala199Val) | Hepatoencephalopathy due to combined oxidative phosphorylation defect type 1 [RCV001149555] | uncertain significance | 3 | 158649064 | 158649064 | Human | 1 | name |
| 28870224 | CV888245 | single nucleotide variant | NM_024996.7(GFM1):c.701G>A (p.Arg234Gln) | Hepatoencephalopathy due to combined oxidative phosphorylation defect type 1 [RCV001145270] | uncertain significance | 3 | 158652107 | 158652107 | Human | 1 | name |
| 38459528 | CV918810 | single nucleotide variant | NM_024996.7(GFM1):c.607A>G (p.Ile203Val) | Hepatoencephalopathy due to combined oxidative phosphorylation defect type 1 [RCV001195913] | uncertain significance | 3 | 158649075 | 158649075 | Human | 1 | name |
| 38463403 | CV918811 | single nucleotide variant | NM_024996.7(GFM1):c.881C>T (p.Pro294Leu) | Hepatoencephalopathy due to combined oxidative phosphorylation defect type 1 [RCV001199013] | uncertain significance | 3 | 158653350 | 158653350 | Human | 1 | name |
| 38476813 | CV931812 | single nucleotide variant | NM_024996.7(GFM1):c.324C>A (p.Tyr108Ter) | Hepatoencephalopathy due to combined oxidative phosphorylation defect type 1 [RCV004570433]|not provided [RCV001204850] | pathogenic|likely pathogenic | 3 | 158646254 | 158646254 | Human | 1 | name |
| 40906632 | CV977817 | single nucleotide variant | NM_024996.7(GFM1):c.443T>C (p.Val148Ala) | Hepatoencephalopathy due to combined oxidative phosphorylation defect type 1 [RCV001280044]|Inborn genetic diseases [RCV004978236]|not provided [RCV003481048] | uncertain significance | 3 | 158646818 | 158646818 | Human | 2 | name |
| 40906633 | CV977818 | single nucleotide variant | NM_024996.7(GFM1):c.616G>T (p.Gly206Cys) | Hepatoencephalopathy due to combined oxidative phosphorylation defect type 1 [RCV001280045] | uncertain significance | 3 | 158649084 | 158649084 | Human | 1 | name |
| 42722805 | CV985200 | deletion | NM_024996.7(GFM1):c.1424del (p.Arg475fs) | Hepatoencephalopathy due to combined oxidative phosphorylation defect type 1 [RCV003459761]|See cases [RCV003156151]|not provided [RCV002616147] | pathogenic|likely pathogenic | 3 | 158665380 | 158665380 | Human | 1 | name |
| 126740223 | CV1016196 | single nucleotide variant | NM_024996.7(GFM1):c.1324G>T (p.Glu442Ter) | Hepatoencephalopathy due to combined oxidative phosphorylation defect type 1 [RCV001329386] | pathogenic | 3 | 158662628 | 158662628 | Human | 1 | name |
| 126911063 | CV1037334 | single nucleotide variant | NM_024996.7(GFM1):c.1936C>T (p.Leu646Phe) | not provided [RCV001354979] | uncertain significance | 3 | 158690189 | 158690189 | Human | | name |
| 127252181 | CV1055317 | single nucleotide variant | NM_024996.7(GFM1):c.2012G>A (p.Arg671His) | not provided [RCV001378703] | likely pathogenic|likely benign | 3 | 158690265 | 158690265 | Human | | name |
| 127268764 | CV1059668 | single nucleotide variant | NM_024996.7(GFM1):c.1090C>T (p.Arg364Ter) | Hepatoencephalopathy due to combined oxidative phosphorylation defect type 1 [RCV003463027]|not provided [RCV001389333] | pathogenic|likely pathogenic | 3 | 158658928 | 158658928 | Human | 1 | name |
| 127266169 | CV1059671 | single nucleotide variant | NM_024996.7(GFM1):c.1576C>T (p.Arg526Ter) | Hepatoencephalopathy due to combined oxidative phosphorylation defect type 1 [RCV001831380]|not provided [RCV001381644] | pathogenic|likely pathogenic | 3 | 158666361 | 158666361 | Human | 1 | name |
| 127239509 | CV1108773 | single nucleotide variant | NM_024996.7(GFM1):c.1823G>A (p.Arg608Gln) | Hepatoencephalopathy due to combined oxidative phosphorylation defect type 1 [RCV001449604]|not provided [RCV001865913] | pathogenic|likely pathogenic|uncertain significance | 3 | 158684582 | 158684582 | Human | 1 | name |
| 150425939 | CV1183292 | single nucleotide variant | NM_024996.7(GFM1):c.1256C>T (p.Ala419Val) | Hepatoencephalopathy due to combined oxidative phosphorylation defect type 1 [RCV001832761]|Inborn genetic diseases [RCV002568379]|not provided [RCV001558686] | uncertain significance | 3 | 158660908 | 158660908 | Human | 2 | name |
| 150434452 | CV1243954 | single nucleotide variant | NM_024996.7(GFM1):c.2143A>G (p.Met715Val) | Hepatoencephalopathy due to combined oxidative phosphorylation defect type 1 [RCV001827557]|not provided [RCV001665161] | conflicting interpretations of pathogenicity|uncertain significance | 3 | 158691354 | 158691354 | Human | 1 | name |
| 150548797 | CV1294520 | single nucleotide variant | NM_024996.7(GFM1):c.1814C>T (p.Ser605Phe) | not provided [RCV001752012] | uncertain significance | 3 | 158684573 | 158684573 | Human | | name |
| 151803056 | CV1354442 | single nucleotide variant | NM_024996.7(GFM1):c.1199G>C (p.Arg400Pro) | not provided [RCV001867300]|not specified [RCV003331220] | uncertain significance | 3 | 158659037 | 158659037 | Human | | name |
| 151856578 | CV1387648 | single nucleotide variant | NM_024996.7(GFM1):c.1814C>G (p.Ser605Cys) | not provided [RCV001996608] | uncertain significance | 3 | 158684573 | 158684573 | Human | | name |
| 8691209 | CV141169 | single nucleotide variant | NM_024996.7(GFM1):c.1990G>A (p.Val664Ile) | Hepatoencephalopathy due to combined oxidative phosphorylation defect type 1 [RCV000999813]|not provided [RCV000676471]|not specified [RCV000125227] | benign|likely benign|conflicting interpretations of pathogenicity | 3 | 158690243 | 158690243 | Human | 1 | name |
| 151723320 | CV1414135 | single nucleotide variant | NM_024996.7(GFM1):c.1792C>T (p.Pro598Ser) | not provided [RCV002020476] | uncertain significance | 3 | 158684551 | 158684551 | Human | | name |
| 151883680 | CV1432195 | single nucleotide variant | NM_024996.7(GFM1):c.1882C>T (p.Arg628Ter) | Hepatoencephalopathy due to combined oxidative phosphorylation defect type 1 [RCV003471141]|not provided [RCV002000104] | pathogenic|likely pathogenic | 3 | 158684641 | 158684641 | Human | 1 | name |
| 151889303 | CV1435857 | single nucleotide variant | NM_024996.7(GFM1):c.1468G>A (p.Glu490Lys) | not provided [RCV001963402] | uncertain significance | 3 | 158665424 | 158665424 | Human | | name |
| 151867582 | CV1451387 | single nucleotide variant | NM_024996.7(GFM1):c.1834C>T (p.Gln612Ter) | not provided [RCV001939353] | pathogenic | 3 | 158684593 | 158684593 | Human | | name |
| 151826795 | CV1467335 | single nucleotide variant | NM_024996.7(GFM1):c.1415G>A (p.Arg472Lys) | Inborn genetic diseases [RCV005343125]|not provided [RCV001901406] | uncertain significance | 3 | 158665371 | 158665371 | Human | 1 | name |
| 151785617 | CV1493958 | single nucleotide variant | NM_024996.7(GFM1):c.1642C>T (p.Gln548Ter) | Hepatoencephalopathy due to combined oxidative phosphorylation defect type 1 [RCV004571752]|not provided [RCV001951507] | pathogenic|likely pathogenic | 3 | 158682035 | 158682035 | Human | 1 | name |
| 151888773 | CV1504438 | single nucleotide variant | NM_024996.7(GFM1):c.1186C>T (p.Gln396Ter) | Hepatoencephalopathy due to combined oxidative phosphorylation defect type 1 [RCV003464329]|not provided [RCV001963289] | pathogenic|likely pathogenic | 3 | 158659024 | 158659024 | Human | 1 | name |
| 151729180 | CV1505328 | single nucleotide variant | NM_024996.7(GFM1):c.1544C>T (p.Pro515Leu) | Inborn genetic diseases [RCV003289392]|not provided [RCV002021112] | uncertain significance | 3 | 158666329 | 158666329 | Human | 1 | name |
| 152122484 | CV1521624 | single nucleotide variant | NM_024996.7(GFM1):c.2129A>G (p.Lys710Arg) | not provided [RCV002135887] | likely benign | 3 | 158691340 | 158691340 | Human | | name |
| 152144736 | CV1651723 | indel | NM_024996.7(GFM1):c.368-13_368-12delinsAA | not provided [RCV002138645] | likely benign | 3 | 158646730 | 158646731 | Human | | name |
| 155670647 | CV1771019 | single nucleotide variant | NM_024996.7(GFM1):c.1484G>C (p.Gly495Ala) | not provided [RCV002297333] | uncertain significance | 3 | 158665440 | 158665440 | Human | | name |
| 155797668 | CV1859457 | single nucleotide variant | NM_024996.7(GFM1):c.1897G>C (p.Ala633Pro) | Hepatoencephalopathy due to combined oxidative phosphorylation defect type 1 [RCV002465084] | uncertain significance | 3 | 158684656 | 158684656 | Human | 1 | name |
| 329954672 | CV1860011 | single nucleotide variant | NM_024996.7(GFM1):c.2167T>C (p.Cys723Arg) | Hepatoencephalopathy due to combined oxidative phosphorylation defect type 1 [RCV003233002] | likely pathogenic | 3 | 158691378 | 158691378 | Human | 1 | name |
| 156263924 | CV1869344 | single nucleotide variant | NM_024996.7(GFM1):c.2009G>A (p.Arg670Gln) | Inborn genetic diseases [RCV005351082]|not provided [RCV003060461] | likely benign|uncertain significance | 3 | 158690262 | 158690262 | Human | 1 | name |
| 155953692 | CV1876511 | single nucleotide variant | NM_024996.7(GFM1):c.1601C>T (p.Pro534Leu) | not provided [RCV003074295] | uncertain significance | 3 | 158666386 | 158666386 | Human | | name |
| 156395822 | CV1877217 | single nucleotide variant | NM_024996.7(GFM1):c.2215A>C (p.Thr739Pro) | Inborn genetic diseases [RCV003068579]|not provided [RCV003068580] | uncertain significance | 3 | 158691426 | 158691426 | Human | 1 | name |
| 156410515 | CV1882558 | single nucleotide variant | NM_024996.7(GFM1):c.1577G>A (p.Arg526Gln) | not provided [RCV003072100] | uncertain significance | 3 | 158666362 | 158666362 | Human | | name |
| 156188880 | CV1882725 | single nucleotide variant | NM_024996.7(GFM1):c.1384G>A (p.Asp462Asn) | not provided [RCV003083807] | uncertain significance | 3 | 158665340 | 158665340 | Human | | name |
| 156179940 | CV1888301 | single nucleotide variant | NM_024996.7(GFM1):c.1324G>C (p.Glu442Gln) | not provided [RCV003083523] | uncertain significance | 3 | 158662628 | 158662628 | Human | | name |
| 156379120 | CV1903255 | single nucleotide variant | NM_024996.7(GFM1):c.1199G>A (p.Arg400His) | not provided [RCV003093129] | uncertain significance | 3 | 158659037 | 158659037 | Human | | name |
| 8596316 | CV19201 | single nucleotide variant | NM_024996.7(GFM1):c.1487T>G (p.Met496Arg) | Hepatoencephalopathy due to combined oxidative phosphorylation defect type 1 [RCV000004379] | pathogenic | 3 | 158665443 | 158665443 | Human | 1 | name |
| 156129183 | CV1924556 | single nucleotide variant | NM_024996.7(GFM1):c.1043A>T (p.Asp348Val) | not provided [RCV002640645] | uncertain significance | 3 | 158654591 | 158654591 | Human | | name |
| 156166584 | CV1959898 | single nucleotide variant | NM_024996.7(GFM1):c.1363A>G (p.Met455Val) | not provided [RCV002573685] | uncertain significance | 3 | 158662667 | 158662667 | Human | | name |
| 156253472 | CV1993633 | single nucleotide variant | NM_024996.7(GFM1):c.2236A>G (p.Lys746Glu) | not provided [RCV002627528] | uncertain significance | 3 | 158691447 | 158691447 | Human | | name |
| 155905691 | CV2007339 | single nucleotide variant | NM_024996.7(GFM1):c.1393A>T (p.Lys465Ter) | not provided [RCV002681379] | pathogenic | 3 | 158665349 | 158665349 | Human | | name |
| 156225644 | CV2048330 | single nucleotide variant | NM_024996.7(GFM1):c.1126G>T (p.Gly376Ter) | not provided [RCV002790803] | pathogenic | 3 | 158658964 | 158658964 | Human | | name |
| 156025835 | CV2055815 | single nucleotide variant | NM_024996.7(GFM1):c.1037G>A (p.Ser346Asn) | not provided [RCV002820841] | uncertain significance | 3 | 158654585 | 158654585 | Human | | name |
| 156053177 | CV2060143 | single nucleotide variant | NM_024996.7(GFM1):c.1914G>T (p.Leu638Phe) | not provided [RCV002796836] | uncertain significance | 3 | 158690167 | 158690167 | Human | | name |
| 156087304 | CV2095198 | single nucleotide variant | NM_024996.7(GFM1):c.1403A>G (p.Lys468Arg) | not provided [RCV002912910] | uncertain significance | 3 | 158665359 | 158665359 | Human | | name |
| 10410153 | CV210962 | single nucleotide variant | NM_024996.7(GFM1):c.1114C>T (p.Arg372Cys) | Inborn genetic diseases [RCV002517220]|not provided [RCV000197604] | likely pathogenic|uncertain significance | 3 | 158658952 | 158658952 | Human | 1 | name |
| 10411325 | CV210963 | single nucleotide variant | NM_024996.7(GFM1):c.1181G>A (p.Arg394Gln) | not provided [RCV000200029] | likely pathogenic | 3 | 158659019 | 158659019 | Human | | name |
| 10409260 | CV210965 | single nucleotide variant | NM_024996.7(GFM1):c.1369C>T (p.Pro457Ser) | not provided [RCV000195753]|not specified [RCV004700590] | likely pathogenic|uncertain significance | 3 | 158662673 | 158662673 | Human | | name |
| 10411701 | CV210966 | single nucleotide variant | NM_024996.7(GFM1):c.1457C>T (p.Thr486Ile) | Inborn genetic diseases [RCV002517219]|not provided [RCV000488200] | likely benign|conflicting interpretations of pathogenicity|uncertain significance | 3 | 158665413 | 158665413 | Human | 1 | name |
| 10411633 | CV210967 | single nucleotide variant | NM_024996.7(GFM1):c.1583C>T (p.Thr528Ile) | not provided [RCV000200666]|not specified [RCV005406931] | likely pathogenic|uncertain significance | 3 | 158666368 | 158666368 | Human | | name |
| 10409898 | CV210970 | single nucleotide variant | NM_024996.7(GFM1):c.2011C>T (p.Arg671Cys) | Hepatoencephalopathy due to combined oxidative phosphorylation defect type 1 [RCV000763507]|not provided [RCV000197077] | pathogenic|likely pathogenic | 3 | 158690264 | 158690264 | Human | 1 | name |
| 10411083 | CV210971 | single nucleotide variant | NM_024996.7(GFM1):c.2165C>T (p.Pro722Leu) | Hepatoencephalopathy due to combined oxidative phosphorylation defect type 1 [RCV001835722]|not provided [RCV000199524] | likely pathogenic|uncertain significance | 3 | 158691376 | 158691376 | Human | 1 | name |
| 156153427 | CV2131905 | single nucleotide variant | NM_024996.7(GFM1):c.1738A>G (p.Lys580Glu) | Inborn genetic diseases [RCV004983247]|not provided [RCV002982735] | uncertain significance | 3 | 158682131 | 158682131 | Human | 1 | name |
| 155988721 | CV2133390 | single nucleotide variant | NM_024996.7(GFM1):c.1294A>G (p.Thr432Ala) | not provided [RCV002996462] | uncertain significance | 3 | 158660946 | 158660946 | Human | | name |
| 156202162 | CV2134733 | single nucleotide variant | NM_024996.7(GFM1):c.1091G>A (p.Arg364Gln) | Inborn genetic diseases [RCV002985257]|not provided [RCV002985256] | uncertain significance | 3 | 158658929 | 158658929 | Human | 1 | name |
| 156030614 | CV2141992 | single nucleotide variant | NM_024996.7(GFM1):c.1585A>G (p.Ile529Val) | Inborn genetic diseases [RCV004632128]|not provided [RCV002976587] | uncertain significance | 3 | 158666370 | 158666370 | Human | 1 | name |
| 155994374 | CV2156156 | single nucleotide variant | NM_024996.7(GFM1):c.1239T>A (p.Tyr413Ter) | not provided [RCV002996717] | pathogenic | 3 | 158660891 | 158660891 | Human | | name |
| 156208684 | CV2160330 | single nucleotide variant | NM_024996.7(GFM1):c.1461G>C (p.Glu487Asp) | not provided [RCV003042248] | uncertain significance | 3 | 158665417 | 158665417 | Human | | name |
| 156115049 | CV2221372 | single nucleotide variant | NM_024996.7(GFM1):c.1046A>G (p.Asn349Ser) | Inborn genetic diseases [RCV002761930] | likely benign | 3 | 158654594 | 158654594 | Human | 1 | name |
| 156168532 | CV2237318 | single nucleotide variant | NM_024996.7(GFM1):c.2215A>G (p.Thr739Ala) | Inborn genetic diseases [RCV002787923] | uncertain significance | 3 | 158691426 | 158691426 | Human | 1 | name |
| 156001284 | CV2391881 | single nucleotide variant | NM_024996.7(GFM1):c.1201A>G (p.Met401Val) | Inborn genetic diseases [RCV002779416] | uncertain significance | 3 | 158659039 | 158659039 | Human | 1 | name |
| 156438338 | CV2401574 | single nucleotide variant | NM_024996.7(GFM1):c.1600C>T (p.Pro534Ser) | not provided [RCV003108278] | uncertain significance | 3 | 158666385 | 158666385 | Human | | name |
| 243050202 | CV2419584 | single nucleotide variant | NM_024996.7(GFM1):c.1213A>G (p.Met405Val) | Inborn genetic diseases [RCV003239327]|not provided [RCV003156516] | uncertain significance | 3 | 158659051 | 158659051 | Human | 1 | name |
| 401761232 | CV2726685 | single nucleotide variant | NM_024996.7(GFM1):c.1684G>C (p.Glu562Gln) | Inborn genetic diseases [RCV003299779] | uncertain significance | 3 | 158682077 | 158682077 | Human | 1 | name |
| 401726588 | CV2736146 | single nucleotide variant | NM_024996.7(GFM1):c.1348G>A (p.Val450Ile) | not provided [RCV003312593] | uncertain significance | 3 | 158662652 | 158662652 | Human | | name |
| 401883853 | CV2764690 | single nucleotide variant | NM_024996.7(GFM1):c.1132C>G (p.Leu378Val) | Inborn genetic diseases [RCV003365978] | uncertain significance | 3 | 158658970 | 158658970 | Human | 1 | name |
| 401925891 | CV2798481 | single nucleotide variant | NM_024996.7(GFM1):c.2155A>G (p.Arg719Gly) | GFM1-related disorder [RCV003405778] | uncertain significance | 3 | 158691366 | 158691366 | Human | | name , trait , alternate_id |
| 401907176 | CV2804649 | single nucleotide variant | NM_024996.7(GFM1):c.1525G>T (p.Glu509Ter) | GFM1-related disorder [RCV003422468]|not provided [RCV003720905] | pathogenic|likely pathogenic | 3 | 158666310 | 158666310 | Human | 1 | name , trait , alternate_id |
| 401941346 | CV2836003 | single nucleotide variant | NM_024996.7(GFM1):c.1516C>T (p.Gln506Ter) | Hepatoencephalopathy due to combined oxidative phosphorylation defect type 1 [RCV003461687] | likely pathogenic | 3 | 158665472 | 158665472 | Human | 1 | name |
| 401943212 | CV2836012 | single nucleotide variant | NM_024996.7(GFM1):c.1193T>C (p.Leu398Pro) | Hepatoencephalopathy due to combined oxidative phosphorylation defect type 1 [RCV003468269]|not specified [RCV004587497] | likely pathogenic|uncertain significance | 3 | 158659031 | 158659031 | Human | 1 | name |
| 401942885 | CV2836036 | single nucleotide variant | NM_024996.7(GFM1):c.1981C>T (p.Gln661Ter) | Hepatoencephalopathy due to combined oxidative phosphorylation defect type 1 [RCV003468280] | likely pathogenic | 3 | 158690234 | 158690234 | Human | 1 | name |
| 404977334 | CV2850163 | single nucleotide variant | NM_024996.7(GFM1):c.1396T>C (p.Phe466Leu) | Hepatoencephalopathy due to combined oxidative phosphorylation defect type 1 [RCV003486088] | uncertain significance | 3 | 158665352 | 158665352 | Human | 1 | name |
| 405219829 | CV2870282 | single nucleotide variant | NM_024996.7(GFM1):c.2041G>C (p.Val681Leu) | not provided [RCV003553713] | uncertain significance | 3 | 158690294 | 158690294 | Human | | name |
| 11595079 | CV289271 | single nucleotide variant | NM_024996.7(GFM1):c.1406G>A (p.Gly469Asp) | Hepatoencephalopathy due to combined oxidative phosphorylation defect type 1 [RCV000366352]|not provided [RCV002520101] | uncertain significance | 3 | 158665362 | 158665362 | Human | 1 | name |
| 11592746 | CV293125 | single nucleotide variant | NM_024996.7(GFM1):c.1343A>G (p.Asp448Gly) | GFM1-related disorder [RCV003957777]|Hepatoencephalopathy due to combined oxidative phosphorylation defect type 1 [RCV000341858]|not provided [RCV000911472] | likely benign|conflicting interpretations of pathogenicity|uncertain significance | 3 | 158662647 | 158662647 | Human | 1 | name , trait , alternate_id |
| 11597558 | CV293546 | single nucleotide variant | NM_024996.7(GFM1):c.1384G>T (p.Asp462Tyr) | Combined oxidative phosphorylation deficiency [RCV000395721]|Hepatoencephalopathy due to combined oxidative phosphorylation defect type 1 [RCV001526738] | uncertain significance | 3 | 158665340 | 158665340 | Human | 2 | name |
| 11652810 | CV293569 | single nucleotide variant | NM_024996.7(GFM1):c.1385A>G (p.Asp462Gly) | Hepatoencephalopathy due to combined oxidative phosphorylation defect type 1 [RCV000306955] | uncertain significance | 3 | 158665341 | 158665341 | Human | 1 | name |
| 402519193 | CV3002366 | duplication | NM_024996.7(GFM1):c.1452dup (p.Asp485Ter) | not provided [RCV003690160] | pathogenic | 3 | 158665405 | 158665406 | Human | | name |
| 405171379 | CV3030188 | single nucleotide variant | NM_024996.7(GFM1):c.1536T>A (p.Tyr512Ter) | not provided [RCV003704710] | pathogenic | 3 | 158666321 | 158666321 | Human | | name |
| 405786562 | CV3258290 | single nucleotide variant | NM_024996.7(GFM1):c.1207G>A (p.Ala403Thr) | Inborn genetic diseases [RCV004387794] | uncertain significance | 3 | 158659045 | 158659045 | Human | 1 | name |
| 405786568 | CV3258291 | single nucleotide variant | NM_024996.7(GFM1):c.1535A>T (p.Tyr512Phe) | Inborn genetic diseases [RCV004387795] | uncertain significance | 3 | 158666320 | 158666320 | Human | 1 | name |
| 405868974 | CV3400678 | single nucleotide variant | NM_024996.7(GFM1):c.1548T>A (p.Cys516Ter) | Hepatoencephalopathy due to combined oxidative phosphorylation defect type 1 [RCV004576681] | likely pathogenic | 3 | 158666333 | 158666333 | Human | 1 | name |
| 405868978 | CV3400680 | single nucleotide variant | NM_024996.7(GFM1):c.2097T>G (p.Tyr699Ter) | Hepatoencephalopathy due to combined oxidative phosphorylation defect type 1 [RCV004576683] | likely pathogenic | 3 | 158691165 | 158691165 | Human | 1 | name |
| 407512867 | CV3433022 | single nucleotide variant | NM_024996.7(GFM1):c.1138A>G (p.Lys380Glu) | Inborn genetic diseases [RCV004626939] | uncertain significance | 3 | 158658976 | 158658976 | Human | 1 | name |
| 408386794 | CV3518546 | single nucleotide variant | NM_024996.7(GFM1):c.1848C>A (p.His616Gln) | not provided [RCV004760864] | uncertain significance | 3 | 158684607 | 158684607 | Human | | name |
| 408392578 | CV3519505 | single nucleotide variant | NM_024996.7(GFM1):c.1511A>G (p.Tyr504Cys) | not provided [RCV004763801] | uncertain significance | 3 | 158665467 | 158665467 | Human | | name |
| 597679369 | CV3688051 | single nucleotide variant | NM_024996.7(GFM1):c.1883G>A (p.Arg628Gln) | Inborn genetic diseases [RCV004982468] | uncertain significance | 3 | 158684642 | 158684642 | Human | 1 | name |
| 597679375 | CV3688052 | single nucleotide variant | NM_024996.7(GFM1):c.1550T>C (p.Ile517Thr) | Inborn genetic diseases [RCV004982469] | uncertain significance | 3 | 158666335 | 158666335 | Human | 1 | name |
| 597679379 | CV3688053 | single nucleotide variant | NM_024996.7(GFM1):c.1967C>T (p.Ala656Val) | Inborn genetic diseases [RCV004982470] | uncertain significance | 3 | 158690220 | 158690220 | Human | 1 | name |
| 598125443 | CV3884003 | single nucleotide variant | NM_024996.7(GFM1):c.2118C>A (p.Cys706Ter) | not provided [RCV005236358] | uncertain significance | 3 | 158691186 | 158691186 | Human | | name |
| 598250573 | CV3967054 | single nucleotide variant | NM_024996.7(GFM1):c.1265G>T (p.Gly422Val) | Inborn genetic diseases [RCV005345736] | uncertain significance | 3 | 158660917 | 158660917 | Human | 1 | name |
| 598220124 | CV3967055 | single nucleotide variant | NM_024996.7(GFM1):c.2172A>T (p.Leu724Phe) | Inborn genetic diseases [RCV005340400] | uncertain significance | 3 | 158691383 | 158691383 | Human | 1 | name |
| 598250577 | CV3967056 | single nucleotide variant | NM_024996.7(GFM1):c.2015A>G (p.His672Arg) | Inborn genetic diseases [RCV005345737] | uncertain significance | 3 | 158690268 | 158690268 | Human | 1 | name |
| 598220128 | CV3967057 | single nucleotide variant | NM_024996.7(GFM1):c.1421C>T (p.Thr474Ile) | Inborn genetic diseases [RCV005340401] | uncertain significance | 3 | 158665377 | 158665377 | Human | 1 | name |
| 616939257 | CV4015587 | single nucleotide variant | NM_024996.7(GFM1):c.1799C>G (p.Ser600Cys) | not provided [RCV005413099] | uncertain significance | 3 | 158684558 | 158684558 | Human | | name |
| 14394181 | CV609503 | single nucleotide variant | NM_024996.7(GFM1):c.1429G>T (p.Asp477Tyr) | Hepatoencephalopathy due to combined oxidative phosphorylation defect type 1 [RCV001825499]|not provided [RCV000757328] | uncertain significance | 3 | 158665385 | 158665385 | Human | 1 | name |
| 21071254 | CV790354 | single nucleotide variant | NM_024996.7(GFM1):c.1781G>A (p.Cys594Tyr) | Hepatoencephalopathy due to combined oxidative phosphorylation defect type 1 [RCV000987348] | uncertain significance | 3 | 158684540 | 158684540 | Human | 1 | name |
| 21071256 | CV790355 | single nucleotide variant | NM_024996.7(GFM1):c.1822C>T (p.Arg608Trp) | Hepatoencephalopathy due to combined oxidative phosphorylation defect type 1 [RCV000987349]|not provided [RCV002550600] | likely pathogenic|uncertain significance | 3 | 158684581 | 158684581 | Human | 1 | name |
| 21404285 | CV800339 | single nucleotide variant | NM_024996.7(GFM1):c.1546T>C (p.Cys516Arg) | Hepatoencephalopathy due to combined oxidative phosphorylation defect type 1 [RCV001002682] | pathogenic | 3 | 158666331 | 158666331 | Human | 1 | name |
| 21404290 | CV800340 | single nucleotide variant | NM_024996.7(GFM1):c.1571C>T (p.Ala524Val) | Hepatoencephalopathy due to combined oxidative phosphorylation defect type 1 [RCV001002684] | pathogenic | 3 | 158666356 | 158666356 | Human | 1 | name |
| 28912121 | CV800341 | single nucleotide variant | NM_024996.7(GFM1):c.1922C>A (p.Ala641Glu) | Hepatoencephalopathy due to combined oxidative phosphorylation defect type 1 [RCV001002679]|not provided [RCV004720762]|not specified [RCV004689951] | pathogenic|likely pathogenic|uncertain significance | 3 | 158690175 | 158690175 | Human | 1 | name |
| 26900472 | CV827646 | single nucleotide variant | NM_024996.7(GFM1):c.2008C>T (p.Arg670Ter) | Hepatoencephalopathy due to combined oxidative phosphorylation defect type 1 [RCV003387961]|not provided [RCV001067859] | pathogenic|likely pathogenic | 3 | 158690261 | 158690261 | Human | 1 | name |
| 28874453 | CV888246 | single nucleotide variant | NM_024996.7(GFM1):c.1118G>A (p.Ser373Asn) | Hepatoencephalopathy due to combined oxidative phosphorylation defect type 1 [RCV001147219] | uncertain significance | 3 | 158658956 | 158658956 | Human | 1 | name |
| 28876710 | CV888247 | single nucleotide variant | NM_024996.7(GFM1):c.1852A>G (p.Met618Val) | Hepatoencephalopathy due to combined oxidative phosphorylation defect type 1 [RCV001148121] | uncertain significance | 3 | 158684611 | 158684611 | Human | 1 | name |
| 28876713 | CV888248 | single nucleotide variant | NM_024996.7(GFM1):c.1948A>G (p.Met650Val) | Hepatoencephalopathy due to combined oxidative phosphorylation defect type 1 [RCV001148122]|Inborn genetic diseases [RCV002557175]|not provided [RCV002559421] | uncertain significance | 3 | 158690201 | 158690201 | Human | 2 | name |
| 38494684 | CV953374 | single nucleotide variant | NM_024996.7(GFM1):c.1180C>T (p.Arg394Trp) | Hepatoencephalopathy due to combined oxidative phosphorylation defect type 1 [RCV001836211]|not provided [RCV001241465] | uncertain significance | 3 | 158659018 | 158659018 | Human | 1 | name |
| 40906635 | CV977820 | single nucleotide variant | NM_024996.7(GFM1):c.1198C>T (p.Arg400Cys) | Hepatoencephalopathy due to combined oxidative phosphorylation defect type 1 [RCV001280047]|not provided [RCV002542941] | uncertain significance | 3 | 158659036 | 158659036 | Human | 1 | name |
| 401943197 | CV2836016 | microsatellite | NM_024996.7(GFM1):c.154_155del (p.Ala53fs) | Hepatoencephalopathy due to combined oxidative phosphorylation defect type 1 [RCV003468270] | likely pathogenic | 3 | 158645699 | 158645700 | Human | | name |
| 401941383 | CV2836024 | duplication | NM_024996.7(GFM1):c.113_116dup (p.Val40fs) | Hepatoencephalopathy due to combined oxidative phosphorylation defect type 1 [RCV003461700] | likely pathogenic | 3 | 158645659 | 158645660 | Human | 1 | name |
| 401941384 | CV2836026 | deletion | NM_024996.7(GFM1):c.114_115del (p.Val40fs) | Hepatoencephalopathy due to combined oxidative phosphorylation defect type 1 [RCV003461701]|not provided [RCV003779037] | pathogenic|likely pathogenic | 3 | 158645661 | 158645662 | Human | 1 | name |
| 405868971 | CV3400677 | microsatellite | NM_024996.7(GFM1):c.287_288del (p.Arg96fs) | Hepatoencephalopathy due to combined oxidative phosphorylation defect type 1 [RCV004576680] | likely pathogenic | 3 | 158646212 | 158646213 | Human | | name |
| 14707610 | CV631017 | deletion | NM_024996.7(GFM1):c.291_292del (p.Gly99fs) | Hepatoencephalopathy due to combined oxidative phosphorylation defect type 1 [RCV003461170]|not provided [RCV000807566] | pathogenic|likely pathogenic | 3 | 158646220 | 158646221 | Human | 1 | name |
| 38477084 | CV931811 | deletion | NM_024996.7(GFM1):c.247_248del (p.Asp83fs) | Hepatoencephalopathy due to combined oxidative phosphorylation defect type 1 [RCV003462686]|not provided [RCV001204932] | pathogenic|likely pathogenic | 3 | 158646176 | 158646177 | Human | 1 | name |
| 12894699 | CV406137 | duplication | NM_024996.7(GFM1):c.166_169dup (p.Ser57Ter) | Hepatoencephalopathy due to combined oxidative phosphorylation defect type 1 [RCV003470574]|not provided [RCV000483794] | pathogenic|likely pathogenic | 3 | 158645709 | 158645710 | Human | 1 | name |
| 14705498 | CV631018 | duplication | NM_024996.7(GFM1):c.401_404dup (p.Arg136fs) | Hepatoencephalopathy due to combined oxidative phosphorylation defect type 1 [RCV004569574]|not provided [RCV000801094] | pathogenic|likely pathogenic | 3 | 158646775 | 158646776 | Human | 1 | name |
| 127235758 | CV1059670 | deletion | NM_024996.7(GFM1):c.1466_1467del (p.Lys489fs) | not provided [RCV001382468] | pathogenic | 3 | 158665421 | 158665422 | Human | | name |
| 127261322 | CV1059672 | deletion | NM_024996.7(GFM1):c.1595_1596del (p.Pro532fs) | not provided [RCV001380497] | pathogenic | 3 | 158666380 | 158666381 | Human | | name |
| 151876858 | CV1360327 | deletion | NM_024996.7(GFM1):c.1096_1099del (p.Gly366fs) | not provided [RCV001907173] | pathogenic | 3 | 158658934 | 158658937 | Human | | name |
| 151760709 | CV1380161 | microsatellite | NM_024996.7(GFM1):c.1532_1533del (p.Glu511fs) | Hepatoencephalopathy due to combined oxidative phosphorylation defect type 1 [RCV003471167]|See cases [RCV002252739]|not provided [RCV001970149] | pathogenic|likely pathogenic | 3 | 158666313 | 158666314 | Human | | name |
| 151768934 | CV1486430 | microsatellite | NM_024996.7(GFM1):c.1874_1875del (p.Ser625fs) | not provided [RCV001914793] | pathogenic | 3 | 158684630 | 158684631 | Human | | name |
| 156112906 | CV2093031 | deletion | NM_024996.7(GFM1):c.1474_1480del (p.Val492fs) | not provided [RCV002913854] | pathogenic | 3 | 158665430 | 158665436 | Human | | name |
| 156297112 | CV2159190 | microsatellite | NM_024996.7(GFM1):c.1470_1471del (p.Glu490fs) | not provided [RCV003045382] | pathogenic | 3 | 158665423 | 158665424 | Human | | name |
| 401941345 | CV2836002 | deletion | NM_024996.7(GFM1):c.1905_1908del (p.Gln636fs) | Hepatoencephalopathy due to combined oxidative phosphorylation defect type 1 [RCV003461686] | likely pathogenic | 3 | 158684662 | 158684665 | Human | 1 | name |
| 401941348 | CV2836005 | deletion | NM_024996.7(GFM1):c.1044_1056del (p.Asn349fs) | Hepatoencephalopathy due to combined oxidative phosphorylation defect type 1 [RCV003461689] | likely pathogenic | 3 | 158654591 | 158654603 | Human | 1 | name |
| 597683384 | CV3720940 | deletion | NM_024996.7(GFM1):c.1527_1530del (p.Arg510fs) | Hepatoencephalopathy due to combined oxidative phosphorylation defect type 1 [RCV005031320] | likely pathogenic | 3 | 158666310 | 158666313 | Human | 1 | name |
| 21404275 | CV800337 | deletion | NM_024996.7(GFM1):c.1297_1300del (p.Asp433fs) | Hepatoencephalopathy due to combined oxidative phosphorylation defect type 1 [RCV001002676]|not provided [RCV001384808] | pathogenic | 3 | 158660946 | 158660949 | Human | 1 | name |
| 26884710 | CV827645 | duplication | NM_024996.7(GFM1):c.1255_1277dup (p.Ser427fs) | Hepatoencephalopathy due to combined oxidative phosphorylation defect type 1 [RCV003462551]|not provided [RCV001052419] | pathogenic|likely pathogenic | 3 | 158660906 | 158660907 | Human | 1 | name |
| 156004765 | CV2166703 | insertion | NM_024996.7(GFM1):c.1623_1624insG (p.Gln542fs) | not provided [RCV003017440] | pathogenic | 3 | 158682016 | 158682017 | Human | | name |
| 151726209 | CV1438135 | insertion | NM_024996.7(GFM1):c.1167_1168insTT (p.Arg390fs) | not provided [RCV001891750] | pathogenic | 3 | 158659005 | 158659006 | Human | | name |
| 402489922 | CV2866608 | indel | NM_024996.7(GFM1):c.841-168_844delinsCTTTCTTCTT | not provided [RCV003572911] | likely pathogenic | 3 | 158653142 | 158653313 | Human | | name |
| 405088719 | CV3024922 | insertion | NM_024996.7(GFM1):c.1026_1027insCC (p.Met343fs) | not provided [RCV003699507] | pathogenic | 3 | 158654574 | 158654575 | Human | | name |
| 156442417 | CV1938645 | deletion | NM_024996.7(GFM1):c.114del (p.Gly39_Val40insTer) | Hepatoencephalopathy due to combined oxidative phosphorylation defect type 1 [RCV003459779]|not provided [RCV003112759] | pathogenic|likely pathogenic|conflicting interpretations of pathogenicity | 3 | 158645661 | 158645661 | Human | 1 | name |
| 401941380 | CV2836018 | indel | NM_024996.7(GFM1):c.362_367delinsTT (p.Thr121fs) | Hepatoencephalopathy due to combined oxidative phosphorylation defect type 1 [RCV003461697] | likely pathogenic | 3 | 158646292 | 158646297 | Human | | name |
| 597946722 | CV3817756 | deletion | NM_024996.7(GFM1):c.929del (p.Leu309_Leu310insTer) | not provided [RCV005160222] | pathogenic | 3 | 158653395 | 158653395 | Human | | name |
| 151738114 | CV1458162 | deletion | NM_024996.7(GFM1):c.2064del (p.Leu687_Tyr688insTer) | not provided [RCV001946822] | pathogenic | 3 | 158690317 | 158690317 | Human | | name |
| 21404283 | CV800336 | deletion | NM_024996.7(GFM1):c.1149_1160del (p.Ile384_Thr387del) | Hepatoencephalopathy due to combined oxidative phosphorylation defect type 1 [RCV001002681] | pathogenic|likely pathogenic | 3 | 158658983 | 158658994 | Human | 1 | name |
| 38467025 | CV953373 | indel | NM_024996.7(GFM1):c.735_747delinsTTAATTAATTAG (p.Ala246_His249delinsTer) | not provided [RCV001247772] | pathogenic | 3 | 158652141 | 158652153 | Human | | name |